Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.153713185178404,0.00312579386801496,0.147586629197095,0.159839741159714,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,42346,-0.530043563641541,0.0121462996790115,-0.553850311012404,-0.506236816270679,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,42611,-0.202609168148753,0.00411764469900002,-0.210679751758793,-0.194538584538713,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,42721,-0.25124485688403,0.00624439546005401,-0.263483871985736,-0.239005841782324,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.150035430311503,0.00314592366516527,0.143869419927779,0.156201440695227,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42676,0.113229871434623,0.00275899652968416,0.107822238236442,0.118637504632804,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,40527,-0.166730000893767,0.00397959588673703,-0.174530008831772,-0.158929992955763,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,42568,-0.168508275770039,0.00406471425579038,-0.176475115711388,-0.16054143582869,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,42644,-0.196743814053225,0.00497434738143662,-0.206493534920841,-0.18699409318561,1.1125369292536e-308
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,42754,-0.19801485009009,0.00502749195745012,-0.207868734326693,-0.188160965853488,1.11253692925372e-308
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,42663,0.0997709455284797,0.00277420958576781,0.0943334947403748,0.105208396316585,1.5447881468387e-270
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,40532,0.0815440230179177,0.00234585530038441,0.0769461466291643,0.0861418994066712,1.14934194082963e-251
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,42587,-0.305791334195611,0.0089948889576168,-0.32342131655254,-0.288161351838682,4.63793495414952e-243
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,40539,0.230768360130477,0.00680069683042057,0.217438994342852,0.244097725918101,1.76939014615535e-240
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PYY,Peptide YY,40116,-0.341363957114259,0.0100726353405797,-0.361106322381795,-0.321621591846722,1.77949969632454e-239
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42495,-0.100572922604965,0.00300343547133609,-0.106459656128783,-0.094686189081146,4.22401011777603e-236
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,40511,-0.27375820763863,0.00815819708906778,-0.289748273933203,-0.257768141344057,1.98374108972076e-235
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,42618,-0.180819090381736,0.00560956033002068,-0.191813828628577,-0.169824352134896,1.23394363653124e-219
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,42636,0.146723632299542,0.00462081019767988,0.137666844312089,0.155780420286994,1.99976266100172e-213
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,-0.104023801164819,0.00338001715118712,-0.110648634781146,-0.0973989675484921,5.57198355172525e-201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,42357,-0.208798020726963,0.00679213457791004,-0.222110604499666,-0.195485436954259,1.78813109842764e-200
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,42721,-0.102809635961908,0.00342164777530832,-0.109516065601512,-0.0961032063223037,4.56583037304217e-192
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42770,0.353626733654036,0.0119733254293791,0.330159015812453,0.37709445149562,7.34277304390135e-186
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,42370,-0.231272631631189,0.00793923832526289,-0.246833538748704,-0.215711724513674,7.5034589958718e-181
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,42754,-0.0806471639925866,0.00290107054089972,-0.08633326225275,-0.0749610657324231,1.85192312355601e-165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0975164259358688,0.00350906930489106,-0.104394201773455,-0.0906386500982823,2.50293511145259e-165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,42569,-0.204029636200116,0.00734776813286509,-0.218431261740532,-0.189628010659701,4.89130814669377e-165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,42636,-0.166582403196804,0.00604471718665508,-0.178430048882648,-0.15473475751096,1.1176473283022e-162
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,42570,-0.0848242911721356,0.00309298418733667,-0.0908865401793155,-0.0787620421649557,3.81551583308632e-161
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,40511,-0.245697228752666,0.00897671761153388,-0.263291595271273,-0.22810286223406,9.14598440914146e-160
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C9,Complement component C9,40532,0.143229484745849,0.00532439006994986,0.132793680208747,0.153665289282951,1.44084143918458e-154
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42721,-0.0873193466224214,0.00327828459329792,-0.0937447844252853,-0.0808939088195575,2.15683066764439e-152
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42585,-0.143880118895649,0.00545372387751119,-0.154569417695571,-0.133190820095727,1.4162831264742e-149
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,-0.213024217281752,0.00815645130976829,-0.229010861848898,-0.197037572714606,1.22131325324899e-146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,42311,-0.136663736559641,0.00523461304065934,-0.146923578119333,-0.126403894999949,1.59465658505599e-146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42705,-0.122289707740318,0.00471511529365025,-0.131531333715873,-0.113048081764764,8.94334079329313e-145
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,42661,-0.210071438644192,0.00811702301865146,-0.225980803760749,-0.194162073527635,3.60130578965833e-144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,40033,0.113210227727846,0.00436871545980553,0.104647545426627,0.121772910029065,1.04539642975057e-143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42357,-0.139181463844247,0.00539488399095824,-0.149755436466525,-0.128607491221969,3.21657099092193e-143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,40013,-0.0832756224609102,0.00323849249658997,-0.0896230677542265,-0.0769281771675939,1.37182977256743e-141
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,42752,0.0913644654374739,0.0035931665887369,0.0843218589235495,0.0984070719513982,2.26485625572568e-139
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,42611,-0.103986104321204,0.00410964861827323,-0.11204101561302,-0.0959311930293889,4.98334283111451e-138
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,42711,-0.350140590090696,0.0138630838171382,-0.377312234372287,-0.322968945809105,1.43217796606143e-137
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FURIN,Furin,42679,-0.0821986797722468,0.00327209051496735,-0.0886119771815828,-0.0757853823629108,3.84940663955359e-136
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,-0.0845251696583652,0.00336855052039638,-0.0911275286783422,-0.0779228106383883,8.04598969540327e-136
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,-0.13988446539003,0.00558186120451224,-0.150824913350874,-0.128944017429186,1.93928399383383e-135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,42794,-0.116322489421574,0.00465956737334607,-0.125455241473333,-0.107189737369816,1.5626694525281e-134
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,41747,-0.105600627348911,0.0042285439906198,-0.113888573570526,-0.0973126811272964,2.20764903644842e-134
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,42711,0.0543897707728391,0.00218779693689555,0.0501016887765238,0.0586778527691544,1.93346140521804e-133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,42794,-0.130371522307458,0.00524716026917741,-0.140655956435046,-0.12008708817987,2.61612321260876e-133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,42655,-0.0833280657783661,0.00338081142839067,-0.0899544561780118,-0.0767016753787204,3.11747214453964e-131
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,42600,-0.25647637927493,0.0104090054441118,-0.276878029945389,-0.23607472860447,3.82202789090537e-131
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40451,-0.135429988987768,0.00553086947030011,-0.146270493149556,-0.12458948482598,4.74856181391582e-129
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42311,-0.134339428356249,0.00550456928972156,-0.145128384164103,-0.123550472548394,1.09445831738474e-128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,-0.169603748087669,0.00700339260963169,-0.183330397602547,-0.155877098572791,7.64222462705986e-127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40283,0.0759364241111512,0.0031446999372355,0.0697728122341696,0.0821000359881328,1.34265571160034e-125
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,42754,-0.0842746510163383,0.00349957127848805,-0.0911338107221748,-0.0774154913105017,1.65968676366447e-125
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,42587,-0.134932096950591,0.00561117792762327,-0.145930005688732,-0.123934188212449,3.95472217092396e-125
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42636,-0.0739805530430674,0.0030868707058427,-0.0800308196265191,-0.0679302864596157,2.49533023554978e-124
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42692,-0.0583292904851821,0.00244191488671925,-0.0631154436631519,-0.0535431373072124,1.51518185912598e-123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,-0.115488256437464,0.00485102519661917,-0.124996265822838,-0.105980247052091,1.04766302355872e-122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,40182,-0.196444301725786,0.00824790980354666,-0.212610204940738,-0.180278398510835,2.67964480421715e-122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,40516,0.0884888027736388,0.00371980577376484,0.0811979834570597,0.0957796220902179,4.21788583743626e-122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,42754,-0.0634901879805565,0.00267769386060927,-0.0687384679473506,-0.0582419080137623,8.27185544986569e-122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,-0.0879246442530613,0.00371430461344001,-0.0952046812954038,-0.0806446072107189,2.06843204115383e-121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,42689,-0.277747986258659,0.011770754580093,-0.300818665235642,-0.254677307281677,1.14514647079321e-120
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,42658,-0.0784098986808019,0.00332557409440063,-0.0849280239058271,-0.0718917734557766,1.76831029517873e-120
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,42636,-0.0808275298974184,0.00344472675696416,-0.0875791943410682,-0.0740758654537687,2.33977799983411e-119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,-0.0981139517569549,0.00418529637954666,-0.106317132660866,-0.0899107708530435,3.63680075380375e-119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42587,-0.189582374557677,0.00812112474780889,-0.205499779063382,-0.173664970051971,3.54414716886962e-118
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,-0.151451204638902,0.0064940929347986,-0.164179626791107,-0.138722782486697,6.53726946819105e-118
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42587,-0.190883384959924,0.00819381766211044,-0.206943267577661,-0.174823502342188,1.04880142931564e-117
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,42594,-0.124151279317047,0.00541027625691783,-0.134755420780606,-0.113547137853488,2.47233848078443e-114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40527,-0.0785832981758346,0.00344550254981462,-0.0853364831734713,-0.071830113178198,1.29512208664852e-112
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42408,-0.109969460088142,0.00483410699019636,-0.119444309788926,-0.100494610387357,2.1042130116452e-112
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,42611,-0.188100568945323,0.00830909373599892,-0.204386392667881,-0.171814745222765,2.21036151780624e-111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,42674,-0.106303372883038,0.00470349258801818,-0.115522218355553,-0.0970845274105222,4.84812970701747e-111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,-0.169193983291628,0.00748498155950635,-0.18386454714826,-0.154523419434995,1.08244158852347e-110
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,42706,-0.0471960609331512,0.00211187617816562,-0.0513353382423558,-0.0430567836239466,1.16431794282091e-108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,42621,0.101280368205115,0.00453395477598664,0.0923938168441807,0.110166919566048,1.47727089959935e-108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,-0.0902875338491912,0.00404295581780308,-0.0982117272520852,-0.0823633404462971,1.61466794787345e-108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42416,-0.185410287692823,0.00833861793835299,-0.201753978851995,-0.169066596533651,1.45426178758264e-107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,42794,-0.0999272187147067,0.0045237333876964,-0.108793736154592,-0.0910607012748218,2.9137126737365e-106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40462,-0.190361439898596,0.00862790326881992,-0.207272130305483,-0.173450749491709,1.20139878527001e-105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,40223,-0.130649971905731,0.00592651031174617,-0.142265932116754,-0.119034011694709,1.9781928061849e-105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42477,-0.332048905999814,0.0151295988250473,-0.361702919696907,-0.302394892302722,6.69749700403309e-105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MME,Neprilysin,42587,-0.179111481754706,0.00819773117404978,-0.195179034855843,-0.163043928653568,5.16699908510113e-104
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,42587,-0.0776594067459697,0.00356888937433678,-0.0846544299196698,-0.0706643835722696,3.36548522318176e-103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MENT,Protein MENT,40283,0.0511720160822047,0.00235013742663053,0.0465657467260088,0.0557782854384005,5.76349916199465e-103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REN,Renin,42636,-0.188137202723343,0.00866379958243795,-0.205118249904921,-0.171156155541764,8.51075317822142e-103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42663,0.0660265421671447,0.00304836530029159,0.0600517461785732,0.0720013381557162,2.71775549163506e-102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42711,-0.0775527042146659,0.00358599663217021,-0.0845812576137196,-0.0705241508156123,5.36581479352676e-102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,40532,0.110000589630644,0.00512292484509954,0.0999596569342484,0.120041522327039,2.77145634229491e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,42754,-0.0663817564016528,0.00310349758018853,-0.0724646116588223,-0.0602989011444833,7.43831869467859e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,40267,-0.0807956199674076,0.00377582466200657,-0.0881962363049405,-0.0733950036298748,1.42135641401408e-99
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,-0.12603071914761,0.0059151763932242,-0.137624464878329,-0.11443697341689,4.4514533038061e-99
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42733,-0.0674953343540045,0.00317688462946721,-0.0737220282277603,-0.0612686404802488,1.45497885785256e-98
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,42611,0.082360119386921,0.00388355089093997,0.0747483596406786,0.0899718791331633,3.30987096720939e-98
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,42587,-0.0908555409166929,0.00431444604745425,-0.0993118551697032,-0.0823992266636825,7.05928492248182e-97
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,-0.0820270720755588,0.00392701520191999,-0.0897240218713219,-0.0743301222797956,2.32568587940168e-95
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,-0.159034493248118,0.00761374403395677,-0.173957431554674,-0.144111554941563,4.29239533122247e-95
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,42754,-0.0692457016913948,0.00333392281259488,-0.0757801904040808,-0.0627112129787089,2.36267923792823e-94
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42689,0.0705184426531618,0.00340330122036527,0.0638479722612459,0.0771889130450777,6.50076339665595e-94
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,42721,0.0748932601629726,0.00364355480106296,0.0677518927528892,0.082034627573056,1.78611938904232e-92
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,-0.0969702526877068,0.0047168685678179,-0.10621531508063,-0.0877251902947837,3.37125138612253e-92
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,42620,-0.0665904501714855,0.00326629124057562,-0.0729923810030137,-0.0601885193399573,5.15945147436047e-91
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42679,-0.0460650259736526,0.00226356946486115,-0.0505016221247804,-0.0416284298225247,1.05010785823772e-90
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,42711,-0.112066697454618,0.00551206482212739,-0.122870344505988,-0.101263050403248,1.53172736538173e-90
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,-0.121275715057851,0.00598193179972236,-0.133000301385307,-0.109551128730395,5.18378187563837e-90
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,42495,-0.0746730000479004,0.003697119082483,-0.0819193534495671,-0.0674266466462338,2.23642712462118e-89
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,-0.112915436074477,0.00561926267290924,-0.123929190913379,-0.101901681235575,1.74557298136527e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OCLN,Occludin,40482,-0.0915200329348282,0.00456759663578627,-0.100472522340969,-0.0825675435286871,8.75535022171797e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,42636,-0.119387385045623,0.00597013998757987,-0.131088859421279,-0.107685910669966,1.08741992879244e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.0549040454269988,0.00274744536412559,0.0495190525133126,0.0602890383406849,1.42097111830903e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,42663,-0.0364911855022643,0.00182848287128146,-0.040075011929976,-0.0329073590745527,2.36926423331514e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,42670,-0.132825070553546,0.00668472703477744,-0.145927135541709,-0.119723005565382,1.28227125131852e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,-0.0925147701365295,0.00466608346706628,-0.101660293731979,-0.0833692465410796,3.12796978781248e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,42659,-0.0605853971420777,0.00306314860047221,-0.0665891683990033,-0.0545816258851522,7.46926741952608e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,42416,0.106567923509302,0.00539025651141451,0.0960030207469294,0.117132826271674,9.22199049023517e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGRN,Agrin,42676,-0.0727876625930269,0.00368741899448799,-0.0800150038222234,-0.0655603213638305,1.58734461384366e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,40511,-0.0566466648005052,0.00286609206576904,-0.0622642052494125,-0.0510291243515978,1.65445658103067e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.0786055998556853,0.00398722066501588,0.0707906473522542,0.0864205523591165,2.61348446743701e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,42654,0.0394344131669455,0.002017627250243,0.0354798637564693,0.0433889625774218,6.60456949193324e-84
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,-0.0987337178499035,0.0050499956400432,-0.108631709304388,-0.0888357263954188,1.02508251618456e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42587,-0.0715582491609994,0.00366853602388285,-0.0787485797678098,-0.064367918554189,1.40595316091704e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,42346,-0.150807947936581,0.00773770563655085,-0.165973850984221,-0.135642044888941,1.99646345808602e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40351,-0.0527456192418555,0.00270679198500923,-0.0580509315324736,-0.0474403069512374,3.43056063560724e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.0896174638564369,0.00463083315474197,-0.0986938968397311,-0.0805410308731426,2.56959644596299e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,-0.111866273584525,0.00577314532274211,-0.1231816384171,-0.100550908751951,2.62371190140992e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,42475,-0.0664562791001646,0.00344044952172953,-0.0731995601627545,-0.0597129980375747,5.21660775434693e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,42721,-0.0564529609117555,0.00292826233408289,-0.062192355086558,-0.0507135667369531,1.00937636449611e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,42754,-0.0865414735496831,0.00449979384266685,-0.0953610694813102,-0.0777218776180561,2.39674306564159e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,42721,-0.24327287936264,0.0126535777522173,-0.268073891756986,-0.218471866968294,2.73413025716819e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40367,-0.0669795440632533,0.003479300228132,-0.0737989725103921,-0.0601601156161146,2.85332213640542e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40283,-0.0740576406780479,0.00384861310661863,-0.0816009223670204,-0.0665143589890754,3.39980238863224e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,-0.154463094659638,0.00803855406798218,-0.170218660632883,-0.138707528686393,3.40136275068899e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42594,-0.100740086409419,0.00525098229361037,-0.111032011704896,-0.0904481611139431,5.9913905159362e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,42676,-0.0816312994616501,0.00425593642450414,-0.0899729348536782,-0.073289664069622,6.41264084063776e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,42651,-0.116774132283871,0.00609166443550762,-0.128713794577466,-0.104834469990276,7.92578256885239e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,-0.178618613249137,0.00937482955039688,-0.196993279167915,-0.160243947330359,7.34521503772462e-80
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,42302,-0.0671726143004983,0.00354393049260739,-0.0741187180660088,-0.0602265105349878,4.63008278037141e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,-0.0611930567793841,0.00323226919944103,-0.0675283044102885,-0.0548578091484796,6.59564810683516e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,40449,-0.139370860433114,0.00736505256645567,-0.153806363463367,-0.124935357402861,1.21232405474312e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,42749,-0.0529227387420955,0.00280636528816615,-0.0584232147069011,-0.0474222627772899,2.52812510372435e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42464,-0.0684600828383087,0.0036308534026286,-0.0755765555074607,-0.0613436101691566,2.8056201942842e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,42764,0.105656926929207,0.00560738993566869,0.0946664426552967,0.116647411203118,3.36531352239528e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,42611,0.0517616795842861,0.00275780646354135,0.0463563789157451,0.0571669802528272,1.32763652811423e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,40283,-0.121014051512546,0.00644252602060342,-0.133641402512929,-0.108386700512164,1.63069368767907e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,-0.0614680216116168,0.00327938952269494,-0.0678956250760989,-0.0550404181471347,2.11515720722801e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,-0.155109125804359,0.00827822645782797,-0.171334449661702,-0.138883801947016,2.50303426144979e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,42326,-0.113813041645074,0.00607553081932016,-0.125721082050942,-0.101905001239207,2.70144524099635e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42618,-0.179503717547933,0.00958778526432427,-0.198295776666009,-0.160711658429858,3.13822041231282e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,42743,-0.0459136487022236,0.0024531005235701,-0.050721725728421,-0.0411055716760262,3.4029450582187e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,42721,0.0311316574058049,0.00166387277903076,0.0278704667589046,0.0343928480527052,3.8266568304741e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42215,-0.192845162226144,0.0103088220785436,-0.213050453500089,-0.172639870952198,4.44759333924835e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.133280246855677,0.00714944407818955,-0.147293157248928,-0.119267336462425,1.36693072656063e-76
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,-0.0755959575832082,0.00407730779689875,-0.0835874808651298,-0.0676044343012866,8.55336998799524e-76
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELE,E-selectin,42794,-0.0953285745749471,0.0051506619089438,-0.105423871916477,-0.0852332772334173,1.50281270727955e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,42594,-0.0937776492236132,0.00507750918819637,-0.103729567232478,-0.0838257312147483,3.12747099541013e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,42711,-0.117179507240058,0.00634667563340246,-0.129618991481526,-0.104740022998589,3.42801339448351e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42587,-0.161599110603524,0.00876486447815434,-0.178778244980706,-0.144419976226341,5.58569137945315e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,40223,-0.117415068611189,0.0063696996872673,-0.129899679998233,-0.104930457224145,9.35639246269344e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,-0.19434891843175,0.0105891100078364,-0.21510357404711,-0.173594262816391,2.50928129320328e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42346,-0.150938707463321,0.00824942777817354,-0.167107585908541,-0.134769829018101,7.21044745224414e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,42613,-0.0586828516281844,0.00320833790403293,-0.064971193920089,-0.0523945093362799,7.72255422738404e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,-0.102116186812737,0.00560213976185122,-0.113096380745965,-0.0911359928795082,2.5018312211617e-73
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.103359576305426,0.00569151586218022,-0.114514947395299,-0.0922042052155527,1.24044385708093e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,-0.0629756834527837,0.0034932966895578,-0.069822544964317,-0.0561288219412504,8.18044519616467e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,42636,-0.0496408809084066,0.00275751999405659,-0.0550456200967575,-0.0442361417200557,1.30014669428618e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,42587,-0.149924320251513,0.00832972280309202,-0.166250576945573,-0.133598063557453,1.38730560245766e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42594,-0.0708957764555822,0.00395208202993356,-0.078641857234252,-0.0631496956769125,3.97551255371617e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,42613,-0.0786676271222726,0.00438644864429287,-0.0872650664650866,-0.0700701877794586,4.29879824127117e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42794,-0.0931297350919165,0.00520870759753183,-0.103338801983079,-0.0829206682007541,1.09328543409115e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,42754,-0.102369645699759,0.00576437066335567,-0.113667812199937,-0.0910714791995824,9.03279609678457e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,40283,-0.0701087300370997,0.00395340303231095,-0.0778573999804292,-0.0623600600937703,2.0815397248603e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,-0.0709458961785476,0.00400665461886266,-0.0787989392315184,-0.0630928531255768,3.37868683703748e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42721,-0.0651908117911651,0.00369383505804342,-0.0724307285049302,-0.0579508950774,6.17473036373213e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42676,-0.0540133711005773,0.0030633286677943,-0.0600174952894542,-0.0480092469117005,8.23333703353026e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,42611,-0.0991604275614157,0.00562376361098379,-0.110183004238944,-0.0881378508838875,8.28220835118816e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,42613,-0.0555713262331178,0.00316812257328468,-0.0617808464767557,-0.0493618059894798,4.02014077611939e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40451,-0.0926888667199127,0.00528482199507452,-0.103047117830259,-0.0823306156095666,5.79403661916585e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,-0.0702539086319654,0.00401576239654434,-0.0781248029291923,-0.0623830143347385,8.69761030050664e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,42794,-0.107865735780987,0.00617013707354988,-0.119959204445145,-0.0957722671168293,1.08034246701134e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,42754,-0.0630175093659423,0.00360925493791938,-0.0700916490442643,-0.0559433696876203,1.58101953344942e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,-0.0546009426277701,0.00313246968743749,-0.0607405832151476,-0.0484613020403926,2.65923961149881e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,42706,-0.0637910573155887,0.00366452402043974,-0.0709735243956506,-0.0566085902355268,3.88725730007086e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42794,-0.0672316258162688,0.00386595858452077,-0.0748089046419295,-0.0596543469906081,5.14624638091685e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,40283,-0.0478089800255514,0.00275295023061374,-0.0532047624775543,-0.0424131975735485,1.12497856418262e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42590,-0.0883751091356523,0.00510250737282745,-0.0983760235863941,-0.0783741946849105,1.76001703933936e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,-0.100799567137261,0.00581596252695053,-0.112198853690084,-0.0894002805844375,2.05486930882431e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0770724552543131,0.00445495609771248,-0.0858041692058296,-0.0683407413027966,2.45310245356859e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,42794,0.0287089260789354,0.00165990066595924,0.0254555207736553,0.0319623313842155,2.59800818261044e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,42721,-0.0985405680305231,0.00570457795059611,-0.109721540813692,-0.0873595952473548,3.78224896877069e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,42594,-0.129462356911666,0.00750693700187931,-0.14417595343535,-0.114748760387983,6.19737003534366e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,42594,-0.0693159506793339,0.00402835400684187,-0.077211524532744,-0.0614203768259238,1.19197775745437e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,42594,0.0590213262477207,0.0034472104933261,0.0522647936808016,0.0657778588146399,5.03857024267968e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,42618,0.0536306697485154,0.00314837222548465,0.0474598601865655,0.0598014793104653,2.16391161504412e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42346,-0.0651838781052887,0.0038269382927055,-0.0726846771589915,-0.057683079051586,2.29065719472798e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42476,-0.126646535239822,0.00745781509673714,-0.141263852829427,-0.112029217650217,5.30368743543678e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,42689,-0.0964409029589614,0.00568502949743969,-0.107583560773943,-0.0852982451439796,6.95556814926859e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,40283,-0.0490280457346129,0.00289624682551763,-0.0547046895126274,-0.0433514019565983,1.74472725910747e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,-0.0601493788063327,0.0035585940580228,-0.0671242231600574,-0.053174534452608,1.94469572236846e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,-0.0683715845676006,0.00404651077985915,-0.0763027456961245,-0.0604404234390766,2.16510746759183e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,40539,0.047662694397241,0.00281866803808933,0.0421381050425859,0.0531872837518961,2.27490402696536e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,42659,0.092136485439604,0.00547779909884663,0.0813999992058646,0.102872971673343,7.62196792415781e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40504,0.0846597382441455,0.00504361641990092,0.0747742500611397,0.0945452264271513,1.77179215123604e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,42638,-0.0899760684137968,0.00536679516261229,-0.100494986932517,-0.0794571498950767,1.88300250302664e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,42721,-0.0456187566851757,0.00272970392807062,-0.0509689763841941,-0.0402685369861572,4.49045320008481e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,42611,-0.0392218785103144,0.00234840685816041,-0.0438247559523088,-0.03461900106832,5.39747057032439e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,40468,-0.058241500536458,0.00348824414999055,-0.0650784590704394,-0.0514045420024765,7.66476990614112e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELN,Elastin,40511,-0.0622128991518838,0.00373992900608393,-0.0695431600038083,-0.0548826382999593,2.08622328108379e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,40511,-0.0447817306266852,0.00270429567868946,-0.0500821501569166,-0.0394813110964539,7.09811120776239e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,-0.0605555272250878,0.00366913478906502,-0.0677470314116553,-0.0533640230385204,1.35230109771386e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42594,-0.107527773409251,0.00652078930868965,-0.120308520454283,-0.0947470263642196,1.70591651765096e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,-0.113453067547642,0.0069090159960608,-0.126994738899921,-0.0999113961953625,7.041226444136e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,42594,-0.0955987013545049,0.00583489977639493,-0.107035104916239,-0.0841622977927708,9.47804455265003e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42573,0.104148235026871,0.0063627180552699,0.0916773076385415,0.1166191624152,1.21798105799962e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,42721,-0.0770453283029211,0.00470841690521883,-0.08627382543715,-0.0678168311686922,1.30533313291292e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,40482,-0.0736420031289105,0.00449673744905411,-0.0824556085290566,-0.0648283977287645,1.36068411933724e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42501,-0.0486313022211917,0.00298220466429896,-0.0544764233632176,-0.0427861810791657,3.28893760592738e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,-0.0741829937880282,0.00454778757830714,-0.0830966574415102,-0.0652693301345462,4.00303922916921e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,40516,-0.0466971964025944,0.00286567772519562,-0.0523139247439778,-0.041080468061211,4.99095939554392e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,40169,-0.0486445460054427,0.00299476868402766,-0.0545142926261369,-0.0427747993847485,1.20317657487706e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,-0.0979358120559222,0.00603620427957102,-0.109766772443881,-0.086104851667963,1.22062999082196e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42794,0.0563120791181112,0.00347386829633006,0.0495032972573043,0.0631208609789181,1.5102012470757e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40223,0.100382415336313,0.00618678097189376,0.0882563246314009,0.112508506041224,1.58683056753756e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.0632052057983938,0.00390187464978219,-0.0708528801119669,-0.0555575314848207,1.84593608505375e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,40283,-0.0735440498913647,0.00453650379342007,-0.082435597326468,-0.0646525024562613,1.95652786419814e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFM,Afamin,40539,-0.0329591696403547,0.00203427579928671,-0.0369463502069567,-0.0289719890737528,2.20562787910569e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,42594,-0.090624932788949,0.00562337478438647,-0.101646747366346,-0.0796031182115515,6.91541901830172e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42555,-0.0536354188939237,0.00333482571615326,-0.0601716772975841,-0.0470991604902633,1.15874158957405e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,42594,0.0748953959221821,0.00466724696181427,0.0657475918770261,0.084043199967338,2.05400928064319e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,42574,-0.0553489245069656,0.00345340030497184,-0.0621175891047104,-0.0485802599092208,2.80655790069238e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,-0.0715212599214716,0.00447644610024257,-0.0802950942779471,-0.0627474255649962,6.1777645991827e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42746,-0.0617799261054338,0.00386786285130575,-0.0693609372939931,-0.0541989149168746,6.55075607190362e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0414481971778445,0.00259799816304943,0.0363561207782676,0.0465402735774214,8.78875032132206e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,40449,-0.181601946297914,0.0113833846772107,-0.203913380265247,-0.159290512330581,1.12859749615664e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42636,-0.122142511083601,0.00767977266480552,-0.13719486550662,-0.107090156660582,1.92974516855639e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEP,Leptin,42636,-0.107434436956567,0.00675849628799241,-0.120681089681032,-0.0941877842321018,2.19566103859957e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42618,-0.0443606933500152,0.00279161246692107,-0.0498322537851805,-0.0388891329148499,2.39684829357939e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.0486119554957768,0.00306246108868202,-0.0546143792295936,-0.0426095317619601,3.13977401488358e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,-0.0475372647160251,0.00299525649842187,-0.053407967452932,-0.0416665619791182,4.08886424832512e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,40223,-0.0905441873860311,0.00572250067498654,-0.101760288709005,-0.0793280860630575,8.92463586580785e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,42594,-0.0899444782735635,0.00569582777821751,-0.10110830071887,-0.0787806558282571,1.13388029244402e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,42679,-0.0711553362668784,0.0045178886819692,-0.0800103980835381,-0.0623002744502188,2.14954292626276e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,42658,-0.106799228208308,0.00678955778593508,-0.12010676146874,-0.0934916949478748,2.92614561880918e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,42721,-0.060509443636567,0.003851744901425,-0.06805886364336,-0.052960023629774,3.98765783196375e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,40511,-0.134403489508815,0.008564030110363,-0.151188988525127,-0.117617990492504,6.30108361626987e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42594,0.0560071645533591,0.00357615234439276,0.0489979059583493,0.0630164231483689,8.50852177046904e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,-0.0814047009298564,0.00520588690152638,-0.0916082392568481,-0.0712011626028647,1.26273232635746e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42676,-0.0443455057792216,0.00284182359256679,-0.0499154800206525,-0.0387755315377907,2.02557538635949e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PXN,Paxillin,42311,-0.0812386863419008,0.00520586732040894,-0.0914421862899023,-0.0710351863938993,2.06762642096481e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,42636,-0.100904489195346,0.00647560178435634,-0.113596668692685,-0.088212309698008,2.86511810515368e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,42760,-0.0800755030013829,0.00514092539688286,-0.0901517167792733,-0.0699992892234926,3.11912215633383e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,40527,-0.0619424402662084,0.00397551033946393,-0.0697344405315577,-0.0541504400008591,3.56884723201398e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42689,-0.0651722309726293,0.00418983777320682,-0.0733843130081147,-0.056960148937144,4.34699580744214e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,-0.0488532973960532,0.00314205473768706,-0.0550117246819199,-0.0426948701101866,4.81491078184577e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42594,-0.108899767043482,0.00706345091482579,-0.122744130836541,-0.0950554032504239,3.57733730393445e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,42188,-0.0624947136908027,0.00406289455826263,-0.0704579870249974,-0.0545314403566079,6.33943152052493e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,42754,-0.063525377918511,0.00413145465207675,-0.0716230290365814,-0.0554277268004406,6.62181611061136e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,-0.0658147285463755,0.00427827855159629,-0.0742001545075043,-0.0574293025852468,7.25600972107765e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,42754,-0.0645625807148332,0.00420138979666295,-0.0727973047162925,-0.0563278567133738,7.59912226491387e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,42594,-0.0736339147339118,0.00482453441750887,-0.0830900021922292,-0.0641778272755944,3.73635316894799e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,42683,-0.0572925497307271,0.00375575154615526,-0.0646538227611914,-0.0499312767002628,4.17279528477628e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_E,,42594,-0.0478324128769267,0.00313672237537054,-0.053980388732653,-0.0416844370212005,4.55924698102102e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POSTN,Periostin,40527,0.0601060134145797,0.00394013351973623,0.0523833517158967,0.0678286751132627,5.01991162275139e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42636,-0.0582211820315379,0.003823224104665,-0.0657147012766813,-0.0507276627863945,6.22206576202545e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,42544,-0.0359754241932801,0.00236544457933969,-0.0406116955687859,-0.0313391528177743,8.40401449291859e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,40283,-0.0707606905263985,0.00464973775800161,-0.0798741765320817,-0.0616472045207154,8.91594987638306e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,42689,-0.0459915461724082,0.00302507133821658,-0.0519206859953127,-0.0400624063495037,9.00110291371292e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,40199,-0.0696550015209187,0.00457946522391473,-0.0786307533597916,-0.0606792496820459,1.01290642203168e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,42754,-0.118154340451922,0.00778298706950992,-0.133408995108161,-0.102899685795682,1.25287312426865e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFI,Complement factor I,40539,-0.0302416223506633,0.00199911488222815,-0.0341598875198305,-0.0263233571814962,3.36411861999815e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,-0.113958871395869,0.00754049241760894,-0.128738236534382,-0.099179506257355,4.19150032401889e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,-0.161146131560225,0.010685640887234,-0.182089987699204,-0.140202275421247,5.69716940886135e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,42618,-0.0429812603379192,0.00285890040256343,-0.0485847051269436,-0.0373778155488949,1.13258008937254e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40511,-0.102820966981735,0.00684097826818806,-0.116229284387383,-0.0894126495760863,1.43143692046854e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MLN,Promotilin,42594,-0.135411652326438,0.00902015275918296,-0.153091151734436,-0.117732152918439,1.57406973227586e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42594,-0.0419048718186247,0.0027950693197399,-0.0473832076853149,-0.0364265359519345,2.10763969057029e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.057788536427995,0.00386342719858762,-0.0653608537372267,-0.0502162191187632,3.51554498530793e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,42711,-0.0686978326450043,0.00459776366669013,-0.077709449431717,-0.0596862158582916,4.43493238816835e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.0428765532244127,0.00287153195473836,-0.0485047558556999,-0.0372483505931255,5.19635332520158e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,40223,-0.0498144018436119,0.00334113762514492,-0.0563630315888959,-0.0432657720983278,8.73135106178889e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42711,-0.100693161680876,0.00676025922468307,-0.113943269761255,-0.0874430536004969,8.82938794817468e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,42480,-0.0561353806522056,0.00377331891194274,-0.0635310857196134,-0.0487396755847979,1.16766731106161e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,42636,-0.0537884835278195,0.00362359546450792,-0.0608907306382551,-0.046686236417384,1.87508127631085e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,-0.0647041440258789,0.00436177259234314,-0.0732532183068715,-0.0561550697448864,2.15055617506198e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40482,-0.0941131456372836,0.00635531991291039,-0.106569572666588,-0.0816567186079792,3.72654265096984e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.0721843667360637,0.00489034816591973,-0.0817694491412664,-0.0625992843308611,6.3022503822272e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,-0.0634384643200667,0.00430581591517173,-0.0718778635138033,-0.0549990651263301,9.43252628514841e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,42716,-0.0877862537556607,0.00595899463482221,-0.0994658832399123,-0.0761066242714092,9.62174276519274e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42580,-0.0308058969076445,0.00209155300759452,-0.0349053408025298,-0.0267064530127592,1.0140065478286e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,42794,-0.0938176355630566,0.00637195435565857,-0.106306666100147,-0.0813286050259658,1.07881645902314e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,42676,-0.063479281908193,0.00431315595222169,-0.0719330675745476,-0.0550254962418385,1.18489800871549e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,42357,-0.0818524757197271,0.00557146266833059,-0.0927725425496551,-0.0709324088897991,1.7708625057561e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,42668,0.0583124313469122,0.0039705152338291,0.0505302214886072,0.0660946412052172,1.86665321378821e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,42611,-0.0463612132073239,0.00317578637577294,-0.0525857545038389,-0.0401366719108089,6.70074660692205e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,-0.0768326032090195,0.00527063407469851,-0.0871630459954285,-0.0665021604226104,8.99725554514109e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,42476,-0.0937467136429843,0.00643185012607758,-0.106353139890096,-0.0811402873958723,9.4101139053396e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,42676,0.0629263506731682,0.00431764876066359,0.0544637591022676,0.0713889422440688,9.45187150131413e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,-0.0411121769290737,0.00282203522886229,-0.0466433659776437,-0.0355809878805036,1.03227743427002e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,42648,-0.0478887507589044,0.00328914832077775,-0.0543354814676288,-0.0414420200501801,1.16842369460233e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42706,-0.0983277419229688,0.00675968228753036,-0.111576719206528,-0.0850787646394093,1.4122621532499e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42587,-0.087523550035767,0.00603530475875457,-0.099352747362926,-0.0756943527086081,2.6874755940095e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,-0.064397043348997,0.00444172803793068,-0.0731028303033411,-0.0556912563946529,2.83522200602745e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,42689,-0.0477582301718586,0.00330465257448017,-0.0542353492178397,-0.0412811111258775,5.47487915720634e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,42477,-0.0682008313626255,0.00472553575818501,-0.0774628814486681,-0.0589387812765828,7.31756998056436e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0367657328229694,0.00255416034083968,0.0317595785549236,0.0417718870910152,1.24893728494509e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,40527,-0.0410126536625524,0.00284888276215838,-0.0465964638763828,-0.035428843448722,1.40975994647622e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,40223,-0.0866565355331138,0.00602517851289005,-0.0984658854183783,-0.0748471856478493,1.7556191093359e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,42611,-0.0569119984081446,0.00396202979523665,-0.0646775768068085,-0.0491464200094808,1.91383404551431e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,-0.0591784416797632,0.00412240360045853,-0.0672583527366619,-0.0510985306228645,2.15894622179519e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42668,0.0446338606421445,0.00311898218688146,0.0385206555558569,0.0507470657284322,4.10207698915098e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,42711,-0.0882425363911185,0.00617640751670466,-0.10034829512386,-0.0761367776583773,5.69552656774742e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,42495,-0.0579925405501215,0.00407595371046259,-0.0659814098226282,-0.0500036712776149,1.32704565415449e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,40532,-0.0386726528495882,0.0027168167858749,-0.043997613749903,-0.0333476919492734,1.38030710120218e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42587,-0.0965861745610828,0.00680304067733188,-0.109920134288653,-0.0832522148335123,2.0266913190782e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EZR,Ezrin,42711,-0.0344888786243581,0.00242959896944535,-0.039250892604471,-0.0297268646442452,2.07610570487852e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,40483,-0.0548207173018716,0.00386081843579313,-0.0623879214360261,-0.047253513167717,2.27413222826933e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42640,-0.0580410497022069,0.00409495656671214,-0.0660671645729627,-0.0500149348314511,2.81928464959353e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,40511,-0.0660450936947401,0.00465740301437971,-0.0751736036029244,-0.0569165837865559,2.94376154905154e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,-0.0990594673230257,0.00701853700498291,-0.112815799852792,-0.0853031347932592,7.65931680970181e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42611,0.0391109744957807,0.00277428679288837,0.0336733723817195,0.0445485766098419,8.19541008895848e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,-0.0437572164989783,0.00310478633111011,-0.0498425977079541,-0.0376718352900025,9.99181928709532e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.0528201185003231,0.00375089913054706,-0.0601718807961953,-0.0454683562044508,1.01997343487533e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,42663,-0.0461723866776944,0.00328105374386852,-0.0526032520156767,-0.0397415213397121,1.16217832349134e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,-0.0954319796155702,0.00678603030491907,-0.108732599013212,-0.0821313602179288,1.52595210908326e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,42587,-0.0460235582936233,0.00327609171951614,-0.0524446980638749,-0.0396024185233717,1.63261825970064e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,39872,-0.0350462761250207,0.00249340887330315,-0.0399333575166949,-0.0301591947333465,1.77226862197669e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40283,-0.0334587254262833,0.00238143023581776,-0.0381263286884861,-0.0287911221640805,1.85570311111368e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,42679,-0.0514409540012009,0.00366629874674504,-0.0586268995448212,-0.0442550084575807,2.07378561943786e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,40539,-0.0451661152739167,0.00321881245362479,-0.0514749876830213,-0.0388572428648121,2.33343140529685e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,42679,-0.0380088373366992,0.00271451027191066,-0.043329277469644,-0.0326883972037543,3.08741553607792e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,42676,-0.0970120795654538,0.00692875542160727,-0.110592440191804,-0.0834317189391035,3.11914551022128e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40199,-0.114024163228051,0.00814178666199287,-0.129982065085557,-0.0980662613705449,3.48561431170271e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,42437,-0.0606670761367753,0.00434594945948063,-0.0691851370773574,-0.0521490151961933,5.64486442555652e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40532,0.0392029635750791,0.00281023813119685,0.0336948968379332,0.0447110303122249,7.23937834867093e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42594,-0.088298402276721,0.00634277839322841,-0.100730247927449,-0.0758665566259933,9.50883977736938e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,-0.0400632239920349,0.00287940300039865,-0.0457068538728163,-0.0344195941112536,1.04795719100782e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,-0.0616870691247988,0.00443426591260106,-0.0703782303134969,-0.0529959079361007,1.08373936238844e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,40451,-0.06440886784275,0.00462857781221548,-0.0734808803546923,-0.0553368553308076,1.17214600349419e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40283,-0.106079000268043,0.0076250862557111,-0.121024169329236,-0.0911338312068489,1.24763139371624e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42636,-0.049108846092509,0.00354503341881185,-0.0560571115933803,-0.0421605805916378,2.42642345533255e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAST,Gastrin,40483,-0.205970482107232,0.0149024870047624,-0.235179356636566,-0.176761607577897,4.2566083313109e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40511,-0.0493693631161348,0.00357493027689797,-0.0563762264588548,-0.0423624997734148,4.95939141084777e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,40199,-0.116022119569181,0.00841255422861717,-0.132510725857271,-0.0995335132810913,6.51319885128169e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42611,-0.0750472044919866,0.0054590926663711,-0.0857470261180739,-0.0643473828658992,1.0308025000882e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42652,0.0501799339075839,0.00365075853255991,0.0430244471837665,0.0573354206314014,1.05892847208974e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,-0.0396574156442786,0.00289157821216944,-0.0453249089401307,-0.0339899223484265,1.59699959000094e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,42671,-0.0433865330008782,0.00316524862725748,-0.0495904203103028,-0.0371826456914535,1.77246832077024e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42311,-0.0402309512177077,0.00293828869004471,-0.0459899970501953,-0.0344719053852201,2.21738813156223e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42587,-0.171446092150749,0.0125622245351226,-0.196068052239589,-0.146824132061909,3.98255056477582e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,40223,-0.0835184089618907,0.00612209840893053,-0.0955177218433946,-0.0715190960803869,4.92988657698584e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,42581,0.0869545788571883,0.00638255942471769,0.0744447623847416,0.0994643953296349,5.50856004016317e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,-0.0828955237370047,0.0060818616880703,-0.0948159726456224,-0.0709750748283869,5.7187555950455e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,42495,-0.0955143852516007,0.00701409422719749,-0.109262009936908,-0.0817667605662936,6.02134433166211e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42620,-0.0684518430248006,0.00502735539038199,-0.0783054595899493,-0.0585982264596519,6.11776801919327e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,42676,-0.0939880908979411,0.00690601508471375,-0.10752388046398,-0.0804523013319022,6.64121662453216e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42771,0.0859698254622212,0.00632738976827115,0.0735681415164098,0.0983715094080327,8.97605605904869e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42594,-0.0796469886634462,0.00587294148773148,-0.0911579539793999,-0.0681360233474925,1.27136324677542e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,-0.0487462338062092,0.00359900540339702,-0.0558002843968674,-0.0416921832155511,1.60471926194675e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,42587,-0.0736568015118124,0.00546412031503139,-0.0843664773292739,-0.0629471256943508,3.79915782374146e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,-0.0998566772770894,0.00740883019093505,-0.114377984451322,-0.0853353701028567,3.91979633722592e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41948,-0.0602024748608186,0.00447281186253248,-0.0689691861113822,-0.0514357636102549,5.14649652004884e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40199,-0.116355348277241,0.00864057164930987,-0.133290868709888,-0.0994198278445937,5.22185696540692e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42594,-0.0793650087471293,0.00592053091496142,-0.0909692493404537,-0.067760768153805,1.03309759201897e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,-0.0928333761083744,0.00693120788087662,-0.106418543554893,-0.0792482086618562,1.2176057105542e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,42679,-0.0716895629616787,0.00535837254569615,-0.0821919731512432,-0.0611871527721143,1.45530857421044e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTR,Transthyretin,40424,-0.0345644486105921,0.00258584991224441,-0.0396327144385911,-0.0294961827825931,1.92553231179421e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,42441,-0.0492015836524205,0.0036850268059931,-0.056424236192167,-0.0419789311126741,2.11027125547425e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSN,Gelsolin,40488,0.0266470890390748,0.00199631907648605,0.0227343036491621,0.0305598744289874,2.45436652192604e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,42488,0.0379496482517635,0.00284491630984336,0.0323736122844706,0.0435256842190565,2.47824488181291e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,42677,-0.0589071789544577,0.00441862430680633,-0.0675676825957981,-0.0502466753131173,2.72848754641392e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,-0.0615669465532852,0.00462491302850609,-0.0706317760891572,-0.0525021170174133,3.56106702657817e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42569,-0.0346462456514568,0.00260334941665006,-0.0397488105080909,-0.0295436807948226,3.72672061970149e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40451,-0.0938916871323527,0.00708409317273955,-0.107776509750922,-0.0800068645137832,8.50871361650221e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,40527,0.0817943190592849,0.00617171286117484,0.0696977618513822,0.0938908762671876,8.55683631885105e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,42794,-0.0793501773334127,0.00599454061040824,-0.0910994769298129,-0.0676008777370126,9.43907827423691e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,42566,-0.0627085387267237,0.00474112594662539,-0.0720011455821095,-0.053415931871338,1.09485631820241e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42346,-0.148170926022107,0.0112115948884857,-0.170145652003538,-0.126196200040675,1.27097302706834e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,42495,-0.117743831202843,0.00891512058261039,-0.13521746754476,-0.100270194860927,1.4146596678245e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,42346,-0.063895299272072,0.00485245385477124,-0.0734061088274236,-0.0543844897167203,2.39024190203107e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,-0.0781611219681469,0.00593993337915713,-0.0898033913912949,-0.0665188525449989,2.65562301726794e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,42711,-0.030888149979994,0.00235178765248364,-0.0354976537788619,-0.026278646181126,3.65627866486992e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,-0.0372114374049645,0.00283540968490531,-0.042768840387379,-0.0316540344225501,4.19046404185209e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,40449,-0.143874570398258,0.0109569049395413,-0.165350104079759,-0.122399036716757,4.24051276013461e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,42125,-0.0453090594080005,0.00345889794066214,-0.0520884993716982,-0.0385296194443027,5.88281609867631e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,40511,-0.0432449352709022,0.00330216772048706,-0.0497171840030569,-0.0367726865387476,6.66015727414509e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,42754,-0.122541751354661,0.0093637920410181,-0.140894783755057,-0.104188718954266,6.7427420921493e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42595,-0.0431484847592668,0.00331571127353857,-0.0496472788554024,-0.0366496906631312,1.75753691382995e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,42587,-0.150268546689644,0.0115475432259521,-0.17290173141251,-0.127635361966778,1.76516010963246e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,42678,-0.0892321468991635,0.00688295962759925,-0.102722747769258,-0.0757415460290689,3.30218126305433e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,40199,-0.06224231080454,0.00479846945178408,-0.0716473109300368,-0.0528373106790432,3.39033730144889e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,42587,-0.0933093125949222,0.00720621182837069,-0.107433487778529,-0.0791851374113157,4.05897588832824e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42676,-0.052109923653423,0.00402700663900295,-0.0600028566658688,-0.0442169906409773,4.50309281763873e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,42754,-0.04843662671013,0.00374514306355201,-0.0557771071146919,-0.041096146305568,4.90794757450737e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42676,-0.0371183959638459,0.00287032750473786,-0.0427442378731321,-0.0314925540545597,5.01327683858498e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40483,-0.0626088686620974,0.00486482581824383,-0.0721439272658553,-0.0530738100583395,1.22543004761116e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,42654,-0.0765336505095201,0.00596378835197219,-0.0882226756793856,-0.0648446253396547,1.77514896449398e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,42339,-0.0504731293491934,0.00394110904218641,-0.0581977030718788,-0.0427485556265081,2.50918271717095e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,-0.0393838513943539,0.00307919193383873,-0.0454190675846778,-0.03334863520403,3.40003527473421e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,42711,-0.0479311912926938,0.00375015626941686,-0.0552814975807508,-0.0405808850046368,3.43139294428826e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42676,-0.0527547163091117,0.00412772317474373,-0.0608450537316094,-0.044664378886614,3.459142914255e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,40511,-0.0886187079393457,0.00695103078449551,-0.102242728276957,-0.0749946876017345,5.66887703382319e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,-0.0505831254122853,0.0039723088442357,-0.0583688507469873,-0.0427974000775834,6.3210615565587e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,42636,-0.048563045012639,0.00381510586919851,-0.056040652516268,-0.0410854375090099,6.65026048508221e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42600,-0.0625478398937659,0.00493349273115506,-0.0722174856468298,-0.052878194140702,1.26709872562742e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,-0.114720287330831,0.00904986995076325,-0.132458032434327,-0.0969825422273347,1.30121367784741e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,-0.0639072565550089,0.00504206749997027,-0.0737897088549507,-0.0540248042550672,1.47044429825128e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,42594,-0.0454452717758111,0.00360422970677247,-0.0525095620010852,-0.0383809815505371,3.03009560450823e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAYN,Layilin,42476,-0.0486889693765734,0.00386335420034581,-0.0562611436092511,-0.0411167951438956,3.28458436684554e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,42588,0.0497007416432979,0.00394631196016304,0.0419659702013784,0.0574355130852175,3.6413379565039e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,42646,-0.0588790956958714,0.00467758077083034,-0.0680471540066988,-0.0497110373850439,3.95276989365825e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANG,Angiogenin,42618,-0.0431198802752734,0.00343185550478906,-0.0498463170646599,-0.0363934434858868,5.26968955037643e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42587,-0.108041869802144,0.00861720730642073,-0.124931596122728,-0.0911521434815592,7.35978097266733e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD248,Endosialin,40527,0.0524366386522898,0.00418169400838331,0.0442405183958585,0.0606327589087211,7.83828652539145e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40116,-0.046488672570317,0.00370729436009403,-0.0537549695161014,-0.0392223756245327,7.97836254510877e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,42311,-0.0792004933155992,0.00632017123974503,-0.0915880289454995,-0.066812957685699,8.06223677844454e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFH,Complement factor H,39956,-0.0295046329163918,0.00235665824055677,-0.034123683067883,-0.0248855827649005,1.03274028927487e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,40199,-0.120267510426347,0.00961747694260121,-0.139117765233845,-0.101417255618848,1.22242569297208e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,42754,-0.0957425564226347,0.00767303107177071,-0.110781697323305,-0.0807034155219641,1.54631261748391e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42545,-0.0575399510959821,0.00461162666290406,-0.0665787393552741,-0.0485011628366902,1.56980551188396e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,40283,-0.0656160843569206,0.00527050510254524,-0.0759462743579093,-0.0552858943559319,2.41800496887034e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,-0.0547180774970181,0.00440201045206684,-0.0633460179830691,-0.0460901370109671,2.80057236377823e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40482,-0.0730846802944158,0.00589235917718554,-0.0846337042816995,-0.0615356563071321,4.24457661397969e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,40539,-0.0389637995401971,0.00314308422114612,-0.0451242446136435,-0.0328033544667507,4.59299422919572e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42713,-0.0366236663264162,0.0029608298898171,-0.0424268929104577,-0.0308204397423747,5.91427524694359e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,42336,-0.0503345249765335,0.00406970062423732,-0.0583111382000387,-0.0423579117530284,6.08287822402358e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,-0.0439605317075079,0.00356292565648092,-0.0509438659942105,-0.0369771974208053,8.66331307816683e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,42711,-0.045274417049832,0.00367303826914043,-0.0524735720573472,-0.0380752620423167,1.00628798969145e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42679,-0.114586913094323,0.00929855595123883,-0.132812082758751,-0.0963617434298952,1.04586162435356e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,40511,-0.0705418002188551,0.00573148952897526,-0.0817755196956466,-0.0593080807420636,1.36881290672366e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,-0.0348385615574633,0.00283248079938026,-0.0403902239242486,-0.029286899190678,1.39369406145414e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42370,-0.0868535494172711,0.00706181335200599,-0.100694703587203,-0.0730123952473394,1.41819809498359e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40482,-0.0668599745481289,0.0054350603624661,-0.0775126928585625,-0.0562072562376954,1.47763983821158e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,40223,-0.0648351995072736,0.00527112031843208,-0.0751665953314005,-0.0545038036831468,1.52340760497163e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42679,0.0549502413878358,0.00447794480014548,0.0461734695795507,0.063727013196121,1.97115785465627e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42721,-0.101211395295916,0.00826417541352763,-0.11740917910643,-0.0850136114854017,2.64830866496555e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,-0.105385207443624,0.00860640086260594,-0.122253753134332,-0.0885166617529167,2.9814836917954e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,40456,-0.136105184054848,0.0111164730917664,-0.15789347131471,-0.114316896794986,3.00182911186496e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40527,-0.0293139875527167,0.00239692974716474,-0.0340119698571596,-0.0246160052482738,3.53700909209591e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,-0.0795277661603508,0.00650408566964369,-0.0922757740728525,-0.0667797582478492,3.65091583317909e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,-0.0439047850048131,0.00361084610868368,-0.0509820433778332,-0.0368275266317931,7.73321982476322e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,42721,-0.0497561998621995,0.00409233211898851,-0.057777170815417,-0.041735228908982,7.77167477213061e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40223,-0.0402300723457909,0.0033293843937707,-0.0467556657575815,-0.0337044789340003,2.10223406086638e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,42317,-0.0609996847537327,0.0050600044042077,-0.0709172933859797,-0.0510820761214856,2.72771814223984e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42611,0.0647970178765779,0.00538205982393389,0.0542481806216675,0.0753458551314883,3.26890525088043e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,42370,-0.0576943418128868,0.00480379637995156,-0.0671097827175919,-0.0482789009081818,4.6756762309525e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,-0.0545259277505599,0.0045377368225827,-0.063419891922822,-0.0456319635782978,4.68877159098275e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42346,-0.0784537849210478,0.0065368080008685,-0.09126592860275,-0.0656416412393455,5.16761813326798e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,42439,-0.058690091348708,0.00489354496156232,-0.0682814394733701,-0.0490987432240458,5.70294209849763e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,42311,-0.0779861865614143,0.00650283255269577,-0.090731738364698,-0.0652406347581306,5.77417782870607e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,42556,-0.10170543950612,0.00848670087985981,-0.118339373230645,-0.0850715057815946,6.34906737063904e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0648412359136262,0.00541810924975254,-0.0754607300431412,-0.0542217417841113,7.71610213764523e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,42636,-0.0850862226497584,0.00712764833572141,-0.0990564133877724,-0.0711160319117445,1.10386731103214e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42346,-0.0582444754507147,0.00487974133786766,-0.0678087684729353,-0.0486801824284941,1.13330051693993e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,42592,-0.0683748813441748,0.00573261877461445,-0.0796108141424191,-0.0571389485459305,1.24700117639831e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42346,-0.0765538813269684,0.00642138103078392,-0.0891397881473049,-0.0639679745066319,1.34256829402958e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42370,-0.102970709529276,0.00864035638902055,-0.119905808051757,-0.0860356110067962,1.41193579839062e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,-0.0414481505830476,0.00347994096954892,-0.0482688348833635,-0.0346274662827317,1.52161924722374e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40451,-0.0353682767760675,0.00296830979911274,-0.0411861639823285,-0.0295503895698065,1.54536942351354e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,40511,0.0427909985313885,0.0035932232143367,0.0357482810312886,0.0498337160314884,1.66483344069858e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,42488,-0.043139377029436,0.00362464971753222,-0.0502436904757992,-0.0360350635830728,1.69623753586977e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,-0.0621410711065628,0.00522877428946622,-0.0723894687139165,-0.051892673499209,2.09087865361174e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,42754,-0.0571133489854591,0.00481169536074435,-0.066544271892518,-0.0476824260784001,2.45900098774124e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,0.0239122394588874,0.00201508338801925,0.0199626760183697,0.0278618028994051,2.56153473138848e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,40511,-0.111093681451351,0.00935762910614656,-0.129434634499399,-0.0927527284033042,2.57305695658743e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,-0.0512854112132499,0.00432659920629488,-0.0597655456575879,-0.042805276768912,3.01015187309501e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,-0.11784479434807,0.00993979068896936,-0.13732678409845,-0.0983628045976899,3.14801365514967e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,42509,-0.0642896575801442,0.00542665507365123,-0.0749259015245006,-0.0536534136357878,3.23648966139607e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,-0.0720115126230836,0.00608337969136017,-0.0839349368181496,-0.0600880884280177,3.63864909143601e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,42495,0.0418912134841314,0.00354046571301852,0.0349519006866151,0.0488305262816477,3.85977555715222e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,-0.116844355691361,0.00989141831091564,-0.136231535580756,-0.0974571758019668,4.83991299878325e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,-0.0993396506835724,0.00841796962963654,-0.11583887115766,-0.0828404302094848,5.94841673438443e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,42571,-0.0371667203745753,0.00315531114749838,-0.0433511302236721,-0.0309823105254785,7.18784093640935e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,42636,-0.0299266528462238,0.0025412412439743,-0.0349074856844135,-0.0249458200080342,7.40699338754159e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,-0.0624268298944275,0.00531277654347923,-0.0728398719196468,-0.0520137878692082,1.07725200703552e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDK,Midkine,42638,-0.0612304497909314,0.00521831841674978,-0.0714583538877609,-0.0510025456941018,1.22075762776174e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,42754,-0.0589060725428848,0.0050210220492492,-0.0687472757594132,-0.0490648693263564,1.24388447985825e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,-0.102970587539213,0.00877255267458722,-0.120164790781404,-0.0857763842970217,1.24519658768755e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,42594,-0.0871807955404204,0.00743124092236854,-0.101746027748263,-0.0726155633325781,1.25242759780241e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,42754,-0.0573786757846297,0.00490211694105749,-0.0669868249891024,-0.047770526580157,1.70548668101186e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,40449,-0.10326110703479,0.00882074663907759,-0.120549770447383,-0.0859724436221984,1.793965714284e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,42594,-0.0705480890530891,0.00603092596986348,-0.0823687039540215,-0.0587274741521566,1.86166541560172e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,40515,-0.0671112398889016,0.0057355726933314,-0.0783529623678312,-0.0558695174099721,1.91332312975746e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,42754,-0.0688806060641347,0.00589832421542341,-0.0804413215263646,-0.0573198906019048,2.33318973986132e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,40342,-0.0288740102836548,0.00247423068101997,-0.033723502418454,-0.0240245181488557,2.76079940498838e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,42721,-0.0768639311343776,0.0065901251462268,-0.0897805764209821,-0.0639472858477731,2.76424088286729e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,40257,-0.0599377565787793,0.00513757953273179,-0.0700074124629336,-0.0498681006946249,2.87973612530589e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,42590,-0.109087492489032,0.00935766199629895,-0.127428510001778,-0.0907464749762858,2.97191869683838e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,42365,-0.0473475216841897,0.00406732064483312,-0.0553194701480626,-0.0393755732203168,3.62504586578478e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,-0.0636664424864635,0.00546777212382697,-0.0743832758491643,-0.0529496091237626,3.75043361964482e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,40527,-0.136316724829727,0.0117161986339748,-0.159280474152317,-0.113352975507136,4.11516274108573e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,40483,-0.0342245751406456,0.00294487244529442,-0.0399965251334227,-0.0284526251478686,4.79880672613597e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,40449,-0.117761648763773,0.0101330003569577,-0.13762232946341,-0.0979009680641358,4.81323059080009e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,40509,0.0890020093001686,0.00766877999045819,0.0739712005188705,0.104032818081467,5.76801753617895e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42654,-0.0613501315767555,0.00529837491839962,-0.0717349464168187,-0.0509653167366922,7.36895598852993e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0439367449939832,0.00379308102559303,0.0365023061838209,0.0513711838041456,7.47382458768838e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40199,-0.149568758082326,0.012916067616649,-0.174884250610958,-0.124253265553694,7.84724308654627e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,42611,-0.0295345383870599,0.00255650491176164,-0.0345452880141127,-0.0245237887600071,9.99683446239606e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,42611,-0.0684687694010449,0.00592956664598224,-0.08009072002717,-0.0568468187749197,1.06742196224811e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,-0.0918807465728083,0.00797076203056643,-0.107503440152719,-0.0762580529928981,1.42484132012638e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.0476228947154217,0.00413605730652829,-0.0557295670362172,-0.0395162223946263,1.57356628701961e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,40283,-0.0388512307992498,0.00337317324558426,-0.0454626503605949,-0.0322398112379046,1.60189673699752e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42566,-0.0455256785979236,0.0039557576852503,-0.0532789636610142,-0.037772393534833,1.65989448138468e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40136,-0.0961271623275461,0.00835471137803236,-0.11250239662849,-0.0797519280266027,1.84713450319748e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,40223,-0.0472839753765756,0.00411227854689891,-0.0553440413284975,-0.0392239094246537,2.00644642453876e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40483,-0.0365837175980709,0.00318197590711831,-0.0428203903760228,-0.030347044820119,2.01279689599307e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40451,-0.0928437436265655,0.008100772388592,-0.108721257508206,-0.0769662297449251,3.04338835131801e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42311,-0.0670921706288148,0.00585673483736427,-0.0785713709100488,-0.0556129703475809,3.07069086035778e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42600,-0.0233088948106703,0.00203798350043758,-0.0273033424715279,-0.0193144471498126,3.75878066427733e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,42572,-0.0520476252779208,0.00455398567723576,-0.0609734372053029,-0.0431218133505388,4.13047112445279e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,40383,-0.0315629922807913,0.00276071888424074,-0.0369740012939032,-0.0261519832676795,4.20749255953974e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,-0.0941269305548683,0.00824264088456554,-0.110282506688617,-0.0779713544211199,4.88581137332533e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,42676,-0.0505069421555464,0.00442970709771048,-0.0591891680670589,-0.0418247162440338,5.61417597006813e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42351,-0.0640878535226135,0.00562728046572025,-0.0751173232354252,-0.0530583838098018,6.56588327530484e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,42594,-0.0966051148183422,0.00848358993639039,-0.113232951093667,-0.079977278543017,6.63910339471804e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,40430,-0.0500276857809921,0.00439172358828064,-0.0586354640140221,-0.041419907547962,6.73531526567595e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40223,-0.0843850082131816,0.00741267853133414,-0.0989138581345965,-0.0698561582917667,7.38336200786732e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42594,-0.0488728241990291,0.00429643280003225,-0.0572938324870923,-0.0404518159109659,7.61565510025775e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,-0.045201677858091,0.00397800141174779,-0.0529985606251167,-0.0374047950910653,8.75259380615142e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,-0.0570992591491027,0.00503157769749683,-0.0669611514361965,-0.0472373668620089,1.04047593318703e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,42333,-0.0587613806616996,0.00517806916404023,-0.0689103962232184,-0.0486123651001807,1.04173734705172e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,40462,-0.0847937048654008,0.00748671581321236,-0.099467667859297,-0.0701197418715046,1.4113309496224e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,42346,-0.0737161632478768,0.00652353054616867,-0.0865022831183674,-0.0609300433773862,1.79315533581818e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,-0.0794398353775866,0.00702766935600481,-0.093214067315356,-0.0656656034398171,1.82330995889712e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,-0.0523014455417631,0.00463138431699389,-0.0613789588030711,-0.0432239322804551,2.06607556329575e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,-0.121060213599721,0.0107210789033191,-0.142073528250226,-0.100046898949216,2.07326210606366e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,42346,-0.086235600497903,0.00764798528325083,-0.101225651653075,-0.0712455493427314,2.36165126895106e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,-0.0428906873977182,0.00380481101364151,-0.0503481169844556,-0.0354332578109808,2.58716931814158e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,42676,-0.0527482746186534,0.00468697854765852,-0.0619347525720641,-0.0435617966652427,2.98102175116939e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,-0.0977244612468962,0.00868687407925878,-0.114750734442243,-0.080698188051549,3.13880859597096e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,42711,0.0437272882778654,0.00388817994859984,0.0361064555786097,0.0513481209771211,3.25904642236973e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42346,-0.056912371959382,0.00506957119849679,-0.0668487315084357,-0.0469760124103283,4.10961280780325e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NADK,NAD kinase,42636,-0.0627809382081776,0.00560235895808036,-0.0737615617660151,-0.0518003146503401,5.11403457488262e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,-0.125071250914799,0.0111647474700566,-0.14695415595611,-0.103188345873488,5.65820105721286e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42636,-0.0987651692461776,0.00884939284542964,-0.11610997922322,-0.0814203592691355,8.49939054451934e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,-0.0607083218668677,0.00544839074142137,-0.0713871677200536,-0.0500294760136819,1.04247542785479e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,42495,-0.0398469169783904,0.00357738543113401,-0.046858592423413,-0.0328352415333677,1.09055318612666e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.0460301911566853,0.00413346761344581,-0.0541317876790391,-0.0379285946343315,1.18186887820335e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,42346,-0.0459637194475936,0.00413618272060181,-0.0540706375799732,-0.0378568013152141,1.45998561081977e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,42711,-0.0580014113183837,0.00523142591295035,-0.0682550061077664,-0.047747816529001,1.92146416349833e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,-0.0491674737487142,0.00443417214307525,-0.0578584511491417,-0.0404764963482867,2.00405796382693e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,-0.051147525030691,0.00461905469829107,-0.0602008722393415,-0.0420941778220405,2.24706415725336e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,-0.0561284081550279,0.00506828135520429,-0.0660622396112283,-0.0461945766988275,2.37222032294669e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,-0.0252577378310425,0.00228116987795009,-0.0297288307918247,-0.0207866448702603,2.38908542395002e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40511,-0.0304334906144308,0.00274908699424857,-0.035821701123158,-0.0250452801057036,2.44055289243988e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,-0.156801957678522,0.0141768654825787,-0.184588614024376,-0.129015301332668,2.72991358217151e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42611,-0.0567953160392229,0.00515435341036581,-0.0668978487235399,-0.046692783354906,4.08912541908991e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,-0.110028470964576,0.00999698182863036,-0.129622555348692,-0.0904343865804607,4.69046405856785e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,-0.0684998478208001,0.00623058427590995,-0.0807117930015836,-0.0562879026400166,5.36959015941326e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,42711,-0.0338744226618899,0.00308314529108167,-0.03991738743241,-0.0278314578913698,5.79709506588568e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,-0.0829450975234303,0.00755072081009671,-0.0977445103112198,-0.0681456847356407,6.31256978905725e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42594,-0.118197716200425,0.0107663300337001,-0.139299723066477,-0.0970957093343723,6.3795994833085e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,40058,-0.0600453014881076,0.00546896782702523,-0.070764478429077,-0.0493261245471381,6.73716018311385e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,-0.0776362168994739,0.00707999688639478,-0.0915130107968077,-0.0637594230021401,7.72920802378174e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40116,-0.0712570074260602,0.00650989212498618,-0.0840163959910331,-0.0584976188610873,9.6801772557501e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0460412321636754,0.0042115895709622,-0.0542959477227613,-0.0377865166045895,1.05785780575097e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,-0.10732567055177,0.00982267819998361,-0.126578119823738,-0.0880732212798024,1.12885804172218e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,42255,-0.0772541796651339,0.00707145102558826,-0.0911142236752869,-0.0633941356549809,1.15567489325703e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42311,-0.0943818311813862,0.00864026620966776,-0.111316752952335,-0.0774469094104374,1.17097758788482e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,42754,-0.104249808708877,0.00954931041290417,-0.122966457118169,-0.0855331602995848,1.24575568288999e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,-0.0390078847048447,0.00357368144807448,-0.0460123003430707,-0.0320034690666187,1.27163230114782e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,40451,-0.110358416726956,0.0101087421922625,-0.13017155142379,-0.0905452820301211,1.31275475848578e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.0656210747279874,0.00601588824395448,-0.0774122156861382,-0.0538299337698366,1.38184695643628e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42711,-0.0514012043397543,0.004712444536662,-0.0606375956316118,-0.0421648130478967,1.38219934111398e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,0.0382107358017813,0.00350518073717722,0.0313405815569139,0.0450808900466486,1.4830141080537e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,-0.0484293419327782,0.00444741720347357,-0.0571462796515864,-0.03971240421397,1.69294592894845e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42613,-0.0903832032579188,0.00830367931882228,-0.10665841472281,-0.0741079917930271,1.7757070312514e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,42581,-0.0472036738888692,0.00434531595599677,-0.0557204931626228,-0.0386868546151155,2.24699374349085e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40449,-0.0497711482776235,0.00458190115270717,-0.0587516745369296,-0.0407906220183174,2.37536636860085e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,42711,-0.0637008326525883,0.00587124267714178,-0.0752084682997862,-0.0521931970053904,2.59451561067346e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GH1,Somatotropin,42613,0.190653399987173,0.0175737764190359,0.156208798205863,0.225098001768484,2.62460709898398e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,40346,-0.0311087050562875,0.00286732710269454,-0.0367286661775688,-0.0254887439350061,2.74773935229904e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,42640,0.042253976082271,0.00389750011073763,0.0346148758652253,0.0498930762993168,2.84364394498995e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,40457,-0.0644262525813594,0.00594021558828765,-0.0760690751344032,-0.0527834300283156,2.84809969986249e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,-0.0317972590727491,0.00293321565694616,-0.0375463617603636,-0.0260481563851347,2.86376181043054e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42346,-0.0666605342957565,0.00616038298992138,-0.0787348849560024,-0.0545861836355106,3.56918902917377e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,42575,-0.0579445262709466,0.00536020133111241,-0.0684505208799269,-0.0474385316619662,3.98912148044579e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42611,0.0455881597462519,0.00422157578029013,0.0373138712168833,0.0538624482756205,4.5034369296122e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.0267627034609463,0.00248211744838229,0.021897753262117,0.0316276536597756,5.38273011262437e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RETN,Resistin,42598,-0.0477808630592059,0.00443743971612239,-0.0564782449028058,-0.039083481215606,6.30463023558554e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42594,-0.0562075920591992,0.00522191295992736,-0.0664425414606569,-0.0459726426577416,6.57339662019127e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,42136,-0.100670534472888,0.00935920903024695,-0.119014584172172,-0.0823264847736036,7.18825632672865e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,-0.0488027070149144,0.0045376272413431,-0.0576964564079469,-0.0399089576218819,7.21753084360596e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,-0.0256096055552634,0.00238149251663787,-0.0302773308878736,-0.0209418802226532,7.33326151679087e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,40527,-0.0458106562213241,0.00426229347488647,-0.0541647514321016,-0.0374565610105466,8.16367368507838e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,-0.0791214449702643,0.00736700775682014,-0.0935607801736318,-0.0646821097668969,8.5322148819562e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40283,-0.0457323738543284,0.00426037691016494,-0.0540827125982516,-0.0373820351104051,9.50057589818036e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,40302,-0.142018490508544,0.0132315112155225,-0.167952252490968,-0.11608472852612,9.59752441054621e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,42587,-0.0356361713891849,0.00332583662110087,-0.0421548111665426,-0.0291175316118271,1.11080477022942e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,42534,-0.076485789411191,0.00715431220708062,-0.090508241337069,-0.0624633374853129,1.43883775957578e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,42475,-0.0556385183279428,0.00520655317496777,-0.0658433625508796,-0.0454336741050059,1.51328729041998e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COCH,Cochlin,40511,-0.0514228298640212,0.00481391340844857,-0.0608581001445804,-0.041987559583462,1.6504884535584e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,42754,-0.0378527139726386,0.00354649515399722,-0.0448038444744731,-0.030901583470804,1.72943040156448e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,42754,0.00954107694958197,0.000894970057666698,0.00778693563655525,0.0112952182626087,1.97609010608005e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,-0.0529563600923672,0.00497227809889222,-0.0627020251661959,-0.0432106950185384,2.31767635078281e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,40499,-0.0480526580954772,0.0045146652807853,-0.0569014020458164,-0.0392039141451381,2.48615751767537e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,42760,-0.0310419377998064,0.00291866667190555,-0.0367625244767413,-0.0253213511228716,2.58206164479818e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,42594,-0.102511091763664,0.00963831806055555,-0.121402195162353,-0.0836199883649752,2.58610374011441e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,42721,0.0375345110594368,0.00353231588712299,0.0306111719206758,0.0444578501981979,2.86223085420806e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,42538,-0.0780020559812879,0.00735081096113133,-0.0924096454651053,-0.0635944664974705,3.35612143717812e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,-0.102321027561471,0.00965875690693412,-0.121252191099061,-0.0833898640238797,4.06463077630262e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,40136,-0.0437086044262556,0.00412932744210714,-0.0518020862127856,-0.0356151226397256,4.6782301181841e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,40449,-0.111628871566536,0.0105472051139864,-0.132301393589949,-0.0909563495431222,4.69923276288446e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,-0.0214111798983998,0.00202455295521779,-0.0253793036906267,-0.017443056106173,4.92064112719807e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,40483,-0.041669613068588,0.00394138930225352,-0.0493947361010048,-0.0339444900361711,5.29762985540917e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,42594,0.0477931512333636,0.00452280980021967,0.038928444024933,0.0566578584417941,5.35586720953351e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGN,Mimecan,42611,-0.0478897772485637,0.00453985485982819,-0.0567878927738269,-0.0389916617233004,6.50234186463834e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,42711,-0.0306723446409137,0.00291080027861248,-0.0363775131869942,-0.0249671760948332,7.31451194639053e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,42654,-0.0335103884584017,0.00318290944314956,-0.0397488909669748,-0.0272718859498286,8.0671988332952e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,40482,-0.111965879856716,0.0106363534523529,-0.132813132623328,-0.0911186270901046,8.56636361111735e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,-0.104827812594205,0.00997097197363679,-0.124370917662533,-0.0852847075258769,9.8637401228753e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42311,-0.0652202090475809,0.00620713680630122,-0.0773861971879312,-0.0530542209072305,1.01154976444551e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,42611,-0.0794381080109231,0.00756397725700547,-0.0942635034346538,-0.0646127125871924,1.06205437576801e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,-0.0465604098399292,0.00443695426986106,-0.0552568402088569,-0.0378639794710016,1.15831306785355e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,42495,-0.0573307495237416,0.00546720631459684,-0.0680464739003514,-0.0466150251471318,1.25706916975424e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,-0.0897954182449135,0.00856034405053964,-0.106573692583971,-0.0730171439058558,1.26967471689235e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42611,0.0481136632534261,0.00459355735873172,0.0391102908303119,0.0571170356765402,1.42486853821871e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,40482,-0.0591390893651101,0.00564527476376468,-0.0702038279020889,-0.0480743508281314,1.46067567939498e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,42594,-0.0969068290718535,0.00926385505784669,-0.115063984985233,-0.078749673158474,1.64035435784911e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40387,-0.0338836691319394,0.00323858439880759,-0.0402312945536023,-0.0275360437102765,1.68364021036268e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,42721,-0.0422242233860357,0.00403935013579642,-0.0501413496521967,-0.0343070971198748,1.77099675798814e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,40451,-0.0386295783402546,0.00369425632521708,-0.0458703207376801,-0.0313888359428292,1.78677862047206e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42595,-0.0312551208929695,0.00299166842125828,-0.0371187909986357,-0.0253914507873033,1.8863608831429e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREH,Trehalase,40527,-0.0795522469430727,0.00762141018027398,-0.0944902108964097,-0.0646142829897357,2.16730161605317e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,-0.0764581804247857,0.00732812920656719,-0.0908213136696574,-0.062095047179914,2.27491073489863e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,42794,-0.0586890515723408,0.00563501030038529,-0.0697336717610959,-0.0476444313835856,2.63474839632859e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,42495,-0.0554560139044531,0.0053248559803704,-0.0658927316259791,-0.0450192961829272,2.66201817234487e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,-0.0852260046136318,0.00818182559993283,-0.1012623827895,-0.0691896264377634,2.73194709202825e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,42346,-0.0605509494369839,0.00582011129104754,-0.0719583675674371,-0.0491435313065307,2.98693397018013e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,42692,-0.066320212107397,0.00637775477467321,-0.0788206114657565,-0.0538198127490375,3.13070131877722e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,-0.0406798662256221,0.00391325841541421,-0.048349852719834,-0.0330098797314103,3.2446673979245e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42587,-0.0890486092590559,0.00857091614549291,-0.105847604904222,-0.0722496136138898,3.44576538305194e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,42711,-0.0847498473327053,0.00815747645822058,-0.100738501190818,-0.068761193474593,3.4532486033598e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,42679,-0.0335221352087647,0.00322733367879646,-0.0398477092192058,-0.0271965611983237,3.5379037929364e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42681,-0.0290550525407298,0.00279749281187987,-0.0345381384520143,-0.0235719666294453,3.56881999049806e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40283,-0.0409824774126442,0.00394566319832743,-0.0487159772813659,-0.0332489775439224,3.71676385546423e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42711,-0.0707407153498303,0.00682196050060349,-0.0841117579310132,-0.0573696727686475,4.23619114037634e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42495,-0.0249797800292279,0.00241425488525063,-0.0297117196043192,-0.0202478404541367,5.38323372040493e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42679,-0.0349008740493917,0.00337675740333479,-0.0415193185599279,-0.0282824295388555,6.02530678682627e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42594,-0.0898030867768962,0.008689189712109,-0.10683389861263,-0.0727722749411626,6.06991078032465e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,-0.0549555020704012,0.0053236083714008,-0.0653897744783468,-0.0445212296624557,6.86320471393321e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42311,-0.0608360431786442,0.00589428965879185,-0.0723888509098763,-0.0492832354474122,7.03710022622616e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40283,-0.0428285200851242,0.00414992008484248,-0.0509623634514154,-0.0346946767188329,7.38820038454128e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,-0.0682447445715808,0.00661877137302337,-0.0812175364627066,-0.055271952680455,8.16305389139207e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40287,-0.0686288215963386,0.00666018343624788,-0.0816827811313844,-0.0555748620612927,8.71046157892758e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,-0.0611858545475583,0.00594642762649747,-0.0728408526954934,-0.0495308563996233,9.74905128653972e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,42594,-0.0954421013583594,0.00927940555395247,-0.113629736244106,-0.0772544664726126,1.01359750745774e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,42611,0.0272009390154906,0.00264475809070549,0.0220172131577078,0.0323846648732733,1.01875316627421e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,42357,-0.0611323314248903,0.00594598148095871,-0.0727864551275694,-0.0494782077222112,1.06112863961278e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,42130,-0.0263751206563928,0.00256731113536225,-0.0314070504817028,-0.0213431908310828,1.15464171299826e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.0325968291111452,0.00318429660280846,-0.0388380504526497,-0.0263556077696406,1.73759997693293e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42737,-0.0446498003653079,0.00436930590661333,-0.0532136399422701,-0.0360859607883458,1.99987872813219e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40182,-0.126375405592724,0.012365996870656,-0.15061275945921,-0.102138051726239,2.08320956811587e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,40116,-0.0713357833023232,0.00698036283301889,-0.0850172944550403,-0.0576542721496062,2.08835993787855e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,42587,-0.0736149257231316,0.0072083892284308,-0.087743368610856,-0.0594864828354073,2.14386947743286e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,-0.0610303594513677,0.00597802810040526,-0.072747294528162,-0.0493134243745734,2.21544194620903e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,42441,0.0295101117438244,0.00289491598313975,0.0238360764168705,0.0351841470707783,2.59917538519606e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,0.0259431569772358,0.00254685050979941,0.0209513299780289,0.0309349839764426,2.78830498799302e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,42370,-0.0470439335400411,0.00463347452039262,-0.0561255436000106,-0.0379623234800716,3.93995458400775e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,-0.0793596607557547,0.00783181294139926,-0.0947100141208972,-0.0640093073906121,4.81541345869089e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42794,-0.0336464975648431,0.00332803575195164,-0.0401694476386683,-0.0271235474910179,6.0603406438784e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42794,-0.0681870771386105,0.00675209498991062,-0.0814211833188353,-0.0549529709583857,6.79923923577728e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,40440,-0.0299677310202652,0.00297746702452673,-0.0358035663883376,-0.0241318956521928,9.95705144904808e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,40470,-0.0335655491239591,0.00333810352502404,-0.0401082320330062,-0.027022866214912,1.09568834174954e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42794,-0.0423447725894235,0.00421429787840323,-0.0506047964310938,-0.0340847487477531,1.13517151605885e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40449,-0.0484692826599086,0.00482372216683833,-0.0579237781069117,-0.0390147872129055,1.17809581108889e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,42679,-0.0844086711488843,0.00840823338614757,-0.100888808585734,-0.0679285337120351,1.24571346370289e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,40527,-0.0288940947117493,0.00287738355570561,-0.0345337664809323,-0.0232544229425663,1.25332600078709e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,42594,-0.0866164641845052,0.00864357167831979,-0.103557864674012,-0.0696750636949984,1.49309788305022e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,40054,-0.0748494941810217,0.00746727984774505,-0.089485362682602,-0.0602136256794414,1.51837870506564e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,42618,-0.0414525143257323,0.00413793500826781,-0.0495628669419372,-0.0333421617095274,1.54179593083177e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42311,-0.0799037388028614,0.00797850066835325,-0.0955416001128338,-0.0642658774928891,1.59278374367086e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASPN,Asporin,40511,0.0289721375159151,0.00289454576574622,0.0232988278150526,0.0346454472167777,1.73847570204241e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42346,-0.0581987243123259,0.00583924274853817,-0.0696436400994607,-0.046753808525191,2.57573694434213e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,40283,-0.0320280662067981,0.00321553946769751,-0.0383305235634852,-0.025725608850111,2.84459932412192e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,42563,-0.0371452747198345,0.00373174088692249,-0.0444594868582026,-0.0298310625814665,2.92240356721969e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40283,-0.0677295411194359,0.00680380442466323,-0.0810649977917758,-0.0543940844470959,3.01223049344688e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40449,-0.0780813829822651,0.00784424112315447,-0.0934560955836479,-0.0627066703808824,3.02280093495796e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,40283,-0.0519873477626585,0.00522285379724586,-0.0622241412052604,-0.0417505543200567,3.03745750114479e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,42636,0.0317769368188754,0.0031961200006658,0.0255125416175704,0.0380413320201804,3.27507978610703e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,-0.0196494485978392,0.00197663033779121,-0.02352364405991,-0.0157752531357684,3.31771664873974e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42760,-0.0339508132861453,0.00342139399106592,-0.0406567455086345,-0.0272448810636561,3.96068082538393e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,42679,-0.057568495430388,0.00582037680946096,-0.0689764339769315,-0.0461605568838445,5.46170730648715e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBIN,Erbin,42587,-0.102932550792316,0.0104122616969568,-0.123340583718351,-0.0825245178662802,5.75482967567617e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,-0.064063727292768,0.00648468773102233,-0.0767737152455718,-0.0513537393399643,6.34160435574545e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,-0.0865994915949094,0.00877696131120302,-0.103802335764867,-0.0693966474249515,6.98566567508531e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,-0.0299129729919609,0.00303244136903815,-0.0358565580752757,-0.0239693879086461,7.34879918625021e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,-0.0649740200665774,0.0065998477576266,-0.0779097216715256,-0.0520383184616293,8.91691090950724e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,42600,-0.0306037621191486,0.00311067065844693,-0.0367006766097046,-0.0245068476285926,9.19376176918415e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,42642,-0.0689021666487255,0.0070107030078985,-0.0826431445442066,-0.0551611887532445,1.01587842306605e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,40483,-0.063675462954315,0.00648048127847864,-0.0763772062601332,-0.0509737196484969,1.0756956353193e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40449,-0.0850864037584481,0.00866153895834921,-0.102063020116813,-0.0681097874000837,1.10053913715215e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,-0.107768074458901,0.0109915355291248,-0.129311484095985,-0.086224664821816,1.32351228615404e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALB2,Calretinin,42311,-0.0321960493861744,0.00328724953297688,-0.0386390584708091,-0.0257530403015397,1.42460432468331e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,40451,-0.0212840437338203,0.00217248755233917,-0.025542119336405,-0.0170259681312355,1.42628584846208e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40532,-0.0659425752038825,0.00673325653815546,-0.0791397580186672,-0.0527453923890978,1.47424540034785e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,-0.030125535395507,0.00307790502059939,-0.0361582292358818,-0.0240928415551322,1.51182546346558e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,-0.0945607685346946,0.00966193314856336,-0.113498157505879,-0.0756233795635104,1.5264340021395e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42754,-0.0549909758170423,0.00561969430080878,-0.0660055766466275,-0.0439763749874571,1.54449497335316e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,-0.0660971191059468,0.00675467199934106,-0.0793362762246553,-0.0528579619872383,1.55286740070411e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,-0.0409886484844628,0.00419709174807107,-0.0492149483106821,-0.0327623486582435,1.93197595005035e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWC2,Brorin,42456,-0.0410851890589847,0.00421107955001477,-0.0493389049770137,-0.0328314731409558,2.05915562364329e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,42578,-0.0825152083784249,0.00846868145458973,-0.0991138240294208,-0.0659165927274291,2.33190431719209e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,-0.0439545761171211,0.00451245114944086,-0.0527989803700252,-0.035110171864217,2.4872463569204e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,-0.0578707360432823,0.00594156182477836,-0.0695161972198479,-0.0462252748667167,2.50146684327656e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,-0.102684205639272,0.0105560987450273,-0.123374159179526,-0.0819942520990185,2.72832006837262e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,-0.0628879414656262,0.00646581716526489,-0.0755609431095454,-0.050214939821707,2.76060918085426e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,-0.111706341108242,0.0114826992106015,-0.134212431561021,-0.0892002506554628,2.80436247127346e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOST,Sclerostin,42613,-0.0387716453536368,0.00399243123198248,-0.0465968105683224,-0.0309464801389511,3.19415513881307e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40199,-0.0489162664020828,0.00503596738983576,-0.0587867624861609,-0.0390457703180047,3.24686130761974e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42711,-0.0943051648251073,0.00971880223686591,-0.113354017209364,-0.0752563124408501,3.44591789412319e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,-0.0321746312699294,0.00331644627022119,-0.0386748659595629,-0.0256743965802958,3.62458151915893e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,-0.0281886405151999,0.00290819559142112,-0.0338887038743853,-0.0224885771560145,3.82615515875964e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42737,-0.0310016045250538,0.00319851876824132,-0.0372707013108068,-0.0247325077393008,3.82975230866569e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,42495,-0.0538333215051751,0.00555722463405988,-0.0647254817879325,-0.0429411612224177,4.04832435227735e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,0.021310323613027,0.00220027287729905,0.0169977887735209,0.0256228584525332,4.12612396774664e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,42594,-0.0795189808577729,0.00821813102568825,-0.0956265176681219,-0.063411444047424,4.50132179099288e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGRN,Neugrin,40483,-0.0230319155314706,0.0023816455522932,-0.0276999408139653,-0.018363890248976,4.89468668488896e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,42261,-0.0718372038844525,0.00743234565931774,-0.0864046013767152,-0.0572698063921897,5.00804794119409e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,-0.045348330971606,0.00469101266855185,-0.0545427158019677,-0.0361539461412444,5.08079670629438e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,-0.0215286557509728,0.00222820762185042,-0.0258959426897997,-0.017161368812146,5.34476098076705e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,-0.0526220792039456,0.00544883512475084,-0.0633017960484573,-0.041942362359434,5.3953687785211e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,42346,-0.0644750267576725,0.00667950113138087,-0.077566848975179,-0.051383204540166,5.66391997251231e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,42587,-0.0295291450944635,0.00306256230999602,-0.0355317672220557,-0.0235265229668713,6.26311916221941e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,42495,-0.058696366403029,0.00611890748055277,-0.0706894250649124,-0.0467033077411456,1.0096112037051e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,42590,-0.0297863909540009,0.00310552842136335,-0.035873226659873,-0.0236995552481287,1.02031194339283e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,42711,-0.0585699563622923,0.00610815992654891,-0.0705419498183281,-0.0465979629062564,1.04470526606418e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,-0.0732091617413484,0.00763728797625477,-0.0881782461748078,-0.0582400773078891,1.11486714997431e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,42587,-0.0756051303239583,0.00789287717145556,-0.0910751695800112,-0.0601350910679054,1.15076869607286e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,42611,-0.0435502403027544,0.00455486135312131,-0.0524777685548721,-0.0346227120506366,1.36289825817809e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42587,-0.0329710248315322,0.00345009630058337,-0.0397332135806756,-0.0262088360823888,1.42636489935594e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,42636,-0.0411169912429144,0.00431746263669775,-0.049579218010842,-0.0326547644749868,1.95800625468719e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,-0.06253017936952,0.00657158314495921,-0.07541048233364,-0.0496498764054,2.18161580817946e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40383,-0.0582559785484473,0.00612429874795664,-0.0702596040944424,-0.0462523530024523,2.2467276631348e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42311,-0.0500772536055668,0.00526674331235491,-0.0604000704977824,-0.0397544367133512,2.2730165862066e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,40283,0.0509203256664682,0.00536498698559205,0.0404049511747078,0.0614357001582286,2.74996226038955e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,42636,0.0365395325486589,0.00385165107801864,0.0289902964357424,0.0440887686615754,2.77917284266003e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,42679,-0.0385210899745181,0.00406110973622581,-0.0464808650575207,-0.0305613148915155,2.81400787603194e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,40379,0.106472133825448,0.0112216706672244,0.0844776593176879,0.128466608333207,2.8290887330644e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NBN,Nibrin,42370,-0.0519152338595861,0.00547449952445106,-0.0626452529275102,-0.041185214791662,2.88547021888863e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,42580,-0.0280544019014927,0.00296883194099992,-0.0338733125058525,-0.0222354912971329,3.95629753749497e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,42711,-0.0566050568535162,0.00599304944233578,-0.0683514337604944,-0.0448586799465381,4.12383752821121e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,-0.0735496552404566,0.00779560429279232,-0.0888290396543296,-0.0582702708265837,4.68708311000883e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,42676,-0.100676651164538,0.0106935820774055,-0.121636072036253,-0.0797172302928237,5.50388409161357e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,42311,-0.0336658527447481,0.00357586392496519,-0.0406745460376799,-0.0266571594518164,5.5230535314253e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,42794,-0.0255082426526688,0.00270975795089812,-0.0308193682364291,-0.0201971170689085,5.55974445803357e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,-0.0867549585204105,0.00921802076927204,-0.104822279228184,-0.0686876378126373,5.8392148922753e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,40511,-0.0715433985575296,0.00761586770437034,-0.0864704992580954,-0.0566162978569637,6.88168547206999e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,42636,0.0497282080918155,0.00529648434087704,0.0393470987836965,0.0601093173999345,7.02355281777988e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42587,-0.131126948505786,0.0139907022303626,-0.158548724877297,-0.103705172134275,8.20740832316704e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,0.0426442419509094,0.00455491879341064,0.0337166011158246,0.0515718827859943,9.02390508990593e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,42711,-0.0359565307172737,0.00384232938852083,-0.0434874963187746,-0.0284255651157729,9.38846487228742e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,40466,-0.0630882471360239,0.006741211746845,-0.0763010221598401,-0.0498754721122077,9.60782471188657e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42346,-0.0382374735778151,0.00408703465503041,-0.0462480615016748,-0.0302268856539555,9.62335013779182e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42587,-0.0370219231739498,0.00395991370747676,-0.0447833540406043,-0.0292604923072954,1.02141837182056e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,42711,-0.0295122977375085,0.00315919194448616,-0.0357043139487014,-0.0233202815263156,1.09398119734414e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,-0.0460005703231823,0.00492714416459102,-0.0556577728857807,-0.0363433677605839,1.18611211950776e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,42357,-0.0473898296376846,0.00508414486777256,-0.0573547535785188,-0.0374249056968504,1.3323993689711e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,40116,-0.0465921309821207,0.00499700425424242,-0.0563862593204358,-0.0367980026438056,1.33583156478319e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,-0.0321611436549279,0.0034548171250738,-0.0389325852200725,-0.0253897020897833,1.53401631660212e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42311,-0.036448675619773,0.0039184063342293,-0.0441287520348624,-0.0287685992046836,1.59518658325823e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42346,-0.0314726078224746,0.00338779591207955,-0.0381126878101505,-0.0248325278347987,1.78232216243467e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,42689,-0.0540257441156316,0.00581646407202885,-0.0654260136968082,-0.0426254745344551,1.80218306006179e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40483,-0.0310633116860248,0.00334812092312199,-0.0376256286953439,-0.0245009946767057,2.04400797509896e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,40199,-0.0521680487601896,0.00562325487404867,-0.063189628313325,-0.0411464692070542,2.06499259620728e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,-0.054543181516143,0.00588378417660071,-0.0660753985022803,-0.0430109645300056,2.14248999797533e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,-0.0616167471059133,0.00664761866640465,-0.0746460796920664,-0.0485874145197602,2.1594896378035e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40451,-0.108081625324455,0.0116621436985713,-0.130939426973654,-0.085223823675255,2.24657693660163e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,-0.0679710128227033,0.00733889817892784,-0.0823552532534018,-0.0535867723920047,2.31547941381282e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,42495,-0.0391424182654743,0.00422701601324659,-0.0474273696514376,-0.030857466879511,2.35212220325703e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40302,-0.0538839445231646,0.00581941438820993,-0.0652899967240561,-0.0424778923222732,2.43426686072997e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42721,-0.0376177828499739,0.00406738564607211,-0.0455898587162753,-0.0296457069836726,2.60958792226826e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,-0.0754460782499168,0.00815507218130718,-0.0914300197252788,-0.0594621367745547,2.61419904171073e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42676,-0.116835236923845,0.0126388231858011,-0.141607330368015,-0.0920631434796751,2.72189074861577e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,40199,-0.0327565553987334,0.0035479539329579,-0.0397105451073309,-0.0258025656901359,3.12709960722971e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,-0.0252022085469315,0.0027328253689812,-0.0305585462701347,-0.0198458708237284,3.34903847953468e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,-0.101026949093777,0.0109839052894293,-0.122555403461058,-0.0794984947264954,4.19329382707453e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42357,-0.0681879953111092,0.00742016822140098,-0.0827315250250551,-0.0536444655971632,4.5289120071779e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,-0.0897320681716154,0.00976694677822342,-0.108875283856933,-0.0705888524862975,4.60793814563833e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42346,-0.0358213452498107,0.00390182695717022,-0.0434689260858644,-0.0281737644137571,4.91681425269088e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,42594,-0.036045648894624,0.00393071412983391,-0.0437498485890985,-0.0283414492001495,5.39839364382012e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40482,-0.0582607825962593,0.0063553495542694,-0.0707172677226273,-0.0458042974698913,5.69297121090012e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORT1,Sortilin,42613,-0.0345595399641342,0.00378495164541842,-0.0419780451891543,-0.0271410347391141,7.76110062211716e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BSG,Basigin,42746,-0.0203375939906742,0.00222828263352553,-0.0247050279523842,-0.0159701600289641,8.02242707133916e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,40166,-0.0420726662782679,0.00461065883230296,-0.0511095575895817,-0.0330357749669541,8.41946409481741e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,42794,-0.0390047166057174,0.00428620649888989,-0.0474056813435416,-0.0306037518678932,1.02672970386528e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40449,-0.0771421462123668,0.00848321385279933,-0.0937692453638535,-0.0605150470608801,1.11950764578466e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42658,-0.0650685057643596,0.00716265380236272,-0.0791073072169906,-0.0510297043117287,1.18613321562351e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,-0.0488483693502642,0.00538029212043353,-0.0593937419063139,-0.0383029967942145,1.24373935324541e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,40223,-0.0284034625097539,0.00312860017703761,-0.0345355188567476,-0.0222714061627602,1.28609440823032e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,42636,-0.0325828992322869,0.0035976052564897,-0.0396342055350067,-0.0255315929295671,1.52582446490384e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42754,-0.0617305162689746,0.00682498215690708,-0.0751074812965125,-0.0483535512414367,1.70072789329128e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40511,-0.0685046929041631,0.00757177553691733,-0.083345372956521,-0.0536640128518051,1.70297237530319e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,-0.0317031578727876,0.00350977399190217,-0.0385823148969159,-0.0248240008486593,1.89680541306244e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,42754,-0.0253252270623977,0.00280546981907842,-0.0308239479077914,-0.019826506217004,1.99755330606945e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,42746,-0.0487175776855818,0.00539964905147709,-0.0593008898264769,-0.0381342655446867,2.08534098602854e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,40511,-0.0909141321275607,0.0100772835313522,-0.110665607849011,-0.0711626564061103,2.15010990537783e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,-0.0369390546366766,0.00409964956565662,-0.0449743677853636,-0.0289037414879897,2.38479534655432e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,42794,0.0257289747953788,0.00285846837911057,0.0201263767723221,0.0313315728184355,2.53059869994032e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42311,-0.0612623226528845,0.00681320051556555,-0.0746161956633929,-0.047908449642376,2.76412553766866e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,0.0382514054862729,0.00425601283844071,0.0299096203229291,0.0465931906496167,2.86092991017155e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,40418,-0.042259025055377,0.00470169829276852,-0.0514743537092033,-0.0330436964015507,2.91908084059338e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNST,Consortin,42636,-0.0997013604256776,0.0111003065371381,-0.121457961238468,-0.0779447596128869,3.01243481532329e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELP,P-selectin,42689,-0.0514388734881258,0.00572874985083671,-0.0626672231957657,-0.0402105237804858,3.0876136796676e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,40483,-0.0757981222374721,0.0084405790839035,-0.092341657241923,-0.0592545872330213,3.1302477862705e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,42638,0.0196689457837557,0.00219589348143261,0.0153649945601478,0.0239728970073636,3.76480815966872e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PI3,Elafin,42446,-0.0521882672659511,0.00582981999371292,-0.0636147144536284,-0.0407618200782738,3.95225112446339e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42689,0.0277519446193652,0.00310590247296633,0.0216643757723511,0.0338395134663792,4.58402421219162e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42611,-0.089013499021017,0.00996923176270004,-0.108553193275909,-0.0694738047661249,4.85904887485412e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,42562,-0.0696424245406913,0.00780023143222207,-0.0849308781478465,-0.054353970933536,4.88620774274454e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,-0.0699350902555585,0.00783051277868723,-0.0852828953017854,-0.0545872852093315,4.88641556150439e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42679,0.0268324435800087,0.00300560167328781,0.0209414643003646,0.0327234228596529,4.91509432754855e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,42669,-0.0273448661042647,0.00306925146123086,-0.0333605989682772,-0.0213291332402522,5.78688323684739e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,40532,-0.0430680599296273,0.00483579180924808,-0.0525462118757536,-0.0335899079835011,6.08950988869931e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,42636,-0.109465668273069,0.0123038892727725,-0.133581291247703,-0.0853500452984346,6.47227163886759e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40199,-0.0814281334171025,0.00915063479411449,-0.0993633776135669,-0.0634928892206381,6.53829119485332e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,-0.0646368774899033,0.00726913901235431,-0.0788843899541177,-0.0503893650256888,6.76358073855233e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRN,Progranulin,42552,-0.0223712252209492,0.0025163607226419,-0.0273032922373273,-0.0174391582045711,6.86664782282801e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,0.034184037923384,0.00384547257775848,0.0266469116709773,0.0417211641757906,6.9128781860803e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,0.0218852760069474,0.00246359257687436,0.0170566345562736,0.0267139174576211,7.29097745257421e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,40199,-0.0515739894121261,0.00580689713689263,-0.0629555078004357,-0.0401924710238165,7.61952258991891e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,40482,-0.0713693992410799,0.00804387011804347,-0.0871353846724451,-0.0556034138097146,8.22605768824164e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42357,-0.0346669230460157,0.00390949651631973,-0.0423295362180024,-0.0270043098740291,8.44413952884914e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40283,-0.0710985265886995,0.0080401749223729,-0.0868572694365504,-0.0553397837408486,1.07349136588385e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,40223,-0.0547960690525561,0.00620182373498704,-0.0669516435731308,-0.0426404945319816,1.14765052458963e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,-0.102852422289849,0.0116460959136737,-0.125678770280649,-0.0800260742990483,1.15965022341958e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,-0.0271752960875931,0.0030804454670011,-0.0332129692029152,-0.0211376229722709,1.26610192396506e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,-0.0561275062950023,0.00636295173052358,-0.0685988916868286,-0.0436561209031761,1.30696169400838e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,40283,-0.104591248924819,0.0118600795326972,-0.127837004808906,-0.0813454930407327,1.33013780120886e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,-0.0608861961852738,0.00690839182896449,-0.0744266441700442,-0.0473457482005034,1.36280122517468e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,42587,-0.0495115305316638,0.00562137757571951,-0.0605294305800741,-0.0384936304832536,1.43247489177307e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,-0.0611667309429668,0.00695169233764689,-0.0747920479247547,-0.0475414139611789,1.55289733006344e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,40451,-0.0429556601727695,0.00488525563776478,-0.0525307612227885,-0.0333805591227505,1.66877131391537e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,40223,-0.0610968607331163,0.00695387437037962,-0.0747264544990603,-0.0474672669671722,1.7787006421771e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,40223,-0.0655676486876489,0.00746746589467962,-0.080203881841221,-0.0509314155340769,1.8684892273487e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0356571230421049,0.00406455769978936,0.0276905899505178,0.0436236561336921,1.95669002336106e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42594,-0.0438149996824673,0.00499586916894417,-0.0536069032535979,-0.0340230961113367,1.99565124938081e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,42676,0.0578512589522727,0.00660087533831334,0.0449135432891785,0.0707889746153668,2.10399080160139e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,42563,-0.034269952527288,0.00391562722676897,-0.0419445818917552,-0.0265953231628208,2.34275619881447e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40449,-0.035916189779932,0.00410523240744372,-0.0439624452985217,-0.0278699342613424,2.46110887758575e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,40199,-0.0330046708122753,0.00377380302998364,-0.0404013247510433,-0.0256080168735074,2.5378551821981e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,40494,-0.0421585890242445,0.00482894001061096,-0.051623311445042,-0.032693866603447,2.8937288405645e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,40449,-0.062537250822195,0.0071695282694517,-0.0765895262303203,-0.0484849754140696,3.09927383193481e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,42495,0.0229944793114669,0.00263830361479335,0.0178234042264719,0.0281655543964619,3.23048691209089e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,-0.0512879279460528,0.00588840059280142,-0.0628291931079436,-0.039746662784162,3.40002005473982e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40483,-0.0792369791774954,0.00909938641942077,-0.0970717765595601,-0.0614021817954307,3.52417197788789e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,40283,-0.0637271998193604,0.00732546602573141,-0.078085113229794,-0.0493692864089268,3.80674155010935e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42587,-0.0284530436496945,0.00327358143740551,-0.0348692632670093,-0.0220368240323798,3.98087484056211e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,40451,-0.0362195459246334,0.00416605012954938,-0.0443850041785501,-0.0280540876707166,3.98409191762969e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,40539,-0.0151969483948473,0.00174967392091017,-0.0186263092798313,-0.0117675875098634,4.28300952294773e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,40482,-0.0489507479450448,0.00564210286012738,-0.0600092695508945,-0.0378922263391952,4.66117893338147e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,-0.068873024265279,0.00794913251713329,-0.0844533239988603,-0.0532927245316977,5.16466767041314e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,40451,-0.0351803854971157,0.00406645033378781,-0.0431506281513398,-0.0272101428428916,5.77821086174896e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,42346,-0.0492126715326353,0.00569190253168485,-0.0603688004947376,-0.038056542570533,5.94129597985315e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42594,-0.09781253926396,0.011329388058049,-0.120018139857736,-0.0756069386701839,6.61445656433953e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,42794,0.0264596468419188,0.00306891519669679,0.0204445730563931,0.0324747206274445,7.31121181541558e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,0.0241066897742268,0.00279556801795579,0.0186273764590335,0.0295860030894202,7.37670922017276e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,-0.0614786549023126,0.00713759648359528,-0.0754683440101594,-0.0474889657944658,8.06426616198788e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40980,0.0279675558249702,0.00325057192825374,0.0215964348455928,0.0343386768043475,8.67868868300045e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40511,-0.0464886116738718,0.00540763963747137,-0.0570875853633157,-0.0358896379844279,9.27005695844704e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,-0.024309087495618,0.00283039433036996,-0.0298566603831432,-0.0187615146080929,9.99357197071365e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42754,-0.0535544613793907,0.00624047043653118,-0.0657857834349918,-0.0413231393237896,1.0346475691621e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,40451,-0.072950387677143,0.00850830536903537,-0.0896266662004523,-0.0562741091538337,1.12983105965167e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,42311,-0.0589223098068309,0.00688447645687341,-0.0724158836623028,-0.0454287359513591,1.26718549772794e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KAZN,Kazrin,40449,-0.091549946739378,0.0107024845781295,-0.112526816512512,-0.0705730769662443,1.34176022801514e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,-0.0624882723587069,0.00730627880238472,-0.0768085788113809,-0.0481679659060328,1.36052539932501e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,42346,-0.0250321577948318,0.00292832149557156,-0.030771667926152,-0.0192926476635115,1.38593874314686e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,-0.0214450628368935,0.00250895739291768,-0.0263626193270122,-0.0165275063467749,1.39415713195988e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,42594,-0.0712866601891045,0.00836019272113115,-0.0876726379225215,-0.0549006824556874,1.66268271108418e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,40199,-0.0351959795343768,0.00412906493571639,-0.043288946808381,-0.0271030122603727,1.74314237071853e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,40182,-0.0398067186108856,0.00467091150903691,-0.0489617051685979,-0.0306517320531733,1.76908477081357e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42495,-0.0500019090963498,0.00586949843148368,-0.0615061260220578,-0.0384976921706418,1.78191821080041e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,40116,-0.068154059823059,0.00800616741950877,-0.0838461479652962,-0.0524619716808218,1.92170809505813e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,-0.0368056977469167,0.00432446776803599,-0.0452816545722673,-0.0283297409215662,1.94564451293443e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,42611,-0.0336335810163739,0.00395939385514345,-0.0413939929724551,-0.0258731690602928,2.19304892656407e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,39870,-0.108336502218183,0.0127572005483856,-0.133340615293019,-0.0833323891433474,2.29695028959664e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,42494,-0.0605989582922105,0.00714427271978973,-0.0746017328229984,-0.0465961837614226,2.44181963925882e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,40449,-0.0610257837427138,0.00719492615587121,-0.0751278390082213,-0.0469237284772062,2.49459154618275e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,40511,-0.0717171328325482,0.00845763328142313,-0.0882940940641375,-0.0551401716009589,2.54040389169022e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,40342,-0.0948265000172977,0.011196575493615,-0.116771787984783,-0.0728812120498122,2.77951192821477e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,-0.0373676687269454,0.00441575016103603,-0.046022539042576,-0.0287127984113148,2.89473393431122e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,42711,-0.0560081327415727,0.00662466658237055,-0.068992479243019,-0.0430237862401265,3.08813222378748e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,42611,-0.0402900451084987,0.00476559474607307,-0.0496306108108019,-0.0309494794061955,3.0936485724298e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,0.0250903213477667,0.0029746690872433,0.0192599699367698,0.0309206727587635,3.65384524733669e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,42638,-0.0212170922590939,0.00251855391186104,-0.0261534579263415,-0.0162807265918463,3.99406593906899e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,42311,-0.045428418478781,0.00539430225605411,-0.0560012509006471,-0.034855586056915,4.09852345504831e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,-0.028941352787182,0.00344825511326944,-0.0356999328091901,-0.0221827727651739,5.32628836056398e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,42346,-0.03343855358288,0.00398857489276415,-0.0412561603726978,-0.0256209467930623,5.65250174998966e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,42689,-0.038693829347049,0.00462440993241296,-0.0477576728145784,-0.0296299858795196,6.47027352380162e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,-0.0947833279221437,0.0113306350173904,-0.116991372556229,-0.0725752832880585,6.59432776760226e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42663,-0.0239944636206015,0.00287251042355751,-0.0296245840507742,-0.0183643431904288,7.292652101368e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,42779,-0.0304273758130477,0.00364562847547294,-0.0375728076249746,-0.0232819440011207,7.72102386177656e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,40483,-0.064109309077286,0.00768127169602453,-0.0791646016014941,-0.0490540165530779,7.87075845559201e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,40483,-0.0601385378414929,0.0072198362210374,-0.0742894168347262,-0.0459876588482597,9.04569008530979e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,42689,-0.084885775384572,0.0101971878782672,-0.104872263625976,-0.0648992871431683,9.28267181303045e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,40482,-0.0412510188211802,0.00495959080662465,-0.0509718168021645,-0.0315302208401959,1.00208073545601e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40449,-0.0409375878002001,0.00492333481517031,-0.0505873240379339,-0.0312878515624663,1.02286904450318e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42674,-0.0616605129018565,0.00743009579507891,-0.0762235006602112,-0.0470975251435019,1.15142691472643e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,42721,-0.0924806198431,0.0111457834204089,-0.114326355347101,-0.0706348843390985,1.16451180549065e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,-0.0786533575952925,0.00949032663689886,-0.0972543978036143,-0.0600523173869708,1.26527972502932e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,-0.0655769876780695,0.00792178945264721,-0.081103695005258,-0.050050280350881,1.3720763422521e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,-0.0806644666365363,0.00974604878932604,-0.0997667222636153,-0.0615622110094573,1.38720137641119e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42586,-0.0546443894476946,0.00660534497877734,-0.0675908656060982,-0.0416979132892911,1.43180876409461e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2,Complement C2,42663,-0.0194370533996588,0.00235164119814239,-0.0240462701480179,-0.0148278366512997,1.52272501745658e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,42644,0.023503874066159,0.00284425224348941,0.0179291396689198,0.0290786084633983,1.54433992026532e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42636,-0.0665503097141661,0.0080557227725375,-0.0823395263483396,-0.0507610930799926,1.57554350180887e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42636,-0.0246705226204608,0.0029875550882165,-0.0305261305933651,-0.0188149146475564,1.62195314714744e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42587,0.0201387997086472,0.00243967024027984,0.0153570460376987,0.0249205533795957,1.6641137981954e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,-0.0292107734733567,0.00353936608783311,-0.0361479310055096,-0.0222736159412038,1.71518004554731e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,40223,-0.0258768831446161,0.00313766685186972,-0.0320267101742808,-0.0197270561149515,1.80589106766054e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,0.0224647438866945,0.00273007019434802,0.0171138063057724,0.0278156814676166,2.0674030100155e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,42711,-0.11045672136936,0.0134288503760435,-0.136777268106406,-0.0841361746323151,2.12317901262951e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40199,-0.0643166197020781,0.00782135745493349,-0.0796464803137477,-0.0489867590904084,2.20402088889289e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,-0.0671707916235045,0.00816900426323765,-0.0831820399794503,-0.0511595432675588,2.20845179441848e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,40451,-0.0517571054208467,0.00630056178521988,-0.0641062065198776,-0.0394080043218157,2.35972422269275e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,42587,-0.0499427245792711,0.00608627260385327,-0.0618718188828235,-0.0380136302757187,2.4984571185272e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42618,0.0289133902285051,0.00352824340916896,0.021998033146534,0.0358287473104763,2.7351290982153e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,42611,-0.0224293453783316,0.00273787516654731,-0.0277955807047644,-0.0170631100518989,2.79458179153809e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,-0.0444133513236313,0.00542708420141204,-0.0550504363583989,-0.0337762662888637,3.05412965425391e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40482,-0.0605156108961399,0.00739580419219941,-0.0750113871128508,-0.0460198346794291,3.0800717328742e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,42346,-0.0815545251613699,0.00997282617423531,-0.101101264462871,-0.0620077858598687,3.15753851589531e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,40102,-0.0458287814187398,0.00560878525844634,-0.0568220005252946,-0.034835562312185,3.39929690868729e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,42311,-0.0597817684959762,0.00732417447569539,-0.0741371504683391,-0.0454263865236132,3.58658502900687e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40223,-0.0858511456454882,0.0105159446924909,-0.10646239724277,-0.065239894048206,3.59663468840704e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40511,-0.0407623619812323,0.00499588516735278,-0.0505542969092438,-0.0309704270532209,3.7292120394902e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,42721,-0.024867800598317,0.00305089657519284,-0.030847557885695,-0.018888043310939,3.92516153601849e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,42594,-0.0585144664001065,0.00717965232167923,-0.0725865849505978,-0.0444423478496152,3.95875257840081e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,-0.0565657796959841,0.0069497260206105,-0.0701872426963807,-0.0429443166955876,4.394485223872e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,40283,-0.0564334082570413,0.00693453986557712,-0.0700251063935724,-0.0428417101205101,4.4470358198145e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,-0.0542003765498506,0.00666764749985036,-0.0672689656495573,-0.0411317874501439,4.71888611650794e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.0273536937207533,0.00336475750036928,-0.0339486184214771,-0.0207587690200295,4.7701078067859e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPSE,Heparanase,40408,-0.0782204091467127,0.00962568579689687,-0.0970867533086306,-0.0593540649847949,4.89354653034313e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,-0.0636288014411519,0.00783469226778553,-0.0789847982860115,-0.0482728045962922,5.00895185112777e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42711,-0.0262682759773753,0.00323897583174243,-0.0326166686075905,-0.0199198833471602,5.49291205862632e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,42594,-0.0396141025187588,0.00488499620056586,-0.0491886950718679,-0.0300395099656498,5.5291064921934e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42357,-0.0462726031459276,0.00571061640482127,-0.0574654112993773,-0.035079794992478,5.83670662356473e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,42636,-0.0392999209338323,0.00485113461613002,-0.0488081447814472,-0.0297916970862175,5.90949720166156e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,40014,-0.0673824326295865,0.00831789601376604,-0.0836855088165679,-0.0510793564426051,6.04194462233807e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,42587,-0.0744886164923172,0.009199988473867,-0.0925205939010965,-0.0564566390835379,6.1370189486544e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,40511,-0.0238196961555052,0.00294182258476805,-0.0295856684216506,-0.0180537238893598,6.21388934415064e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,42681,-0.0437192698449673,0.00540286933300005,-0.0543088937376474,-0.0331296459522872,6.37569765960441e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,40223,-0.0441198858461692,0.0054628115912065,-0.054826996564934,-0.0334127751274045,7.36445111276663e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,40449,-0.0296542775260759,0.00367320778172496,-0.0368537647782568,-0.022454790273895,7.54883456676779e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,-0.0398712305295457,0.00494102765793248,-0.0495556447390933,-0.030186816319998,7.77806986628286e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,42679,-0.057427779493856,0.00712234055253673,-0.071387566976828,-0.043467992010884,8.06525667171527e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,40482,-0.0455630629536068,0.00565667554753366,-0.0566501470267728,-0.0344759788804409,8.76466212989348e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,-0.0178871651875291,0.0022211995354062,-0.0222407162769252,-0.0135336140981329,8.8971673086882e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,42292,-0.0388733100974103,0.00482937629681997,-0.0483388876391775,-0.0294077325556432,9.03807357531638e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,-0.0246790080081581,0.00306576811297166,-0.0306879135095826,-0.0186701025067337,9.12182571838762e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,-0.0643782379250176,0.00800268854651313,-0.0800635074761833,-0.0486929683738518,9.39427724929512e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42636,-0.0309646126470338,0.0038644553988226,-0.0385389452287261,-0.0233902800653415,1.21443734500682e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,42543,-0.0269252775559249,0.0033603797713401,-0.0335116219077515,-0.0203389332040983,1.21610506887499e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42370,-0.0296788300065505,0.00371094626923134,-0.036952284694244,-0.0224053753188571,1.37353975972412e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,-0.0357537918152379,0.00447408481201667,-0.0445229980467906,-0.0269845855836852,1.44587179505238e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42654,0.0713305336871467,0.00893144320041195,0.0538249050143392,0.0888361623599541,1.50095979161393e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,40269,0.0173061281308629,0.0021679717094857,0.013056903580271,0.0215553526814549,1.57384142167488e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.0341434913267853,0.00428194647729144,-0.0425361064222766,-0.0257508762312941,1.66314191838858e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,-0.0640941662077004,0.00804026358089171,-0.0798530828262482,-0.0483352495891527,1.6917849499327e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40482,-0.0615839323881585,0.00772788117514357,-0.0767305794914399,-0.0464372852848771,1.75256285361529e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40183,-0.0686170557050392,0.00861481285543465,-0.0855020889016911,-0.0517320225083873,1.81509040140602e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42565,-0.0353738224949132,0.0044436681642381,-0.0440834120968198,-0.0266642328930065,1.8509539602236e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40209,-0.045573530340214,0.00572526720516249,-0.0567950540623324,-0.0343520066180955,1.88816423169303e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40483,-0.055422680899343,0.00696423830304727,-0.0690725879733157,-0.0417727738253704,1.91269059870476e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,40223,-0.0387500160085973,0.00488032535948179,-0.0483154537131816,-0.029184578304013,2.21708253701332e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,42476,-0.0511098497547514,0.00644689293202123,-0.063745759901513,-0.0384739396079897,2.40735266050558e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,-0.0459666507379275,0.00580321086931152,-0.057340944041778,-0.0345923574340769,2.54261053934538e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40481,-0.0324580248180804,0.00409911584621354,-0.0404922918766589,-0.0244237577595019,2.63326426076372e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,42594,-0.0269046411761214,0.00340023345595284,-0.033569098749789,-0.0202401836024538,2.71789587469423e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,-0.0416942959686689,0.00526915981290085,-0.0520218492019546,-0.0313667427353832,2.75025637018847e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,42370,-0.0916450830784736,0.0115841827178188,-0.114350081205399,-0.0689400849515487,2.75113826512879e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42370,-0.0485654637385035,0.00614008867538975,-0.0606000375422674,-0.0365308899347396,2.78778731738867e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,40080,-0.0430113301873569,0.0054365928860533,-0.0536670522440214,-0.0323556081306925,2.79057005413781e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,-0.0438101790688901,0.00554135475027601,-0.0546712343794311,-0.0329491237583491,2.86363034502316e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,42311,-0.070113561561466,0.00886982438226671,-0.0874984173507088,-0.0527287057722233,2.89874789341856e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40223,-0.0704871248063103,0.00891893054256955,-0.0879682286697466,-0.053006020942874,2.97959404027554e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,40483,-0.0454812330327291,0.00575561024092703,-0.056762229104946,-0.0342002369605121,2.99773580951524e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,40182,-0.0392380324304146,0.00496914275637358,-0.0489775522329068,-0.0294985126279223,3.14557585705959e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42594,0.0426614154161656,0.00540450957857653,0.0320685766421556,0.0532542541901756,3.16127180707737e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,42642,-0.0759765460511928,0.00963347894747641,-0.0948581647882466,-0.057094927314139,3.34059371729948e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,-0.045735605377247,0.00580165939324707,-0.0571068577880113,-0.0343643529664828,3.43639268617924e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,-0.0397355327156569,0.00504307121343429,-0.0496199522939881,-0.0298511131373256,3.6035480455032e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,42677,0.0337917583462395,0.00429541904147296,0.0253727370249525,0.0422107796675265,3.91005635959907e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,42721,0.0380676141943817,0.00483991492000232,0.0285813809511771,0.0475538474375862,3.95861147890446e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,40199,-0.036184686517685,0.00460365306750078,-0.0452078465299865,-0.0271615265053834,4.19975302661037e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,40482,-0.0525614811662469,0.00670121199994784,-0.0656958566861447,-0.0394271056463491,4.77316189438534e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,42636,-0.0311626477212364,0.00397463317632757,-0.0389529287468384,-0.0233723666956344,4.82865721533949e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42676,-0.0228309108687932,0.00291350972214586,-0.0285413899241991,-0.0171204318133873,4.98947973649885e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,-0.050313908873381,0.00642239809412641,-0.0629018091378688,-0.0377260086088932,5.08197859243431e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42370,-0.0486554378167807,0.00621632136648607,-0.0608394276950934,-0.036471447938468,5.37446014963427e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,42754,-0.0394852274744662,0.00505279104317463,-0.0493886979190885,-0.0295817570298439,5.92109621447136e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,-0.0872944852382666,0.0111756805697407,-0.109198819154958,-0.0653901513215747,6.17195198007236e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,42611,-0.0218545983747751,0.00280307835911379,-0.0273486319586381,-0.016360564790912,6.82466825173037e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40223,-0.0469172779856886,0.00601617910567194,-0.0587089890328057,-0.0351255669385716,6.82819601046328e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,-0.0423671197399795,0.00543880452778159,-0.0530271766144314,-0.0317070628655276,7.21293100550069e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,42654,-0.0446387923980635,0.0057348247912758,-0.0558790489889641,-0.0333985358071629,7.54899684716263e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,42587,-0.04376429296955,0.00563008297128248,-0.0547992555932637,-0.0327293303458364,8.20303990686119e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,-0.0679621459501348,0.00874221416558516,-0.0850968857146818,-0.0508274061855879,8.27682123115506e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,40539,0.0243519358928274,0.00313295912521915,0.0182113360073979,0.0304925357782569,8.33810435576108e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,42370,-0.0595510983799338,0.00766545688072473,-0.0745753938661543,-0.0445268028937134,8.51043774612934e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,42611,0.0229988388254831,0.00296159757061257,0.0171941075870824,0.0288035700638837,8.70735835219204e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,-0.116219469768251,0.0149691440416189,-0.145558992089824,-0.086879947446678,8.94655946450863e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,40451,-0.0259019328082377,0.00333914466541535,-0.0324466563524518,-0.0193572092640236,9.44241749426568e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,-0.0485158420622081,0.00625595800436607,-0.0607775197507656,-0.0362541643736506,9.58099628788433e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,-0.0185778273870957,0.00239704332297026,-0.0232760323001174,-0.013879622474074,9.94961806789402e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40182,-0.0514408757666535,0.00663758398115115,-0.0644505403697098,-0.0384312111635973,1.0004079012742e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40449,-0.0504640075953014,0.0065126482039,-0.0632287980749454,-0.0376992171156574,1.00882044574722e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42636,-0.0581313820259865,0.00750601172424635,-0.0728431650055093,-0.0434195990464637,1.02689662802706e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40283,-0.0429655882322383,0.00554850913318708,-0.053840666133285,-0.0320905103311917,1.05028561382485e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,42346,-0.0753930791393116,0.00973888317759262,-0.0944812901673931,-0.05630486811123,1.05449800514594e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40482,-0.0533641054139415,0.00689507358524476,-0.0668784496410213,-0.0398497611868618,1.08356251429217e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,-0.0460583550126526,0.00596164186014411,-0.0577431730585351,-0.0343735369667701,1.19199651511783e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,42594,-0.0287586898704395,0.00372372941316435,-0.0360571995202416,-0.0214601802206374,1.21580799395824e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,-0.0565378435779893,0.00732479643980525,-0.0708944446000075,-0.042181242555971,1.25974516632358e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,-0.0929769733914796,0.0120473038330746,-0.116589688904306,-0.0693642578786534,1.28501775144736e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40199,-0.0698936817356061,0.00905924972283951,-0.0876498111923715,-0.0521375522788406,1.3125750873708e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42794,-0.0248493155343549,0.00323162080874672,-0.0311832923194985,-0.0185153387492113,1.57914528735827e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,-0.0692933677793233,0.00900980618668719,-0.0869525879052302,-0.0516341476534164,1.58297556138897e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,-0.0612746792468546,0.00797129537598661,-0.0768984181837883,-0.0456509403099208,1.61269925317146e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,42754,-0.0481114703160691,0.00625950501350603,-0.0603801001425409,-0.0358428404895973,1.62029944923461e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42370,-0.0303689764370932,0.00395193652802655,-0.0381147720320253,-0.0226231808421612,1.64330457504405e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,40449,-0.0531577030768218,0.00691902788305198,-0.0667189977276037,-0.0395964084260399,1.68526772744326e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,42636,0.0282872627754472,0.0036838823494289,0.0210668533705665,0.0355076721803279,1.71845854110417e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,-0.0252158884409912,0.0032841438422084,-0.0316528103717197,-0.0187789665102628,1.75153970766737e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42311,-0.0301264606335548,0.00392778927875113,-0.037824927619907,-0.0224279936472026,1.83980945341589e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42721,-0.0419602434232847,0.00548225688677834,-0.0527054669213702,-0.0312150199251991,2.08267414251834e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,-0.0524192263561242,0.00685289932388924,-0.0658509090309471,-0.0389875436813013,2.1923062657507e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,40483,-0.0449734474840049,0.00588669363688541,-0.0565113670123003,-0.0334355279557095,2.35059620021628e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40223,-0.04104916399355,0.00537527541251646,-0.0515847038020823,-0.0305136241850178,2.41356440565734e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,-0.0536745015317238,0.00703651124715727,-0.0674660635761521,-0.0398829394872956,2.54480083168999e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,42624,-0.0430900336369319,0.00565305329126054,-0.0541700180878025,-0.0320100491860612,2.65599183246864e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0533911753084322,0.00700978086825255,-0.0671303458102072,-0.0396520048066572,2.77736880221922e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,42562,-0.0280711986566157,0.00368593657000647,-0.0352956343338284,-0.020846762979403,2.79721212423247e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,42689,-0.0389399650628143,0.0051144248534125,-0.0489642377755028,-0.0289156923501257,2.83905010458891e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,40182,-0.101429220051239,0.0133198459598766,-0.127536118132598,-0.0753223219698813,2.8555762775372e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,40483,-0.0486787426578025,0.00639512012886175,-0.0612131781103716,-0.0361443072052335,2.91702988783056e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,42594,-0.0521854921018474,0.00685987975066411,-0.0656308564131491,-0.0387401277905458,2.9840069045545e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42618,-0.0408517143938717,0.00537333174779326,-0.0513834446195465,-0.0303199841681969,3.09287717034835e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42611,-0.0234084340587396,0.00307943847781546,-0.0294441334752579,-0.0173727346422212,3.12052118311513e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,42495,-0.0278323456689823,0.00366154604932135,-0.0350089759256521,-0.0206557154123125,3.12879683368338e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,40223,-0.0598954332287502,0.00787909094119666,-0.0753384514734956,-0.0444524149840048,3.15689601448148e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42357,-0.0587165986357872,0.00773238763891535,-0.0738720784080613,-0.0435611188635131,3.3209841071624e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,40199,-0.0341728454380395,0.00450365027531562,-0.0429999999776581,-0.0253456908984209,3.51619938488179e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,40283,-0.0574261041202909,0.00756959776111668,-0.0722625157320796,-0.0425896925085022,3.55200354452322e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,42476,-0.0622622800940844,0.00821653784551145,-0.0783666942712868,-0.046157865916882,3.75053207913482e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,-0.0521455546153381,0.00688245254879659,-0.0656351616109794,-0.0386559476196968,3.82467891993884e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,40223,-0.068844794207354,0.00909509726036404,-0.0866711848376675,-0.0510184035770405,4.04729096435604e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,42461,-0.0453815325718215,0.00600749850592157,-0.0571562296434278,-0.0336068355002152,4.49169279158155e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,42636,-0.0808260515521153,0.0107116571215875,-0.101820899510427,-0.0598312035938038,4.79052265136367e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,40483,-0.0516719670315461,0.00685072213744129,-0.0650993824209311,-0.0382445516421612,4.96202008654818e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42676,-0.100452867737127,0.0133434865248768,-0.126606101325886,-0.0742996341483684,5.46927774950103e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,-0.0226983046173096,0.0030159555797973,-0.0286095775537123,-0.0167870316809069,5.56149366726312e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42346,-0.040506347104891,0.00538261119982258,-0.0510562650565433,-0.0299564291532388,5.59689135421344e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,40449,-0.0451692293034083,0.00602161982229896,-0.0569716041551142,-0.0333668544517023,6.80081242480594e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,-0.0730888665346929,0.00974770657465929,-0.0921943714210252,-0.0539833616483607,6.88362814139301e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,-0.0309964697858832,0.00413506225787368,-0.0391011918113156,-0.0228917477604508,7.06993150708522e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,42594,-0.0634705776071217,0.00847903587193241,-0.0800894879161092,-0.0468516672981342,7.56681669794395e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40199,0.0253105999339916,0.00339210907856919,0.018662066139996,0.0319591337279872,9.19143281299983e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,-0.0789924771459984,0.0105960107606113,-0.0997606582367965,-0.0582242960552004,9.54325349614718e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,40199,-0.0227523437641375,0.00305660737156166,-0.0287432942123983,-0.0167613933158766,1.0524522737004e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40482,-0.0466076786342027,0.00626969962658281,-0.058896289902305,-0.0343190673661004,1.13156142974559e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,42794,-0.0193097496633351,0.00259822238489565,-0.0244022655377306,-0.0142172337889397,1.13427303231128e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40283,-0.0289670726311954,0.00389795611615942,-0.0366070666188678,-0.0213270786435229,1.15404562660563e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,42476,0.0380164251069375,0.00511809466747431,0.0279849595586878,0.0480478906551871,1.17110486058233e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,-0.0783217740855642,0.0105562148726279,-0.0990119552359149,-0.0576315929352135,1.26031862268502e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,40482,-0.0499264748304047,0.00673798328728973,-0.0631329220734926,-0.0367200275873168,1.3561572392174e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40116,-0.0512497501266216,0.0069166094393901,-0.0648063046278262,-0.037693195625417,1.35971458683339e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C3,Complement C3,39989,-0.0360321022674532,0.00486477448628075,-0.0455670602605635,-0.026497144274343,1.3910610244811e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,-0.0222270601829487,0.00300205437299976,-0.0281110867540282,-0.0163430336118692,1.39958400787816e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,-0.0263182549370998,0.00355558134440955,-0.0332871943721425,-0.0193493155020571,1.42092380220351e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,-0.063561162647713,0.00859469095666364,-0.0804067569227738,-0.0467155683726523,1.50970670747016e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,40182,-0.0318764059477085,0.00431354724436026,-0.0403309585466546,-0.0234218533487624,1.57683328534384e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,-0.0385379970644255,0.00521706206706169,-0.0487634387158664,-0.0283125554129846,1.59326472591919e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,40532,-0.0223247196649208,0.00302183492689724,-0.0282475161216394,-0.0164019232082022,1.59756127765583e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,-0.0230960908752087,0.00312668366219101,-0.029224390853103,-0.0169677908973143,1.61016119860881e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,-0.0756192672025043,0.0102491734315102,-0.0957076471282642,-0.0555308872767443,1.70027194832486e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40532,-0.0206691592217512,0.00280345363271447,-0.0261639283418716,-0.0151743901016309,1.78784195950255e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASN,Vasorin,42449,0.0208773040296605,0.00283224767593652,0.0153260985848249,0.0264285094744961,1.790043214955e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,42636,-0.0308234155841759,0.00418162239470485,-0.0390193954777974,-0.0226274356905544,1.79025673494853e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGMN,Legumain,42676,-0.0269599275673831,0.00366332931340354,-0.0341400530216541,-0.0197798021131122,1.95416984629266e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,42311,-0.0346371138622346,0.00470926321400686,-0.043867269761688,-0.0254069579627811,2.02105558630609e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,-0.0266678178098619,0.0036261743908595,-0.0337751196159465,-0.0195605160037773,2.05651593979399e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,42689,-0.0232565517207979,0.00316507387521998,-0.0294600965162291,-0.0170530069253668,2.12955386344724e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42602,-0.0262651131386049,0.00358009791066544,-0.0332821050435091,-0.0192481212337006,2.3198033169122e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40482,-0.0273661395617544,0.00373141334109942,-0.0346797097103093,-0.0200525694131996,2.38700361981581e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,-0.0371661700064717,0.00506926154684304,-0.0471019226382841,-0.0272304173746594,2.42886854738515e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,-0.0344805661421359,0.00470383760257904,-0.0437000878431908,-0.025261044441081,2.45699749933621e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,40136,-0.0408777589522531,0.00559207108949399,-0.0518382182876613,-0.0299172996168449,2.8588731828704e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,42594,-0.0305547502439016,0.00418154454158097,-0.0387505775454004,-0.0223589229424029,2.88518213483776e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,42495,-0.0712715117484571,0.0097764430890315,-0.0904333402029589,-0.0521096832939554,3.27146805525879e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,40483,-0.0348345057723873,0.00477759835037704,-0.0441985985391263,-0.0254704130056483,3.27705485997478e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,42357,0.0175930851053263,0.00241374408056759,0.0128621467074138,0.0223240235032388,3.30776877473005e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,40283,-0.040767759284557,0.00559337973061941,-0.051730783556571,-0.0298047350125429,3.3455636940291e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,-0.026444272036622,0.00363010597330588,-0.0335592797443015,-0.0193292643289425,3.44407828630603e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40182,-0.0603285478934821,0.00828757224227983,-0.0765721894883506,-0.0440849062986137,3.58210742267997e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,40283,0.0216291618232297,0.00297445845042559,0.0157992232603956,0.0274591003860639,3.79101333767305e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,42681,-0.0544275282399632,0.0074894795227195,-0.0691069081044934,-0.039748148375433,3.87193328232336e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40199,-0.0425795747866446,0.00586080021978856,-0.0540667432174302,-0.031092406355859,3.97841579352552e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40199,-0.0721843177227914,0.00996821286100718,-0.0917220149303654,-0.0526466205152173,4.73547782409703e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0486666510452922,0.00672491636786471,-0.0618474871263071,-0.0354858149642774,4.84127928650599e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,40116,-0.0488986196168616,0.00675549326077628,-0.0621393864079831,-0.0356578528257401,4.84684180335056e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40229,-0.0420939664083635,0.00582527013920876,-0.0535114958812127,-0.0306764369355143,5.29882122478888e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,-0.039169072340052,0.0054289658187588,-0.0498098453448192,-0.0285282993352847,5.75447277551576e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,40223,0.0317288139609625,0.00439796776325612,0.0231087971449805,0.0403488307769445,5.77154521993671e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,-0.0278164975963064,0.00385894659840766,-0.0353800329291854,-0.0202529622634274,6.0390401060632e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42676,-0.0766559521276437,0.0106691680046311,-0.0975675214167207,-0.0557443828385667,7.08346693822924e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,40511,-0.0399683989236616,0.00556352798737081,-0.0508729137789084,-0.0290638840684148,7.19519535254613e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42679,-0.0445360900821317,0.00620537712510203,-0.0566986292473316,-0.0323735509169317,7.4973943922251e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,-0.0303467647856067,0.00423047593504166,-0.0386384976182884,-0.0220550319529251,7.77364307680008e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,40116,-0.048569527378355,0.00677156785641165,-0.0618418003769218,-0.0352972543797882,7.83685095770196e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,-0.0321980500201471,0.00449360300624702,-0.0410055119123913,-0.023390588127903,8.25651824441942e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,40511,-0.0473165286462542,0.00660605996563424,-0.0602644061788973,-0.0343686511136111,8.4077111756323e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40511,-0.0664136616161257,0.00929860813228875,-0.0846389335554117,-0.0481883896768398,9.73968488169758e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40449,-0.0412823208232973,0.00579786521672395,-0.0526461366480762,-0.0299185049985183,1.14285817695568e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,-0.0425694777653769,0.00598326523629412,-0.0542966776285133,-0.0308422779022404,1.18899827202492e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,42721,-0.0353538287620254,0.00497739620251228,-0.0451095253189494,-0.0255981322051013,1.28293613400205e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,42679,-0.0252012818895154,0.00354889447228017,-0.0321571150551845,-0.0182454487238463,1.2990694739721e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,42370,-0.035172034982449,0.0049610747805604,-0.0448957415523474,-0.0254483284125507,1.41353870994392e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,40250,-0.0479169265005488,0.00675894167901073,-0.0611644521914099,-0.0346694008096878,1.42895631431149e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42443,-0.0832158462699269,0.0117631272389386,-0.106271575658247,-0.0601601168816073,1.57754239021012e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,-0.0268132178426111,0.00379085735596263,-0.0342432982602978,-0.0193831374249243,1.60747636188426e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,-0.0287337887185473,0.00406873103867178,-0.036708501554344,-0.0207590758827506,1.72095200402751e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,42771,-0.0223791872608563,0.00317140356259652,-0.0285951382435455,-0.0161632362781671,1.78957622937662e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42676,-0.0182080745063234,0.00258358911162003,-0.0232719091650987,-0.0131442398475482,1.90891618366572e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,42636,-0.0914650008429675,0.0130102442832201,-0.116965079638079,-0.065964922047856,2.16146933001678e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40223,-0.0392010338046117,0.00557637617726751,-0.050130731112056,-0.0282713364971674,2.18988091623253e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,-0.0548822333554991,0.00781172360851738,-0.0701932116281931,-0.039571255082805,2.23390519740257e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,-0.0218752299592281,0.00311477376093244,-0.0279801865306557,-0.0157702733878006,2.27615005595474e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42794,0.01810034146771,0.00257831654271495,0.0130468410439887,0.0231538418914313,2.32029469676977e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,42216,-0.0549843143164961,0.00783663916492445,-0.070344127079748,-0.0396245015532441,2.39067054669833e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,42594,-0.0497505580303992,0.00709221524975139,-0.0636512999199119,-0.0358498161408864,2.41309924681295e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40519,-0.018332320808617,0.00261422870765905,-0.0234562090756287,-0.0132084325416053,2.47397362850007e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40283,-0.0497690796605831,0.00710342274890015,-0.0636917882484274,-0.0358463710727388,2.58793469133391e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,-0.0438364560194536,0.00626581348761552,-0.05611745045518,-0.0315554615837271,2.75621482811638e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,-0.0649221991413737,0.00928699932200816,-0.0831247178125097,-0.0467196804702377,2.89089763394905e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,-0.030997812068191,0.00443855538332273,-0.0396973806195036,-0.0222982435168784,3.01165486225097e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,42754,-0.0442570775418557,0.00634229004087136,-0.0566879660219636,-0.0318261890617478,3.13111083673829e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,40116,-0.0283305395047637,0.00406913261565485,-0.0363060394314472,-0.0203550395780802,3.5396846673362e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,-0.0645498033135499,0.0092782891375768,-0.0827352500232005,-0.0463643566038994,3.66568778779476e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,42674,-0.0423318623978381,0.00609089986065439,-0.0542700261247207,-0.0303936986709555,3.8202850033256e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,-0.032778893569204,0.00472003012529475,-0.0420301526147817,-0.0235276345236262,3.967742883623e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,-0.0470588225664654,0.00677604770700976,-0.0603398760722045,-0.0337777690607263,3.99600317166077e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,-0.0215729355394961,0.00310921819740991,-0.0276670032064195,-0.0154788678725726,4.1488146143233e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42311,-0.0473334968211483,0.00683920788032738,-0.0607383442665899,-0.0339286493757066,4.69629430552141e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,-0.0203157164315454,0.00293622755020949,-0.026070722429956,-0.0145607104331348,4.80354714908672e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,-0.0658468757899091,0.00953707197585243,-0.0845395368625799,-0.0471542147172383,5.27384138452548e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,42524,-0.0306760091188881,0.00444752017058886,-0.0393931486532423,-0.021958869584534,5.53791197242616e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42638,0.0169819602281694,0.00246416417748149,0.0121521984403057,0.0218117220160332,5.76386363304761e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,42357,-0.0550183323504012,0.00799488851078234,-0.0706883138315346,-0.0393483508692678,6.18247078641877e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,42511,0.023842347819545,0.00346485171985872,0.0170512384486219,0.030633457190468,6.20034166968399e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLGN,Calmegin,40182,-0.0330113347231979,0.00479668316020052,-0.0424128337171909,-0.0236098357292049,6.21807823750059e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,42585,-0.061705594256949,0.00896948044127089,-0.0792857759218399,-0.044125412592058,6.27287054336165e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42594,-0.0170245860708479,0.00247552621337332,-0.0218766174490596,-0.0121725546926362,6.37651688484993e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,-0.0722371575981585,0.010518525808384,-0.0928534681825913,-0.0516208470137258,6.81499722023708e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42636,-0.0479648708974559,0.00698558364726319,-0.0616566148460918,-0.0342731269488201,6.87985718281924e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,-0.0326174116952423,0.00475026700864082,-0.0419279350321783,-0.0233068883583063,6.92906243796621e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,-0.059689085162064,0.00869349257037989,-0.0767283306000086,-0.0426498397241194,6.95799882217557e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40451,-0.0365210683679878,0.00531924453611632,-0.0469467876587758,-0.0260953490771998,6.95807007003589e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42676,-0.0600889971333242,0.00875729141751895,-0.0772532883116613,-0.0429247059549871,7.1068542844611e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,42311,-0.0321486231142115,0.00468743804707861,-0.0413360016864856,-0.0229612445419375,7.2724719770242e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42438,0.026779089743993,0.00390586353857547,0.0191235972083851,0.034434582279601,7.38891646549075e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40483,-0.0370936866580954,0.0054138098449436,-0.0477047539541848,-0.0264826193620059,7.67862435075578e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,42346,-0.0302752357125135,0.00441934162579212,-0.038937145299066,-0.0216133261259609,7.68015559087545e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,40449,-0.0532970963716286,0.00779005853933145,-0.0685656111087183,-0.038028581634539,8.23306687570805e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42190,-0.0847855317144717,0.0123996802242561,-0.109088904954014,-0.0604821584749298,8.40606207134243e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,40283,-0.0482055636261535,0.00704893696526022,-0.0620214800780636,-0.0343896471742435,8.41182266458329e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,42616,-0.0309051586477641,0.00452749690280477,-0.0397790525772614,-0.0220312647182667,9.10009614453108e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,40483,-0.0748844731487877,0.0109757793411605,-0.0963970006574623,-0.0533719456401132,9.39144514649536e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40511,-0.0422978661249932,0.00620048474662712,-0.0544508162283824,-0.0301449160216041,9.45556820727725e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42346,-0.0415769977219436,0.00609760402250941,-0.0535283016060621,-0.0296256938378252,9.59600635342283e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,42721,-0.0153751559134802,0.00225541573331484,-0.0197957707507773,-0.0109545410761832,9.6906239201345e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,42638,-0.0237678879502685,0.00348677791013044,-0.0306019726541241,-0.0169338032464128,9.7212230758655e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42590,-0.0164850294393792,0.00241899040212175,-0.0212262506275378,-0.0117438082512205,9.84050848329556e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,40482,-0.0402387608046513,0.00590843143641086,-0.0518192864200165,-0.028658235189286,1.02273864798169e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,42495,-0.0557394194381225,0.00819037136435584,-0.07179254731226,-0.0396862915639851,1.05026241580877e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,-0.0295593209742041,0.00435602610517581,-0.0380971321403486,-0.0210215098080595,1.20258802620754e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,42546,-0.0390184103976763,0.00575586385549726,-0.0502999035544509,-0.0277369172409016,1.26183678851376e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,40283,-0.0394207222804538,0.00581614213610589,-0.0508203608672213,-0.0280210836936862,1.28199595063677e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42346,-0.039386704881423,0.0058164218545931,-0.0507868917164254,-0.0279865180464205,1.32740969498304e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42587,-0.0701169003738212,0.010361150875813,-0.0904247560904147,-0.0498090446572276,1.36675684457934e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,42346,-0.0408771287651339,0.00604200807390896,-0.0527194645899955,-0.0290347929402724,1.38484475311452e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,-0.0458068226282495,0.00677345651876247,-0.0590827974050239,-0.032530847851475,1.42247392483743e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,40283,-0.0232752924515004,0.00344184057079238,-0.0300212999702535,-0.0165292849327474,1.42494429765344e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,40116,-0.0406056969167145,0.00600720688942006,-0.0523798224199778,-0.0288315714134512,1.45530531619346e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,42611,-0.0358146627395798,0.00530078794206833,-0.0462042071060337,-0.0254251183731258,1.47217933997641e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,42676,-0.0633817530259817,0.00938512264654554,-0.081776593413211,-0.0449869126387525,1.50308507390716e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,42475,-0.0367438490041491,0.00544732728908397,-0.0474206104907537,-0.0260670875175446,1.5903620145635e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,40199,-0.0311307810070701,0.00461792375067812,-0.0401819115583993,-0.022079650455741,1.64837806625767e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,42594,-0.0415721164874282,0.00616855255609733,-0.053662479497379,-0.0294817534774774,1.65587071433514e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40511,-0.0227179277164039,0.00337072012753145,-0.0293245391663656,-0.0161113162664423,1.66328671769917e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40223,-0.0165030841031662,0.00245073485258348,-0.0213065244142298,-0.0116996437921026,1.7334647965417e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,42292,-0.0613767441579534,0.00912185709690765,-0.0792555840678924,-0.0434979042480144,1.78504843486418e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,-0.0614528026294554,0.00913858258679662,-0.0793644244995768,-0.043541180759334,1.84671828460617e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,40483,-0.0199427599110052,0.0029665390769716,-0.0257571765018695,-0.0141283433201408,1.87158382470826e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,-0.0238887597898325,0.00356013039415148,-0.0308666153623694,-0.0169109042172956,2.02416082873002e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,40532,-0.0196593798053142,0.00293023208913756,-0.0254026347000239,-0.0139161249106046,2.05077114928809e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,40223,-0.0627459502352461,0.00935399964916288,-0.0810797895476053,-0.0444121109228868,2.07070557553068e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,42604,-0.0630331740025779,0.0093991526820029,-0.0814555132593036,-0.0446108347458522,2.07673741251269e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,42326,0.0337738857636391,0.00503869894530538,0.0238980358308405,0.0436497356964376,2.12671670251318e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42794,-0.0158922418189467,0.00237252623469475,-0.0205423932389485,-0.011242090398945,2.18926497812841e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40135,-0.0294699832833573,0.00440374375150566,-0.0381013210363084,-0.0208386455304062,2.30855121173548e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40483,-0.0336917808918738,0.00503669468350772,-0.0435637024715489,-0.0238198593121986,2.34897106286391e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,-0.0600952908424904,0.0089915858573152,-0.0777187991228281,-0.0424717825621526,2.42529942992665e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.0223410980254096,0.00334443461166405,-0.0288961898642712,-0.0157860061865481,2.48221377356228e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,-0.0262974637292586,0.00394036985696244,-0.034020588648905,-0.0185743388096122,2.6102989226123e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,-0.0251290801955131,0.00376569312527775,-0.0325098387210575,-0.0177483216699687,2.62377947006494e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,-0.0418411806955688,0.00628250644561618,-0.0541548933289765,-0.0295274680621611,2.84501513407106e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,42711,-0.0427665420747088,0.00642879541426236,-0.055366981086663,-0.0301661030627546,2.99567472901488e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,-0.0261497958507818,0.00393141924372635,-0.0338553775684854,-0.0184442141330781,3.03585918260932e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,42587,-0.0638850316779845,0.00960823329597916,-0.0827171689381037,-0.0450528944178654,3.06554932005785e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,40449,-0.0384229143368496,0.00577985254379438,-0.0497514253226866,-0.0270944033510127,3.11406730136895e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,42592,-0.0451922909063628,0.00680199149566564,-0.0585241942378674,-0.0318603875748581,3.1712195745761e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42365,-0.0327277268274862,0.00492696324674442,-0.0423845747911053,-0.0230708788638671,3.20356091690346e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42476,-0.0159243270303005,0.00239748283167661,-0.0206233933803866,-0.0112252606802143,3.21279829597143e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,40283,-0.0580145263963764,0.00873568142379715,-0.0751364619870188,-0.040892590805734,3.25912614631585e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0409365537543519,0.00617000183047719,0.0288433501666166,0.0530297573420871,3.37490889383558e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40527,0.0226544621925604,0.00341629360555124,0.0159585267256799,0.0293503976594408,3.47876177530062e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40511,-0.0194173765147045,0.00292888130043872,-0.0251579838635644,-0.0136767691658446,3.51855796170549e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,40527,-0.0563901013734503,0.00851842690531009,-0.0730862181078581,-0.0396939846390425,3.7598013049191e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40449,-0.0522481291438157,0.00789891146440772,-0.0677299956140548,-0.0367662626735766,3.89449393558411e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,-0.0237433187585595,0.00359819291958307,-0.0307957768809423,-0.0166908606361767,4.33894467508821e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,40479,-0.0210157515809343,0.00318564144388905,-0.0272596088109569,-0.0147718943509118,4.38257874405019e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42611,-0.0225941542754225,0.00342583930282148,-0.0293087993089526,-0.0158795092418924,4.40542550322205e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,42370,-0.0619642120790204,0.00940522070939386,-0.0803984446694323,-0.0435299794886084,4.61864959282789e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,-0.0246432485309518,0.00374083252390196,-0.0319752802777996,-0.0173112167841039,4.63693650760671e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,-0.0370952332088932,0.00563435746217278,-0.0481385738347518,-0.0260518925830345,4.75808507833209e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40511,-0.0721536133347423,0.010968068757793,-0.0936510281000166,-0.050656198569468,4.96123661739064e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,42357,-0.024057881203993,0.00365768661560946,-0.0312269469705875,-0.0168888154373985,4.97007622030319e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,-0.0291286758542338,0.00442887417620505,-0.0378092692395957,-0.0204480824688719,5.01263978164155e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,42597,-0.031578857007696,0.00480281176517531,-0.0409923680674396,-0.0221653459479524,5.042970737832e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,40532,-0.0548847451775542,0.00835362153646828,-0.071257843389032,-0.0385116469660764,5.24576638422877e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0259226870985895,0.00394653183037812,0.0181874847110484,0.0336578894861306,5.27462044922238e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALB1,Calbindin,42587,-0.0307978523012607,0.0046912469325194,-0.0399926962889987,-0.0216030083135227,5.39645774116939e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,40527,0.0337322941099077,0.00513755007872152,0.0236626959556136,0.0438018922642019,5.40041290647089e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,40483,-0.0624952278364369,0.00952193502385874,-0.0811582204832,-0.0438322351896738,5.49387875547287e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,-0.0700835264447239,0.0106794682695106,-0.0910152842529647,-0.0491517686364832,5.52892324260275e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.0313458908616343,0.00477782148395856,-0.0407104209701931,-0.0219813607530755,5.55030737773474e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40482,-0.0764252160127306,0.0116520434380302,-0.0992632211512698,-0.0535872108741914,5.65542541501278e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,-0.0331054336205216,0.00505993661948814,-0.0430229093947184,-0.0231879578463249,6.3092857789714e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,42711,-0.0191049850974425,0.00292284788750681,-0.0248337669569559,-0.0133762032379292,6.5266136876583e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39838,0.0762669813021944,0.0116751807128909,0.0533836271049281,0.0991503354994606,6.76772589937492e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,40449,-0.023217118240059,0.00355464891110319,-0.0301842301058212,-0.0162500063742967,6.79295953805076e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,-0.0578667115328684,0.00889783305804715,-0.0753064643266408,-0.040426958739096,8.12775658861551e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,40482,-0.0503885520396961,0.00775156485429391,-0.0655816191541122,-0.0351954849252801,8.34640600011567e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,42679,-0.0377342409262152,0.00580696234417204,-0.0491158871207924,-0.026352594731638,8.41969682742956e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,40267,-0.0682736615882119,0.0105100825782401,-0.0888734234415625,-0.0476738997348612,8.60114320886086e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,40116,-0.0517200554146307,0.00796428453301068,-0.0673300530993316,-0.0361100577299297,8.72173925275852e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,40451,-0.0281307063471376,0.00433326170424394,-0.0366238992874557,-0.0196375134068195,8.83787019971224e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,42778,-0.0159173753631527,0.00245269724964115,-0.0207246619724494,-0.0111100887538561,8.89663008348104e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,-0.035191625956249,0.00542343640149835,-0.0458215613031858,-0.0245616906093122,9.01519540097877e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,42586,-0.0447031326957423,0.00692458764110895,-0.0582753244723159,-0.0311309409191688,1.11425897451228e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAX,Protein max,42311,-0.0690034196195782,0.0107361239918549,-0.0900462226436137,-0.0479606165955427,1.34455731972479e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,40283,-0.0709582593980147,0.0110462147229667,-0.0926088402550294,-0.049307678541,1.38390565377268e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,40223,-0.0192428760491531,0.00299707720716239,-0.0251171473751913,-0.0133686047231148,1.41365083223961e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPART,Spartin,40283,-0.0505806580938777,0.00789636437535243,-0.0660575322695685,-0.035103783918187,1.55881462819033e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,-0.0226025764702039,0.00352997525126827,-0.0295213279626898,-0.0156838249777181,1.57394897324201e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,42311,-0.0401682987246494,0.00630117503226857,-0.0525186017878958,-0.027817995661403,1.89421710161655e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,-0.0306706930276124,0.00481983250121015,-0.0401175647299842,-0.0212238213252405,2.03860593820544e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,40483,-0.0457894628338189,0.00719840332451791,-0.059898333349874,-0.0316805923177638,2.0811686569253e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42346,-0.0299890401090478,0.0047172389400692,-0.0392348284315834,-0.0207432517865122,2.12074334603408e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,42434,-0.0489976521973198,0.00773012831827199,-0.0641487037011329,-0.0338466006935067,2.39490442293076e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42636,-0.0433596211468675,0.00685267279416082,-0.0567908598234227,-0.0299283824703123,2.57229417928841e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40116,-0.0255469640535069,0.00403745288233514,-0.0334603717028838,-0.01763355640413,2.5893014435235e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,-0.039203326855927,0.00619861345751844,-0.0513526092326632,-0.0270540444791909,2.62223094151992e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,42495,-0.0284327968349463,0.00449924593467729,-0.0372513188669138,-0.0196142748029789,2.70854426574163e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.0246362827505326,0.00390461494688581,0.0169832374546364,0.0322893280464287,2.88675061990382e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,42346,-0.0337547492083955,0.00535158494508843,-0.0442438557007689,-0.0232656427160222,2.92790877974184e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,42370,-0.0506607963414635,0.00804201415005625,-0.0664231440755737,-0.0348984486073532,3.0807240268265e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,40199,-0.01744550063383,0.0027700101104567,-0.0228747204503251,-0.0120162808173348,3.1302817301007e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,42214,-0.0537579907542241,0.00853992779412483,-0.0704962492307088,-0.0370197322777394,3.17471103110023e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,40302,-0.0223532729048912,0.00355214394454921,-0.0293154750362077,-0.0153910707735747,3.23332634382536e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,42636,-0.0431925141543523,0.00687177278337077,-0.056661188809759,-0.0297238394989456,3.36899970196836e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,42480,-0.0304332444225193,0.00484609154702761,-0.0399315838546934,-0.0209349049903452,3.49217302787278e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40182,-0.0276828926287283,0.0044255367555936,-0.0363569446696918,-0.0190088405877649,4.11605383828003e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42357,-0.0347790270050133,0.00556327312350243,-0.045683042327078,-0.0238750116829485,4.18976467044946e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,40182,-0.0314837854505527,0.00504276808020559,-0.0413676108877557,-0.0215999600133497,4.44092164983421e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,-0.0121530318371934,0.00194717689322595,-0.0159694985479163,-0.00833656512647059,4.46863700340922e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,40483,-0.0292770501185995,0.00469743134397855,-0.0384840155527974,-0.0200700846844015,4.7521924208414e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40116,-0.044155858154496,0.00710929738040219,-0.0580900810200843,-0.0302216352889077,5.45628624033478e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,42794,-0.0125440343581191,0.00202131150425125,-0.0165058049064515,-0.00858226380978666,5.5967343578515e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.0222048580653529,0.00358115586124693,-0.0292239235533969,-0.015185792577309,5.79369859354279e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40223,-0.0583135974975874,0.00941983838257999,-0.0767764807274442,-0.0398507142677306,6.21017822857845e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,40539,-0.0117940981525737,0.00190683761702541,-0.0155314998819435,-0.00805669642320387,6.41745639172465e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,40199,-0.0260501520295398,0.00421415236998988,-0.03430989067472,-0.0177904133843596,6.57079520633916e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,42705,0.0176068721543412,0.00285098344833497,0.0120189445956046,0.0231947997130777,6.77508937100166e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,42679,-0.0139160882911787,0.00225559167598577,-0.0183370479761108,-0.0094951286062466,7.04233960810657e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42495,-0.0497490350272981,0.00806521983117589,-0.0655568658964028,-0.0339412041581933,7.10098291549965e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TF,Serotransferrin,40539,-0.0135634511150167,0.00219942428298453,-0.0178743227096664,-0.00925257952036705,7.20479173812418e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42721,0.0375956119655589,0.00610119711939301,0.0256372656115486,0.0495539583195692,7.38675517536055e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,42495,-0.0626015469054581,0.0101707792393917,-0.0825362742146659,-0.0426668195962503,7.72157809552056e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.0238462835927508,0.00387436423670812,-0.0314400374966987,-0.0162525296888029,7.72697679866372e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,40223,-0.0143947422592081,0.00233875574301648,-0.0189787035155204,-0.00981078100289579,7.77485276814912e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,42594,-0.043011967534307,0.00700284617075345,-0.0567375460289837,-0.0292863890396302,8.3757132632914e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40482,-0.030339448055965,0.00493925992778073,-0.0400203975144152,-0.0206584985975147,8.39625126519984e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40116,-0.0392963023699725,0.00640328745866168,-0.0518467457889494,-0.0267458589509956,8.70684890415346e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,42370,-0.0301423405414909,0.00491872546652316,-0.0397830424558763,-0.0205016386271055,9.14823406362655e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42357,-0.0688360699775942,0.0112465208285828,-0.0908792508016165,-0.0467928891535719,9.58388659800488e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,-0.0262879641756416,0.00429473014646779,-0.0347056352627185,-0.0178702930885647,9.61616581754976e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,-0.0239635146649889,0.00392193547593054,-0.0316505081978128,-0.016276521132165,1.02834889895246e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRELP,Prolargin,42618,-0.0152893153935088,0.00250559673882043,-0.0202002850015968,-0.0103783457854207,1.07587375544549e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,42679,-0.0387514720981938,0.00635107580614939,-0.0511995806782466,-0.026303363518141,1.07913866002799e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,-0.0584616632677561,0.00958134936177038,-0.077241108016826,-0.0396822185186861,1.08447405806021e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,42679,-0.0360717429670686,0.00591918198114141,-0.0476733396501058,-0.0244701462840314,1.13094517968084e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40482,-0.0731486297270192,0.0120044996841977,-0.0966774491080467,-0.0496198103459916,1.14117641710964e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42587,-0.0132956104543759,0.0021828556874701,-0.0175740076018173,-0.00901721330693454,1.15333808517992e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,42636,-0.0164172695444393,0.00269723377728761,-0.021703847747923,-0.0111306913409555,1.1839275365446e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,42347,-0.0269853137232178,0.00443410991643773,-0.0356761691594357,-0.0182944582869998,1.19097914114644e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,42624,-0.0468298553418856,0.00772297066961404,-0.0619668778543291,-0.0316928328294421,1.36585072311475e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,-0.067834207001667,0.0112336957430604,-0.0898522506580654,-0.0458161633452686,1.59683009185978e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,42679,-0.0343479394968795,0.0056898532380869,-0.0455000518435298,-0.0231958271502291,1.6142615985757e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,40199,-0.0263990172527052,0.00437362458966214,-0.0349713214484429,-0.0178267130569674,1.63114635720515e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42794,-0.044337709271452,0.00735205376908628,-0.0587477346588611,-0.0299276838840429,1.6752800918982e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,40199,-0.0311506388796965,0.00516480811177065,-0.041273662778767,-0.021027614980626,1.67845508069151e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42569,-0.0547079683739249,0.00907330658376732,-0.0724916492781089,-0.036924287469741,1.68746678032572e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,42754,-0.0268996401700324,0.00447267886110735,-0.0356660907378029,-0.018133189602262,1.8541278654193e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40482,-0.0382936033542978,0.00637600476611143,-0.0507905726958762,-0.0257966340127194,1.96141488873563e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40182,-0.0443779840793123,0.0073900862655571,-0.0588625531598042,-0.0298934149988203,1.97299092929164e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,-0.0335782977585208,0.00559656442000049,-0.0445475640217218,-0.0226090314953199,2.03771630647281e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,42261,-0.0189294228034719,0.00316107944432077,-0.0251251385143406,-0.0127337070926032,2.17641266681199e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,-0.0186239996734181,0.00311746229065832,-0.0247342257631085,-0.0125137735837278,2.38394462453302e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40483,-0.0238373036346428,0.00399467252267976,-0.0316668617790952,-0.0160077454901905,2.48492855926779e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40199,-0.0554271309491135,0.00929206810646363,-0.0736395844377822,-0.0372146774604448,2.52167497408125e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",40539,-0.0102997508334776,0.00172704797863073,-0.0136847648715939,-0.00691473679536143,2.53798324416667e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42711,-0.0142598901249668,0.00239146980644142,-0.018947170945592,-0.00957260930434164,2.54114809667013e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,40471,-0.0516511503413871,0.00866142845052759,-0.0686275501044212,-0.0346747505783531,2.54521482159906e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,42689,-0.029382044857442,0.00493105869182182,-0.0390469198934127,-0.0197171698214712,2.60798936947645e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,40527,-0.0270909421100881,0.0045461706101968,-0.0360014365060738,-0.0181804477141023,2.61223877457288e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,42636,-0.0397618390878643,0.00667372188059175,-0.0528423339738241,-0.0266813442019045,2.61775400749151e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,0.0398796043783049,0.00669557626110919,0.0267562749065309,0.0530029338500789,2.64749252130589e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,42437,-0.020933217989282,0.00351518145554371,-0.0278229736421477,-0.0140434623364163,2.66516271359962e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,-0.0595449755327403,0.0100059273744462,-0.0791565931866548,-0.0399333578788258,2.74453580026371e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,42134,-0.0370369359348794,0.00622968051904606,-0.0492471097522097,-0.0248267621175491,2.83168052362127e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42590,-0.050732231515269,0.00853594767423423,-0.0674626889567681,-0.0340017740737699,2.86173005671903e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,40302,-0.0323305453969745,0.00544139733642237,-0.0429956841763624,-0.0216654066175867,2.90740658109158e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,40199,-0.0349565368586415,0.00588433637805908,-0.0464898361596373,-0.0234232375576457,2.92560421850025e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,40532,-0.0165121158096762,0.00278015780622757,-0.0219612251098822,-0.0110630065094702,2.94688054390034e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,-0.0501582616463218,0.00844810308293478,-0.066716543688874,-0.0335999796037696,2.98447434299977e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,40511,-0.0326687330465061,0.00550610593428118,-0.0434607006776972,-0.021876765415315,3.05815519691709e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,42711,-0.0180258369845088,0.00303879249054685,-0.0239818702659806,-0.012069803703037,3.06752633745297e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,42370,-0.0180535076996137,0.00304943302013732,-0.0240303964190828,-0.0120766189801446,3.29385149842755e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,42495,0.0209049047240176,0.00353276350980671,0.0139806882447965,0.0278291212032388,3.35042412559794e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,-0.038661089916452,0.00653443522368021,-0.0514685829548653,-0.0258535968780388,3.370324275376e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,-0.0151971491761747,0.00257616300096376,-0.0202464286580637,-0.0101478696942858,3.74217654060962e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,42611,-0.0210501429693522,0.00356882954925452,-0.028045048885891,-0.0140552370528133,3.76035323033346e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,-0.0501551849805635,0.00850775749497155,-0.0668303896707077,-0.0334799802904192,3.83134308053297e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,40532,0.0161223106717283,0.00273709327536903,0.010757607852005,0.0214870134914516,3.96432292105734e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40283,-0.0716360489068309,0.0122018307308321,-0.0955516371392619,-0.0477204606743999,4.4578945062959e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEXN,Nexilin,40532,-0.0417705711931382,0.00711657824741132,-0.0557190645580644,-0.027822077828212,4.4942123608208e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPARC,SPARC,42679,-0.0420962945859551,0.00717419678909622,-0.0561577202925837,-0.0280348688793265,4.52154398161416e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,42594,-0.0403474112807534,0.00687924173604436,-0.0538307250834003,-0.0268640974781064,4.59457915120503e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,-0.0438545232836214,0.00749522368442493,-0.0585451617050943,-0.0291638848621485,5.02176828569665e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,40182,-0.048539055090595,0.0083060068669032,-0.0648188285497253,-0.0322592816314647,5.24571811529519e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42346,-0.0543480653888981,0.00930622118351881,-0.0725882589085949,-0.0361078718692012,5.34433131799793e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,42573,-0.0415377907329294,0.00712369031010417,-0.0555002237407335,-0.0275753577251252,5.63890592253465e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,42311,-0.0428589621584319,0.00736346829469756,-0.0572913600160391,-0.0284265643008247,6.00487509357871e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,42676,-0.0463588305922288,0.00796580291860645,-0.0619718043126974,-0.0307458568717601,6.02821493689667e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,40449,-0.0261907919215915,0.00450018460705392,-0.0350111537514172,-0.0173704300917659,6.04758807015554e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.0161049327760536,0.00276842158499392,0.0106788264694655,0.0215310390826416,6.14040634350107e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,42734,0.0215232168234115,0.00370533729903711,0.0142607557172988,0.0287856779295243,6.43715942182174e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNC,Tenascin,42689,0.0288406805982266,0.00497019626277882,0.0190990959231801,0.0385822652732731,6.67105173670772e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,40449,-0.0358950576392936,0.00620041167318473,-0.0480478645187357,-0.0237422507598515,7.26375691139552e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,-0.0893136399730212,0.0154752184937001,-0.119645068220673,-0.058982211725369,8.03567126572665e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,-0.0243599333105165,0.00422169792736633,-0.0326344612481545,-0.0160854053728785,8.12782348472709e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,-0.0221833464145002,0.00384541902824369,-0.0297203677098579,-0.0146463251191426,8.19834493667258e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DMD,Dystrophin,40223,-0.0306306720993832,0.00531463098599994,-0.0410473488319431,-0.0202139953668233,8.46144025278481e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,40449,-0.0604975665526798,0.0105023918432375,-0.0810822545654252,-0.0399128785399344,8.61333814759152e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42600,0.010502965286566,0.00182632776623807,0.00692336286473941,0.0140825677083926,9.07246873155421e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,42636,-0.0277719940475452,0.00483522733277031,-0.037249039619775,-0.0182949484753154,9.46469651709466e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,42370,-0.0173859217645056,0.00302731584730615,-0.0233194608252256,-0.0114523827037855,9.50588700120066e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,-0.0572461241529677,0.00998628243416038,-0.076819237723922,-0.0376730105820133,1.01511408975572e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40483,0.0355522540465435,0.00620499709783077,0.0233904597347952,0.0477140483582918,1.03232332242185e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,40302,-0.032271437512621,0.00563326980462821,-0.0433126463296923,-0.0212302286955497,1.03819020551457e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40451,-0.0348002021121261,0.00608076984521785,-0.0467185110087531,-0.0228818932154991,1.0733607431123e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,0.0276592759037736,0.00483625518028039,0.018180215750424,0.0371383360571231,1.09323735121169e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,40283,-0.0337878241938791,0.00590947810501646,-0.0453704012797113,-0.0222052471080468,1.10852405664918e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,-0.0649558744260912,0.0113639005632342,-0.0872291195300303,-0.0426826293221522,1.11382575103159e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40527,-0.0351345979790245,0.00615441665519988,-0.0471972546232162,-0.0230719413348327,1.16603477791956e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40329,-0.0328649643463774,0.00576368458466506,-0.0441617861323209,-0.0215681425604339,1.21369227320829e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,42605,-0.0661801659653303,0.0116114181366971,-0.0889385455132568,-0.0434217864174039,1.22634073747459e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,40436,-0.0515590512554829,0.00905044348665954,-0.0692979204893356,-0.0338201820216302,1.25103214805248e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42587,-0.02459671613382,0.00432026922376178,-0.0330644438123931,-0.0161289884552469,1.27200896502822e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,42357,-0.033269341381314,0.00584827140815845,-0.0447319533413046,-0.0218067294213235,1.30699401696635e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,42370,-0.0384015143467206,0.0067579171172432,-0.0516470318965173,-0.0251559967969239,1.3559249221042e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40482,-0.0503390700164552,0.00886037038376409,-0.0677053959686328,-0.0329727440642776,1.36923589629897e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0164193293021759,0.00289142741574311,0.0107521315673194,0.0220865270370324,1.38569011832707e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,-0.0496512063073226,0.00874352829135737,-0.066788521758383,-0.0325138908562622,1.39136029400195e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,40539,-0.0242721579271724,0.00427933206571042,-0.0326596487759648,-0.01588466707838,1.44633876295839e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40500,-0.027766199527893,0.00490566664618531,-0.0373813061544162,-0.0181510929013698,1.55034072586222e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,40404,-0.028185562165914,0.00498103354870074,-0.0379483879213674,-0.0184227364104605,1.56376569053914e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,42277,-0.0432516625973607,0.00765191484148493,-0.0582494156866711,-0.0282539095080502,1.61531269346547e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42443,-0.0178134964127813,0.00315221771434334,-0.0239918431328943,-0.0116351496926684,1.62710542688526e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,42646,-0.0324238637480174,0.00573814605907994,-0.0436706300238141,-0.0211770974722208,1.63150178576842e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,-0.0136882781726936,0.00242530125491842,-0.0184418686323337,-0.00893468771305355,1.6951243338555e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,40375,-0.0573367226253206,0.0101593852703436,-0.0772491177551941,-0.0374243274954471,1.70464988456821e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,42679,0.023357708324929,0.00413951592976221,0.0152442571025951,0.0314711595472629,1.70854557136645e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40482,-0.0189174360771518,0.00336067804665464,-0.0255043650485949,-0.0123305071057087,1.85524610129575e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,42548,-0.0236534076583065,0.00420351366131027,-0.0318922944344746,-0.0154145208821384,1.86997146142843e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,40449,-0.0180155165374656,0.00320186613484276,-0.0242911741617574,-0.0117398589131738,1.88222049639763e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSPN,Persephin,42594,-0.0536833397442671,0.00954420501231718,-0.0723899815684088,-0.0349766979201255,1.89542688361099e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,-0.0295925270542804,0.00526408029847356,-0.0399101244392885,-0.0192749296692722,1.92961432489897e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0206234753357696,0.00366924059277228,-0.0278151868976032,-0.0134317637739359,1.94778901807807e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,42563,-0.0375154388165973,0.00667905615603193,-0.0506063888824199,-0.0244244887507747,1.98317290392891e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,40532,-0.0381548846994721,0.00679957520987518,-0.0514820521108275,-0.0248277172881168,2.05448737892458e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,42554,-0.0482348188967855,0.00860338940042341,-0.0650974621216154,-0.0313721756719556,2.10561434533278e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,42636,-0.0174127362377368,0.00310700925228973,-0.0235024743722246,-0.0113229981032489,2.13160291925255e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,40482,-0.0439331014408207,0.00785748729266641,-0.0593337765344469,-0.0285324263471945,2.3069165494119e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42495,-0.02291869336534,0.00410102454186181,-0.0309567014673891,-0.0148806852632908,2.33502148302529e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,42594,-0.0340986382840444,0.00610270360987952,-0.0460599373594082,-0.0221373392086805,2.34900365573867e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40502,0.00876720265501075,0.00156970367642184,0.00569058344922395,0.0118438218607975,2.38741081501287e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,42611,-0.0338282609399844,0.00605751098856764,-0.045700982477577,-0.0219555394023919,2.38906123693386e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,42654,-0.0490351992078654,0.00879615583381749,-0.0662756646421477,-0.0317947337735831,2.52845760133217e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,42476,-0.0191886544903323,0.00344517029678174,-0.0259411882720245,-0.0124361207086401,2.60096001019074e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,42311,-0.0294713170586137,0.00529213093526412,-0.0398438936917314,-0.0190987404254961,2.61400773019285e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELL,L-selectin,40539,0.0137280101608295,0.00246500371288464,0.00889660288357564,0.0185594174380834,2.61790670761585e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40116,-0.0669786314715495,0.0120310110312214,-0.0905594130927435,-0.0433978498503556,2.65031622242226e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,-0.0657813242635052,0.0118233594441564,-0.0889551087740517,-0.0426075397529587,2.69218641282888e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42370,-0.0187108984213573,0.00336339439666646,-0.0253031514388235,-0.012118645403891,2.70189658884062e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,-0.0379946246966577,0.00682944676712519,-0.0513803403602231,-0.0246089090330923,2.70669219491149e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,42357,-0.0253821580723521,0.00456494529812377,-0.0343294508566747,-0.0164348652880295,2.74660727018814e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,40449,-0.0207764434169606,0.00374548142285012,-0.0281175870057468,-0.0134352998281744,2.97061010450305e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42754,-0.04105712821811,0.00742141813757924,-0.0556031077677653,-0.0265111486684547,3.22008885697308e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40539,0.00896325517174421,0.00162185839200132,0.00578441272342162,0.0121420976200668,3.33833394402873e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40449,-0.0494473252217333,0.00894803745198195,-0.0669854786276179,-0.0319091718158487,3.34805734014214e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,40511,-0.036298984945756,0.00656901516983219,-0.0491742546786271,-0.0234237152128849,3.35269035101123e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,42311,-0.0410352951909869,0.0074285712641939,-0.055595294868807,-0.0264752955131669,3.37712626274526e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,-0.0428848310617628,0.00777047999856631,-0.0581149718589528,-0.0276546902645729,3.4735191301358e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,40539,-0.0205674340337006,0.00372714534521301,-0.0278726389103181,-0.0132622291570831,3.49849299866482e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,40483,-0.0174014100273452,0.00316435685155013,-0.0236035494563834,-0.0111992705983069,3.89838733732365e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,-0.0404282459888573,0.00735682686075032,-0.0548476266359279,-0.0260088653417867,3.97041258742953e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.0326826381796924,0.00594915532321145,-0.0443429826131868,-0.021022293746198,4.00909024892114e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,0.0185899371476805,0.00338639976340726,0.0119525936114023,0.0252272806839587,4.10093547762393e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,40483,-0.047173107362062,0.00859310741516884,-0.0640155978957929,-0.030330616828331,4.11451177883026e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40449,-0.0330451971977678,0.00602502783222082,-0.0448542517489206,-0.021236142646615,4.23230921876753e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,42311,-0.0204284261317248,0.00373152677535718,-0.0277422186114249,-0.0131146336520248,4.4669228766007e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",42311,-0.0305682378007716,0.00558414930648285,-0.041513170441478,-0.0196233051600653,4.4780276348915e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.0119766988132993,0.00219057833721343,0.00768316527236098,0.0162702323542376,4.66448421782018e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,42664,-0.0240969407818946,0.00441140385164561,-0.03274329233112,-0.0154505892326692,4.78022632757615e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,40269,-0.0230933620293392,0.00422727286404433,-0.0313788168428661,-0.0148079072158123,4.78425940814238e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,-0.0165546170047539,0.00303089790086602,-0.0224951768904513,-0.0106140571190565,4.79257629123539e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,40463,-0.0551611730710415,0.0101039189880297,-0.0749648542875798,-0.0353574918545033,4.87917476521752e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42701,-0.0123605178321338,0.00226450504669625,-0.0167989477236584,-0.00792208794060914,4.88991346663331e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.0371576099025303,0.00681046592101594,0.0238090966973391,0.0505061231077216,4.95751947673013e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAT,Catalase,40361,-0.0306134167549374,0.00561074570785482,-0.0416104783423328,-0.0196163551675419,4.96781618108456e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40223,-0.0313089588285613,0.00574783886264534,-0.0425747229993462,-0.0200431946577765,5.23018415186421e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,42531,-0.0254498696097472,0.00468509353019777,-0.0346326529289349,-0.0162670862905596,5.66733782761807e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,42734,-0.0384384570143261,0.00707800432787664,-0.0523113454969643,-0.0245655685316878,5.71048985525304e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,42597,-0.0229061802985236,0.00421812605056004,-0.0311737073576213,-0.0146386532394259,5.72027990086799e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.0661255069380889,0.0121931279482642,-0.0900240377166868,-0.0422269761594911,5.9562751805868e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,-0.0229927178286164,0.00424699232836407,-0.03131682279221,-0.0146686128650228,6.29356528979134e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40511,-0.0391419829836795,0.00723046244911694,-0.0533136893839487,-0.0249702765834103,6.30728170544176e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,-0.0334805752320118,0.00619093205501604,-0.0456148020598433,-0.0213463484041804,6.50547756420367e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,42587,-0.0184168312729257,0.00340648276302722,-0.0250935374884591,-0.0117401250573924,6.54041609330748e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42311,-0.0348943923161481,0.00645574695918909,-0.0475476563561588,-0.0222411282761375,6.58805622800131e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42357,-0.0194617650254733,0.00360143122159746,-0.0265205702198043,-0.0124029598311422,6.63438565125164e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42311,-0.0289145884464744,0.00535603200269232,-0.0394124111717514,-0.0184167657211975,6.83667201598079e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40302,-0.0377010242989784,0.00698368747270766,-0.0513890517454854,-0.0240129968524714,6.86061486413202e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,42611,-0.0364134400035135,0.00674998274094207,-0.0496434061757599,-0.023183473831267,6.98427025396837e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,40451,-0.0457005836806852,0.00847831322107338,-0.0623180775939891,-0.0290830897673814,7.17634570249217e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40199,-0.0505043370629368,0.00939087841255302,-0.0689104587515407,-0.0320982153743328,7.68509457244713e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,40451,-0.0217391426241409,0.00404365181242855,-0.0296647001765009,-0.0138135850717809,7.76304535702361e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,40116,-0.0222620936268375,0.00414192748244677,-0.0303802714924332,-0.0141439157612419,7.82391355442183e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,-0.0493902332795358,0.00919668777698028,-0.0674157413224172,-0.0313647252366545,8.01007187754437e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,-0.0379806707037743,0.00707288963361363,-0.051843534385657,-0.0241178070218916,8.03983571242804e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,42700,-0.0511356702318347,0.00953680089619542,-0.0698277999883778,-0.0324435404752917,8.36922813377678e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,-0.0593011999633639,0.0110680056798392,-0.0809944910958486,-0.0376079088308791,8.58533424867906e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40451,-0.0189952272673675,0.0035482932290984,-0.0259498819964003,-0.0120405725383346,8.80413798952518e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,42679,-0.0381820977579488,0.00713576409722187,-0.0521681953885037,-0.024196000127394,8.89947951536174e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,42357,-0.0461171406747202,0.00863296433220901,-0.0630377507658498,-0.0291965305835905,9.34664231753173e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,42357,-0.0373398983908964,0.0069979874075903,-0.0510559537097734,-0.0236238430720194,9.66980034618441e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,42611,0.0173095565205103,0.0032496392186466,0.010940263651963,0.0236788493890576,1.01679385670121e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,40483,-0.0388921656282841,0.00730516365972476,-0.0532102864013446,-0.0245740448552236,1.03497826567121e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,40302,-0.0165551941754474,0.00310999195541033,-0.0226507784080517,-0.0104596099428432,1.03928561741148e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,-0.0183754704675575,0.00345481498280004,-0.0251469078338456,-0.0116040331012694,1.06163627417725e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,40451,-0.038485492870668,0.00724040373131558,-0.0526766841840466,-0.0242943015572895,1.08469796432149e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40302,-0.0382443080315826,0.00720928535766987,-0.0523745073326155,-0.0241141087305497,1.14922072027158e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.0189046239344082,0.00356992571847975,-0.0259016783426285,-0.0119075695261879,1.205320062287e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,-0.0151937273670983,0.00287269677386028,-0.0208242130438645,-0.00956324169033217,1.25340649281632e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,42654,-0.0175889777039847,0.0033267856202647,-0.0241094775197036,-0.0110684778882659,1.26228544440121e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BGN,Biglycan,42328,0.0654233276078049,0.0123741721196739,0.041169950253244,0.0896767049623658,1.26271278402129e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40199,-0.0164766383483823,0.00311753930736042,-0.0225870153908087,-0.0103662613059559,1.28009448969317e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42679,-0.0451776258779372,0.00855034591695021,-0.0619363038751597,-0.0284189478807148,1.28558164759284e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40483,-0.0208381468176696,0.00394573450406256,-0.0285717864456322,-0.013104507189707,1.30737803179229e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,40223,-0.0284468658820584,0.00539130656981204,-0.03901382675889,-0.0178799050052268,1.34220476866961e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,42448,-0.0366179524392094,0.00694629448959836,-0.0502326896388222,-0.0230032152395967,1.37377341361277e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40116,-0.0334821154546353,0.00635729079384007,-0.0459424054105619,-0.0210218254987088,1.41517632978664e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,42357,-0.0258344055223572,0.00490681056252146,-0.0354517542248993,-0.0162170568198152,1.42387451374051e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,40532,-0.039613636040137,0.00752475693360282,-0.0543621596299986,-0.0248651124502755,1.43186918212727e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40182,-0.037295376122464,0.0070860214166338,-0.0511839780990662,-0.0234067741458617,1.44212307351238e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,42370,-0.03050984742371,0.00579790897025131,-0.0418737490054026,-0.0191459458420174,1.4456216151271e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,42587,-0.0481907184230393,0.00916601475322931,-0.0661561073393687,-0.0302253295067098,1.48237443851813e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,40116,-0.0234557434759455,0.00446449993000753,-0.0322061633387602,-0.0147053236131307,1.51769805494544e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,-0.0431946569076378,0.00823221698063439,-0.0593298021896812,-0.0270595116255944,1.57447988746346e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,42636,0.0380267725580919,0.00725199648694526,0.0238128594436791,0.0522406856725046,1.59836747163162e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,42342,-0.0218922560385071,0.00417510818138932,-0.0300754680740301,-0.013709044002984,1.59985516815933e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,40382,0.022919642381427,0.00437550599955494,0.0143436506222993,0.0314956341405546,1.65123156254738e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42587,-0.0245148886847267,0.00468418141810592,-0.0336958842642143,-0.0153338931052391,1.68798453860926e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,40511,-0.0161621207419353,0.00309038896443135,-0.0222192831122207,-0.0101049583716498,1.72720499785831e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,-0.0453201655089761,0.00867247120909687,-0.062318209078806,-0.0283221219391463,1.76103489005725e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40283,-0.0133744408669222,0.00255929525696439,-0.0183906595705724,-0.00835822216327201,1.76524807111595e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,40483,-0.0729646492369221,0.0139629428470719,-0.100332017217183,-0.0455972812566611,1.76694363545161e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,-0.0204391771006245,0.00391271176566513,-0.0281080921613282,-0.0127702620399209,1.78428825997396e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPL,Periplakin,40199,-0.0179965083544662,0.00344587128626444,-0.0247504160755445,-0.0112426006333879,1.79620977128789e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40332,-0.0307192599325352,0.00588514653199541,-0.0422541471352462,-0.0191843727298242,1.82345229904611e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40223,-0.016665065745968,0.00319867253004028,-0.022934463904847,-0.0103956675870891,1.92254431641144e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42587,-0.029999999338198,0.00575975611922051,-0.0412891213318702,-0.0187108773445258,1.93139869312782e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,42611,0.0128689926513029,0.00247118659377787,0.00802546692749831,0.0177125183751076,1.94110350328869e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,40283,0.0171374422891424,0.0032963417690309,0.0106766124218418,0.0235982721564429,2.04009423924062e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,40080,-0.0224857133585956,0.00432623572250994,-0.0309651353747151,-0.0140062913424761,2.05619231488838e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42565,-0.013945534330978,0.00268577640905668,-0.0192096560927291,-0.00868141256922688,2.10684621485323e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,40223,-0.0235931699019982,0.00454594051348308,-0.032503213308425,-0.0146831264955714,2.14098663622923e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.0283477610272371,0.00547968523512528,-0.0390879440880826,-0.0176075779663915,2.34018013980895e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.0317715294527883,0.00614368123025517,0.0197299142414881,0.0438131446640884,2.3571465541591e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,42587,-0.0432211868555078,0.00836463001135692,-0.0596158616777674,-0.0268265120332483,2.41123849244584e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40302,-0.0365725324646081,0.00707808246796316,-0.0504455741018159,-0.0226994908274003,2.41993399304437e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,40532,-0.0484024919662627,0.00937472040779548,-0.0667769439655418,-0.0300280399669835,2.47026690848381e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,42495,0.0224180717558566,0.00435132986266935,0.0138894652250247,0.0309466782866886,2.61404141630285e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,42652,-0.0202315094736212,0.00394194551120243,-0.027957722675578,-0.0125052962716645,2.90107810439287e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40166,-0.0297526182525906,0.00579887698139412,-0.0411184171361231,-0.0183868193690582,2.9351383472037e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,42477,-0.0367459345500524,0.00716767654400999,-0.0507945805763119,-0.0226972885237928,2.99140566311262e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,40235,-0.0220369417622582,0.00430304166933471,-0.0304709034341542,-0.0136029800903621,3.08638240768771e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40283,-0.0435001287416298,0.00849420373893099,-0.0601487680699345,-0.0268514894133251,3.08768168336365e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,42346,-0.0348323506101786,0.00680428202684548,-0.0481687433827957,-0.0214959578375614,3.11197328199803e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,-0.0256501007711607,0.0050168306283969,-0.0354830888028186,-0.0158171127395028,3.22724911496154e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,42594,-0.020417613187558,0.00399427470498023,-0.0282463916093192,-0.0125888347657967,3.23636689424118e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,-0.023968314399236,0.00468891526198801,-0.0331585883127325,-0.0147780404857395,3.23677917668095e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,40482,0.0254843110134815,0.00498700539827577,0.015709780432861,0.035258841594102,3.27178325039722e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,40451,-0.0368736686888153,0.00722144459966718,-0.051027700104163,-0.0227196372734676,3.34190039879766e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,42611,-0.0386950812630978,0.00758508212564555,-0.0535618422293631,-0.0238283202968326,3.41623230718851e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,-0.0304020583027115,0.00596871067523843,-0.0421007312261788,-0.0187033853792441,3.56243777197363e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,42711,0.015976284672573,0.00313945507460357,0.00982295272635005,0.022129616618796,3.65033687347235e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,40511,-0.0373730218080526,0.00735582397394234,-0.0517904367969796,-0.0229556068191256,3.81964625421236e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,40199,-0.0329658317725353,0.00649777245825263,-0.0457014657907105,-0.0202301977543602,3.97132478040598e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40116,-0.0188137988387382,0.00371419115759221,-0.0260936135076189,-0.0115339841698575,4.14238304151983e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,-0.0422716844187475,0.00834623423726924,-0.0586303035237952,-0.0259130653136997,4.14346932249787e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40482,-0.0349940186437287,0.00690991438665195,-0.0485374508415665,-0.0214505864458909,4.16331037952537e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,-0.0298523894966353,0.00589895275943547,-0.0414143369051288,-0.0182904420881418,4.23371834507694e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.0258676162034288,0.00511209108965391,-0.0358873147391505,-0.0158479176677071,4.25819738328759e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42794,-0.016869491761588,0.00333720970789837,-0.0234104227890688,-0.0103285607341072,4.36054815954928e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,-0.0273575318913339,0.00541860299203132,-0.0379779937557153,-0.0167370700269525,4.51473034138596e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42587,-0.0112727709526298,0.00223478016857196,-0.0156529400830309,-0.00689260182222879,4.61283792171138e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,-0.0260275606243572,0.00516253080254551,-0.0361461209973464,-0.015909000251368,4.68934171782076e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,40116,-0.0200841510082607,0.00398497984646021,-0.0278947115073227,-0.0122735905091987,4.7307974649237e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,42611,0.0152548534787096,0.00302839192571715,0.00931920530430398,0.0211905016531152,4.78334266788788e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,-0.0474475044188043,0.00943072164419637,-0.0659317188414292,-0.0289632899961795,4.95191620686643e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,42597,-0.0529394483543629,0.0105315975861445,-0.0735813796232061,-0.0322975170855197,5.05364465050312e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,40384,-0.0230824324896496,0.00460688858523083,-0.032111934116702,-0.0140529308625972,5.51420366802653e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFB,Complement factor B,40344,-0.0167361880573583,0.00334147083305039,-0.0232854708901371,-0.0101869052245796,5.56584947376912e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40483,-0.0543207286209048,0.0108517388702006,-0.075590136806498,-0.0330513204353115,5.64943458426537e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,40269,-0.0303099402840518,0.00605873376680848,-0.0421850584669964,-0.0184348221011071,5.74046931936031e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40451,-0.0212004107839472,0.00423937356428552,-0.0295095829699468,-0.0128912385979476,5.79428097965112e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,0.0250566318376655,0.00501232947800526,0.0152324660607752,0.0348807976145558,5.85115332359496e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,42346,-0.0248448826234599,0.00497074342441364,-0.0345875397353106,-0.0151022255116091,5.86055217531703e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C7,Complement component C7,40251,-0.0170056138789855,0.00340378476624131,-0.0236770320208185,-0.0103341957371526,5.93991274204354e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,42346,-0.0296915779963525,0.00595103980337658,-0.0413556160109706,-0.0180275399817344,6.1369757489733e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40223,-0.0269679678092984,0.00540662156206804,-0.0375649460709518,-0.0163709895476451,6.19524372209451e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",40302,-0.023423921576691,0.00469633045398761,-0.0326287292665067,-0.0142191138868753,6.20240455139024e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,42681,-0.0353095308905365,0.00711160546808203,-0.0492482776079773,-0.0213707841730957,6.95202505831193e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,-0.0448992375911539,0.00904836025213529,-0.0626340236853391,-0.0271644514969688,7.07403866243456e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,42311,-0.0251157841914578,0.00508159533148968,-0.0350757110411776,-0.015155857341738,7.8079760651781e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,-0.0144253941248707,0.00292343761127074,-0.0201553318429613,-0.00869545640678001,8.13564433090498e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,40482,-0.0139866601496523,0.00283938459951535,-0.0195518539647024,-0.00842146633460219,8.51427235741996e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40116,-0.0350791178517328,0.00712138502888977,-0.0490370325083567,-0.0211212031951088,8.52104789957013e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40511,-0.0138757213460163,0.00282400861172969,-0.0194107782250065,-0.00834066446702612,9.072491715052e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40223,-0.040948101529841,0.00834115087750006,-0.0572967572497411,-0.0245994458099409,9.27741058302352e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,42587,-0.0701515377162591,0.0142949877286283,-0.0981697136643705,-0.0421333617681476,9.33671258737484e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40199,-0.0105194412340848,0.00214376002867772,-0.0147212108902932,-0.0063176715778765,9.3802799713384e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,-0.0118699400201129,0.00241992229265315,-0.0166129877137131,-0.00712689232651275,9.4473086799198e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40449,0.025866927957822,0.00528081186917674,0.0155165366942356,0.0362173192214085,9.80212031873271e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40451,-0.0246389208510914,0.00503104537757444,-0.0344997697911373,-0.0147780719110455,9.84749727886217e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42439,-0.0146326580048931,0.00299012775620588,-0.0204933084070566,-0.00877200760272952,1.00144514814949e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,40283,-0.0147741190367522,0.00302055113297677,-0.0206943992573867,-0.00885383881611779,1.0163065330151e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,42311,-0.0173600283330676,0.0035540770234248,-0.0243260192989802,-0.010394037367155,1.04894325767973e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,40080,-0.028043036343621,0.00574301114219829,-0.0392993381823297,-0.0167867345049124,1.05977151393201e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.0225028868486623,0.00461306298230562,0.0134612834033433,0.0315444902939813,1.08346972281506e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,-0.0371286816683794,0.00761429316377482,-0.052052696269378,-0.0222046670673808,1.09657007830683e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,40449,-0.0333663960889604,0.00685413626157607,-0.0468005031616495,-0.0199322890162713,1.14225792645604e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40116,-0.02758073841566,0.00567055001003599,-0.0386950164353306,-0.0164664603959895,1.16727002617908e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42587,-0.0297870775774613,0.00612656341536469,-0.0417951418715761,-0.0177790132833466,1.17551098475787e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,40080,-0.0181013768424366,0.00372371124979629,-0.0253998508920373,-0.0108029027928358,1.18358852943305e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40451,-0.0276527148397228,0.00569111354587966,-0.038807297389647,-0.0164981322897987,1.19613893722317e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNLY,Granulysin,42611,-0.0267153460963947,0.00550052800767854,-0.0374963809914446,-0.0159343112013448,1.20601873067287e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,40283,-0.02248255043345,0.0046370380034433,-0.0315711449201988,-0.0133939559467011,1.26104749834806e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,-0.0468988536861706,0.00969431888877261,-0.0658997187081649,-0.0278979886641762,1.3304679577027e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,42311,-0.0343211151125516,0.00711351951923866,-0.0482636133702593,-0.0203786168548438,1.41739959744657e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,-0.0274215024760825,0.0056968318381366,-0.0385872928788303,-0.0162557120733348,1.50263872736345e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,42591,-0.0122979117670442,0.00255685320970785,-0.0173093440580716,-0.0072864794760168,1.52737823567812e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40283,-0.0617091820523572,0.0128334363781768,-0.0868627173535836,-0.0365556467511307,1.54089951040255e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,40527,-0.0485435830381048,0.0101037148520117,-0.0683468641480477,-0.028740301928162,1.57105579267939e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,40483,-0.048866084072582,0.0101920657057334,-0.0688425328558195,-0.0288896352893444,1.65145072444158e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42679,-0.0185514978521444,0.00387480619458538,-0.0261461179935317,-0.010956877710757,1.70476135257895e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,40527,-0.0271881520438228,0.00569434924955361,-0.0383490765729479,-0.0160272275146977,1.82332258598117e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,42311,-0.0180863224226141,0.00378881948752694,-0.0255124086181669,-0.0106602362270613,1.82912176226175e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40182,-0.0238214888293403,0.00499999348038726,-0.0336214760508993,-0.0140215016077812,1.91932834715617e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,40539,0.011320342549462,0.00237879188526336,0.00665791045434579,0.0159827746445782,1.97090456335981e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42311,-0.0246676519896392,0.00519817616443251,-0.0348560772719269,-0.0144792267073515,2.10245428248269e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40483,-0.0111176625337751,0.00234677842559771,-0.0157173482479466,-0.00651797681960357,2.19100678920819e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,42721,-0.0296432462278245,0.00626094611568688,-0.0419147006145708,-0.0173717918410782,2.21683841048902e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40182,-0.0305730317399465,0.00646045295072509,-0.0432355195233677,-0.0179105439565253,2.24719632021367e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,42611,0.013957619185092,0.00295005613920594,0.00817550915224833,0.0197397292179356,2.25354627733806e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42357,-0.0448131337573686,0.00948975498732305,-0.0634130535325218,-0.0262132139822154,2.35639811381206e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40136,-0.0482151423726953,0.0102101322957586,-0.0682270016723821,-0.0282032830730085,2.36108423100793e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,-0.0228698207640633,0.00484385581953214,-0.0323637781703463,-0.0133758633577803,2.37035397570177e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,40302,-0.0361825273906682,0.00767129099812229,-0.0512182577469879,-0.0211467970343485,2.4272170717641e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,42611,-0.0579141177769233,0.0123118816398699,-0.0820454057910684,-0.0337828297627782,2.57757192898175e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,40199,-0.0262925450536692,0.00559525503877883,-0.0372592449296757,-0.0153258451776627,2.64504903051371e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,42794,-0.0417443617412326,0.00889348211101876,-0.0591755866788294,-0.0243131368036359,2.70772520460469e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,42311,-0.021846140526154,0.00466517960567529,-0.0309898925532775,-0.0127023884990304,2.85808568597838e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,40532,0.0281826835017981,0.006020474541464,0.0163825534005286,0.0399828136030675,2.88590711788448e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42357,-0.0300231877790081,0.00641923851263037,-0.0426048952637637,-0.0174414802942526,2.93905527715751e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,42357,-0.0682474069874644,0.0145967234281397,-0.0968569849066182,-0.0396378290683105,2.96108281616949e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,42370,-0.0407199629525418,0.00873029550063299,-0.0578313421337825,-0.0236085837713012,3.12844511719152e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42594,-0.0158251545003645,0.00339351990857438,-0.0224764535211703,-0.00917385547955877,3.14114812331997e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,42587,-0.0353326716192573,0.00758202797719619,-0.0501934464545618,-0.0204718967839527,3.19170230723114e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,42292,-0.0344539990905141,0.00739689559433425,-0.0489519144554092,-0.019956083725619,3.22593737650583e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40302,-0.0366381697253732,0.00786624381155981,-0.0520560075960304,-0.021220331854716,3.23558936165917e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,-0.0338769633032777,0.00729002167270331,-0.0481654057817762,-0.0195885208247793,3.40625150914834e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40429,-0.0414212845337045,0.00891564017571768,-0.0588959392781111,-0.0239466297892978,3.42423086758065e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,42551,-0.0286456711639554,0.00619777391775784,-0.0407933080427608,-0.0164980342851501,3.83747130533122e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,40223,-0.0144187900756902,0.00312342022034046,-0.0205406937075575,-0.00829688644382291,3.94965210434865e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,-0.0129960469709298,0.00282160148539267,-0.0185263858822994,-0.0074657080595602,4.14388137301423e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40283,-0.0409355315229142,0.00888889395783986,-0.0583577636802804,-0.0235132993655481,4.16565766980467e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,-0.0225214930471538,0.00489049532374239,-0.0321068638816889,-0.0129361222126187,4.16662115143549e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.0152827360330303,0.00332285473636045,0.00876994074976386,0.0217955313162968,4.28555032499574e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,-0.0509020803137643,0.011090127054117,-0.0726387293398336,-0.029165431287695,4.48352708284699e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40449,-0.0535335258131872,0.0116694489141392,-0.0764056456849,-0.0306614059414744,4.53444046763173e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,40516,-0.0168856833547132,0.00368356631140029,-0.0241054733250578,-0.00966589338436861,4.60919128481964e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,-0.0129385107667147,0.00282261274868093,-0.0184708317541293,-0.00740618977930011,4.61311010564448e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,40483,-0.0247837010337016,0.00540782584325228,-0.0353830396864761,-0.0141843623809271,4.63418625728635e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,-0.0287253810586449,0.0062783635837241,-0.0410309736827441,-0.0164197884345456,4.80752079488438e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,40539,-0.0240275473394892,0.00526554709213541,-0.0343480196400746,-0.0137070750389038,5.09177701885756e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,40283,-0.0442421539986602,0.00970235063422182,-0.0632587612417349,-0.0252255467555854,5.17159463135706e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42346,-0.0345416872584305,0.00759360700307407,-0.0494251569844557,-0.0196582175324053,5.4438948469221e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,40136,-0.0299682418834183,0.00659330165196588,-0.0428911131212714,-0.0170453706455651,5.5456973684807e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,-0.0176883642758916,0.00389215491400917,-0.0253169879073496,-0.0100597406444337,5.55160264424286e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,-0.0376617243931609,0.00829410322104642,-0.0539181667064119,-0.02140528207991,5.6625940386972e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,40116,-0.0585220960503261,0.0128963659775606,-0.0837989733663449,-0.0332452187343073,5.74305919205004e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,40482,-0.0137095735654855,0.0030278912032519,-0.0196442403238592,-0.00777490680711177,6.02218401533813e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0220871564652787,0.00489087642481402,-0.0316732742579141,-0.0125010386726432,6.35583197388091e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,-0.0272476302802607,0.00603396446324591,-0.0390742006282227,-0.0154210599322987,6.36476485262432e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,-0.0423672597044829,0.00938403781873632,-0.0607599738292061,-0.0239745455797597,6.40222582529192e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,40182,-0.0319684486727279,0.00709148788449963,-0.0458677649263472,-0.0180691324191086,6.6117671792447e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,-0.03044994023866,0.00675486692281983,-0.0436894794073869,-0.0172104010699331,6.61710233795378e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42754,-0.0117818239947721,0.00262564484005954,-0.0169280878812888,-0.00663556010825539,7.27552581859709e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,40451,-0.0187052402727355,0.00416834983845342,-0.0268752059561042,-0.0105352745893668,7.2797618353063e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FST,Follistatin,42654,0.0226689605102986,0.00505376799475164,0.0127635752405854,0.0325743457800118,7.33260640401018e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,40080,-0.0170984152903465,0.00381626139340066,-0.0245782876214118,-0.00961854295928122,7.52596845711309e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0122488474852457,0.00273687149987304,0.00688457934549449,0.0176131156249968,7.68580715610705e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,40109,0.0290737107651088,0.00649896670501447,0.0163357360232804,0.0418116855069371,7.76951116090304e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,-0.0201512612610394,0.00450610209550836,-0.0289832213682358,-0.011319301153843,7.81426998767664e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,-0.0372226548902077,0.00832880180239734,-0.0535471064229065,-0.0208982033575089,7.91754555071782e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,-0.0163191145525829,0.00365421750060774,-0.0234813808537741,-0.00915684825139174,8.04102413589848e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42721,0.0276499405839777,0.00619500115678214,0.0155077383166847,0.0397921428512707,8.13719746816033e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,-0.0543132607611571,0.0121738063178981,-0.0781739211442372,-0.0304526003780769,8.20530571717739e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40136,-0.0349853226779276,0.00784099659450589,-0.0503536760031592,-0.0196169693526961,8.20679221643223e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,42607,-0.0437718001624609,0.00981963290656603,-0.0630182806593303,-0.0245253196655915,8.35624154219901e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42679,0.0115419938323103,0.00259044535862677,0.00646472092940182,0.0166192667352187,8.43318532563449e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,42578,-0.0503515607155344,0.0113109130820221,-0.0725209503562978,-0.028182171074771,8.59256475051607e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,42794,0.0137979314040063,0.00309997347695422,0.00772198338917606,0.0198738794188366,8.61577317916133e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MB,Myoglobin,42794,-0.0243194038810922,0.00546412103600698,-0.0350290811116658,-0.0136097266505185,8.62538245388265e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,40235,0.0160414024067352,0.00360633385658283,0.00897298804783288,0.0231098167656376,8.74727311307346e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,40451,-0.0211120093490585,0.00475327906180516,-0.0304284363101966,-0.0117955823879204,9.01577491780985e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.0134739107918381,0.00303505885856191,-0.0194226261546195,-0.00752519542905677,9.105322853741e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,-0.0227157679648873,0.00512526288864523,-0.0327612832266319,-0.0126702527031426,9.40672617994669e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40482,0.0204466558297611,0.00462477773871022,0.0113820914618891,0.0295112201976332,9.91122938752161e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,40199,-0.0177277359817334,0.00400999062761605,-0.0255873176118609,-0.00986815435160596,9.92362872265881e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,-0.042195706951553,0.00954625321710115,-0.0609063632570712,-0.0234850506460347,9.94120695565918e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42370,-0.0298020509832166,0.0067507406553356,-0.0430335026676743,-0.0165705992987588,1.01985974804132e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,42370,-0.0233247434849393,0.00529249183751515,-0.033698027486469,-0.0129514594834096,1.0557333225523e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,40199,-0.00985818573484289,0.0022382973457365,-0.0142452485324864,-0.00547112293719934,1.07116922770394e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,40483,0.0169588699768897,0.0038543491262046,0.00940434568952867,0.0245133942642507,1.09278668304953e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,42292,-0.0165636976048623,0.00376564709436643,-0.0239443659098205,-0.00918302929990412,1.09795019489469e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,42734,-0.0156009009084489,0.00354689049112821,-0.0225528062710602,-0.00864899554583764,1.09847590962031e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,0.0095478126904856,0.00217083987124566,0.00529296654284411,0.0138026588381271,1.10170022735861e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,-0.0183156291425508,0.00416515938395364,-0.0264793415350999,-0.0101519167500017,1.10613705901273e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42654,0.0202699749625022,0.00461126142502036,0.0112319025694623,0.0293080473555421,1.11234186299209e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40449,-0.0429561058747422,0.00977819298314106,-0.0621213641216987,-0.0237908476277858,1.1279287367369e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40080,-0.0361949014138438,0.00825989140951776,-0.0523842885764986,-0.020005514251189,1.18692473399663e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40223,-0.0330394991796085,0.007544812442742,-0.0478273315673828,-0.0182516667918342,1.20268517150046e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,42261,0.0401221267542729,0.00917245222256003,0.0221441203980552,0.0581001331104905,1.2282344802551e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,-0.0446948737714722,0.0102214313212146,-0.0647288791610528,-0.0246608683818916,1.23839680763804e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,-0.0234217538444998,0.00536988844519433,-0.0339467351970807,-0.0128967724919189,1.30047833664029e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,42594,-0.0160261549906164,0.00368278692679871,-0.0232444173671418,-0.00880789261409089,1.36124832928876e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,40449,-0.0273382699494407,0.00628513040524327,-0.0396571255437175,-0.0150194143551638,1.37540368197514e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,42636,-0.0382353615596799,0.00879774814429546,-0.055478947922499,-0.0209917751968608,1.39635706972249e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,42638,-0.013193658663544,0.00304399252708282,-0.0191598840166263,-0.00722743331046165,1.47269472199632e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,-0.0129203476505364,0.0029826422680402,-0.0187663264958952,-0.00707436880517766,1.49145600270155e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,-0.0165265005795508,0.00381671534397475,-0.0240072626537413,-0.00904573850536025,1.50368748268551e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,-0.0435946311861721,0.0100774687012019,-0.0633464698405278,-0.0238427925318164,1.52995646259284e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,42370,-0.0247354571516022,0.00572529645418125,-0.0359570382017974,-0.0135138761014069,1.56901701782476e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,42262,-0.0205563020089724,0.00476493753984505,-0.0298955795870687,-0.0112170244308761,1.61449163628191e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42616,-0.0437959783131742,0.0101728209307893,-0.0637347073375212,-0.0238572492888271,1.68022388681677e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,0.0528654105965724,0.0122828212840315,0.0287910808798706,0.0769397403132742,1.68932201307558e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42357,-0.0194740165353495,0.00453541411832738,-0.0283634282072711,-0.0105846048634278,1.76924036753101e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,42476,-0.0327989783298455,0.007647604993774,-0.0477882841176425,-0.0178096725420484,1.80917854015124e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,42311,-0.0268928019313721,0.00627124901471207,-0.0391844500002078,-0.0146011538625364,1.81358892773883e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42292,-0.0189534840732785,0.00442333559487999,-0.0276232218392433,-0.0102837463073137,1.84139353993639e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42636,0.0348604958918566,0.00814215378484301,0.0189018744735642,0.0508191173101489,1.86939375147986e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPTC,Opticin,42587,0.020405712191355,0.00476958261238042,0.0110573302710894,0.0297540941116207,1.89632247737393e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,-0.02525845241173,0.00591478796247889,-0.0368514368181886,-0.0136654680052714,1.96467473808762e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,40483,0.0185763984431156,0.00435254275472723,0.0100454146438503,0.027107382242381,1.98895547291418e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,40451,-0.0214241440058311,0.00503905977196441,-0.0313007011588813,-0.0115475868527808,2.13946473423486e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBN1,Drebrin,40199,-0.0218686831295782,0.0051610416818073,-0.0319843248259205,-0.0117530414332359,2.28106071577265e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42618,-0.129127457063663,0.0305439641822517,-0.188993626860876,-0.0692612872664495,2.37767449438866e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,-0.0288916133435341,0.00683410999636738,-0.0422864689364142,-0.0154967577506541,2.37834444148663e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42370,-0.0211931716816672,0.00501954745261398,-0.0310314846887906,-0.0113548586745438,2.43630388616713e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,40182,-0.0295778983919765,0.00701673502260775,-0.0433306990362877,-0.0158250977476653,2.51401463687471e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,-0.0116802207104224,0.0027839562505621,-0.0171367749615241,-0.00622366645932064,2.73967872212825e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,42636,-0.0289223997379186,0.00689768256222771,-0.0424418575598849,-0.0154029419159523,2.76978979756292e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,40483,-0.0167901238012972,0.004008713148632,-0.0246472015726159,-0.00893304602997844,2.83053375639243e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,42721,-0.0185570985681513,0.00443616292560165,-0.0272519779023305,-0.00986221923397207,2.89321502099293e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,-0.012271092735946,0.00293486913186169,-0.0180234362343949,-0.00651874923749705,2.92237707381539e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,42587,-0.036159086598108,0.00865799980768291,-0.0531287662211665,-0.0191894069750495,2.98061920798276e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,-0.0313231421025099,0.00750256541293334,-0.0460281703118593,-0.0166181138931606,2.99922277912026e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40470,-0.0176455977998949,0.00423172357792762,-0.025939776012633,-0.00935141958715674,3.07097281863647e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,39042,-0.0475679127667675,0.011407036726644,-0.0699257047509897,-0.0252101207825453,3.07142372830948e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,42370,-0.034618287513166,0.00830410671738361,-0.0508943366792379,-0.0183422383470941,3.08144124564346e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40223,-0.0261360706137593,0.00627565679774144,-0.0384363579373325,-0.0138357832901861,3.14169596501249e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,42570,-0.0283824617879329,0.00681732788407614,-0.0417444244407221,-0.0150204991351436,3.15670103851419e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,-0.0127271220119981,0.00305927175097995,-0.0187232946439188,-0.00673094938007743,3.19999624472007e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,42594,0.0117076139130816,0.00281762388884889,0.0061850710909378,0.0172301567352254,3.27110184816573e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTD,Biotinidase,40539,-0.00881282497064845,0.00212393311273305,-0.0129757338716052,-0.00464991606969168,3.35933733990175e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,42445,-0.0163859469884585,0.00395053707571209,-0.0241289996568542,-0.00864289432006281,3.3781217751582e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,-0.0149175089185517,0.00360874382115312,-0.0219906468080118,-0.00784437102909155,3.59128409708905e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42357,-0.0215856636706541,0.00523179181522838,-0.0318399756285017,-0.0113313517128064,3.71616702388391e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0166526146234031,0.00403921960086604,-0.0245694850411005,-0.00873574420570566,3.77086122881137e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LXN,Latexin,42461,0.0286658105326001,0.00695410036803579,0.01503577381125,0.0422958472539503,3.77643573283783e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,42276,-0.0206528474771755,0.0050107952560785,-0.0304740061790894,-0.0108316887752617,3.78453775657308e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0127934549872709,0.00310479738340989,-0.0188788578587543,-0.00670805211578756,3.80249521575121e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,42500,0.0204934666008333,0.00497476644100825,0.0107429243764572,0.0302440088252095,3.82020147673185e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42357,-0.0148920329935673,0.00362212377969746,-0.0219913956017743,-0.00779267038536028,3.95638376201093e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42741,-0.022138948770176,0.00538707718051835,-0.032697620043992,-0.01158027749636,3.98609165118845e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,-0.020774322217336,0.00505593907614928,-0.0306839628065886,-0.0108646816280834,3.99914241469755e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,-0.0318745006667826,0.00775940397986724,-0.0470829324673224,-0.0166660688662428,4.01769880912719e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40199,-0.0157334351896589,0.00383093975047243,-0.0232420771005848,-0.0082247932787329,4.03837251273017e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,40283,0.00937889598744242,0.00228408415293033,0.00490209104769897,0.0138557009271859,4.05114298616018e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,42618,-0.0154975681192715,0.00377968236933292,-0.0229057455631641,-0.00808939067537901,4.15170210951453e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40516,0.00772070714396217,0.00189068853729395,0.00401495761086602,0.0114264566770583,4.46593930429596e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,42706,-0.0253093499272096,0.00620366923236282,-0.0374685416226407,-0.0131501582317784,4.53451796205612e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,40182,-0.0256963903836281,0.00629832716351389,-0.0380411116241153,-0.0133516691431408,4.5378140937582e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,-0.014134683547913,0.00346551786426454,-0.0209270985618715,-0.00734226853395455,4.56136257360222e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,-0.025846228187912,0.00634268948203446,-0.0382778995726995,-0.0134145568031244,4.62887823940269e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,0.0148619239082034,0.00364946200210828,0.00770897838407115,0.0220148694323356,4.68643685104292e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,40449,-0.0184377586503493,0.00453164287612518,-0.0273197786875546,-0.00955573861314394,4.76049598545412e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,40532,0.0245963196000392,0.00605486205564535,0.0127287899709743,0.0364638492291041,4.8930769512848e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40116,-0.0191498321933034,0.00472256065009066,-0.0284060510674811,-0.0098936133191257,5.04893153912729e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,40199,-0.0139765503678035,0.00344758932699954,-0.0207338254487226,-0.00721927528688443,5.06943869952766e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,-0.0271253243466784,0.00669244561022224,-0.0402425177427139,-0.0140081309506428,5.08846811264098e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42587,-0.0163326041369452,0.00403807982493484,-0.0242472405938175,-0.00841796768007296,5.26959242431184e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,42303,-0.0448096905616158,0.0110827117886058,-0.066531805667283,-0.0230875754559485,5.30267197191565e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40419,-0.0215383513446086,0.00533190778148891,-0.0319888905963268,-0.0110878120928903,5.39171755567284e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,42770,-0.0247537232509272,0.00613395542087584,-0.0367762758758438,-0.0127311706260106,5.4779284016936e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40223,-0.0393170359731201,0.00976632903352881,-0.0584590408788366,-0.0201750310674037,5.71680370893641e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,42676,-0.00907293410391322,0.00225561276475824,-0.0134939351228394,-0.00465193308498708,5.7926881851902e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,-0.015653496977804,0.0038944576934592,-0.0232866340569841,-0.00802035989862401,5.87193663859164e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.0477101872184264,0.011873673660514,-0.0709825875930337,-0.024437786843819,5.89766666908446e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,-0.0106342832867851,0.00265059508918406,-0.0158294496615859,-0.00543911691198439,6.05947812076946e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,42357,-0.0203106386687931,0.00506950397739238,-0.0302468664644822,-0.0103744108731041,6.19811706241151e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,42594,-0.0128219496365379,0.00321357944147061,-0.0191205653418203,-0.00652333393125548,6.64450516737999e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,-0.0345706389548539,0.00866997890516985,-0.0515637976089868,-0.017577480300721,6.7163709423023e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,42603,-0.0165155742414161,0.00414998581756169,-0.0246495464438371,-0.00838160203899523,6.93743078055152e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,42594,-0.027104343117583,0.0068120420659972,-0.0404559455669375,-0.0137527406682285,6.9603240435892e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42346,-0.0234971341526919,0.00592043519441861,-0.0351011871337524,-0.0118930811716315,7.26135188708088e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,42362,-0.0245779742505213,0.00619617980419456,-0.0367224866667426,-0.0124334618343,7.32809379728599e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,40116,0.0143332584940119,0.00361551554987495,0.00724684801625699,0.0214196689717668,7.40575222178777e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFD,Complement factor D,40539,-0.00858832080979347,0.00216756369266843,-0.0128367456474236,-0.00433989597216335,7.47169070218244e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.0120729567626071,0.00304719975771599,-0.0180454682877304,-0.00610044523748373,7.47867435157607e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,-0.0429605283084114,0.0108438185747434,-0.0642144127149084,-0.0217066439019144,7.4866560203395e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,40136,-0.0181656803269038,0.00459027290672231,-0.0271626152240796,-0.00916874542972811,7.62394224134473e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,42587,0.0120132145794781,0.00303867396641869,0.00605741360529751,0.0179690155536588,7.74316614662661e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,40384,-0.0128452169423783,0.00325828247071102,-0.0192314505849719,-0.00645898329978473,8.11860382469826e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40428,-0.0280907526698712,0.00713063221371063,-0.0420667918087441,-0.0141147135309984,8.21634066101403e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,42711,-0.0120655016993624,0.00306301522030211,-0.0180690115311545,-0.00606199186757023,8.22011238604719e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,42462,0.0248277698161073,0.00630586961420929,0.0124682653722571,0.0371872742599575,8.28426571312771e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,42594,-0.0222487090112703,0.00566007410201705,-0.0333424542512237,-0.0111549637713169,8.50837072342662e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,-0.0474318666573016,0.0120962784054116,-0.0711405723319084,-0.0237231609826948,8.85471205351882e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,40116,-0.0243081395182035,0.00620253099646041,-0.0364651002712659,-0.0121511787651411,8.94344342200556e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40483,-0.0286166909293329,0.00730320469556133,-0.0429309721326331,-0.0143024097260327,8.96739483656503e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,40532,0.0199420364560857,0.00509134702401697,0.0099629962890124,0.0299210766231589,9.02400663958275e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,-0.0373853061768021,0.00954877205992223,-0.0561008994142497,-0.0186697129393545,9.07786822914466e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,40482,-0.0104351475864364,0.00266755443091415,-0.0156635542710281,-0.00520674090184463,9.21179953291782e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,42587,-0.0114037931576927,0.00292535854518306,-0.0171374959062515,-0.00567009040913387,9.7360667979468e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,40460,-0.0369861025228008,0.00949584159235151,-0.0555979520438097,-0.0183742530017918,9.87747108412624e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,42663,-0.0100381611080551,0.00258021296011136,-0.0150953785098734,-0.00498094370623683,0.000100544333587748
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,42676,-0.013248971708825,0.0034064663558547,-0.0199256457663002,-0.00657229765134976,0.000100991679995247
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42346,-0.0217600305708151,0.00559952825227194,-0.0327351059452681,-0.0107849551963621,0.000102389523476612
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40428,-0.0165897779523611,0.00427832171018617,-0.024975288504326,-0.00820426740039616,0.000106076931130306
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40451,-0.017384984000904,0.00448411811132352,-0.0261738554990981,-0.00859611250270989,0.000106347608604047
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,-0.0183268474569226,0.00472704405902101,-0.0275918538126038,-0.00906184110124141,0.000106362714808245
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42676,-0.0342535720396637,0.00888927329670537,-0.0516765477012062,-0.0168305963781211,0.000117047748194254
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,40511,-0.020665588175819,0.00536567404479161,-0.0311823093036105,-0.0101488670480274,0.000118071114738497
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,42611,-0.0355567850562759,0.0092487404184463,-0.0536843162764307,-0.0174292538361212,0.000121356038857238
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,42370,0.0158773132707558,0.00413201444517826,0.00777856495820641,0.0239760615833052,0.000122353086459259
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40302,-0.0296464589715223,0.00772206457075924,-0.0447817055302104,-0.0145112124128342,0.000124126791982624
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,-0.0398071232361832,0.0103709954141536,-0.0601342742479242,-0.0194799722244421,0.000124456306146996
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40182,-0.0153485245629822,0.00400091107846476,-0.0231903102767731,-0.00750673884919124,0.000125622282620771
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,-0.0349584749546827,0.00911395565410144,-0.0528218280367215,-0.0170951218726439,0.000125896541259013
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,40451,-0.0207999823645932,0.00543060750133044,-0.0314439730672008,-0.0101559916619855,0.000128765853802472
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,42559,-0.0284025733026756,0.00745110001706483,-0.0430067293361227,-0.0137984172692286,0.000138542241343529
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_DRA,,42549,-0.0144421572105433,0.00379290949326991,-0.0218762598173523,-0.00700805460373427,0.000140908305835531
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42370,-0.0136194055522952,0.00358016802462624,-0.0206365348805627,-0.00660227622402781,0.000142949378036875
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',40116,-0.0170164395652864,0.00448069351372471,-0.0257985988521868,-0.00823428027838593,0.000146821559069182
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,42495,-0.0127616012373015,0.00336549369183361,-0.0193579688732954,-0.00616523360130764,0.000150162630171532
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCT,Secretin,40182,-0.0195191719080192,0.00516537560174075,-0.0296433080874311,-0.00939503572860734,0.000158387796551564
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,-0.0108930588953354,0.00288992638133516,-0.0165573146027523,-0.00522880318791849,0.000164410079814659
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.00990581894083283,0.00263467147632512,0.00474186284723558,0.0150697750344301,0.000170774582635555
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,40451,-0.0154105547959144,0.00410759199240514,-0.0234614351010285,-0.00735967449080031,0.000176503733173283
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,-0.0283123155209564,0.00756102867116128,-0.0431319317164326,-0.0134926993254803,0.000181662059984391
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40302,-0.0134965638118411,0.00360483312486536,-0.0205620367365772,-0.00643109088710496,0.000182014092697524
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42311,-0.0161145227689941,0.00431225605111725,-0.0245665446291839,-0.00766250090880431,0.000187084319027956
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40116,-0.0217403229532892,0.0058418482102714,-0.0331903454454211,-0.0102903004611572,0.000199052295970294
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,40223,-0.0239326360884274,0.00643566179956092,-0.0365465332155668,-0.011318738961288,0.000201201021261884
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40490,-0.00864494782289483,0.00232921119776459,-0.0132102017705134,-0.00407969387527624,0.000206996100394621
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40223,-0.029514269639167,0.00795457914780205,-0.045105244768859,-0.013923294509475,0.000207990304131017
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,-0.0351093836217889,0.00946608675722808,-0.0536629136659559,-0.0165558535776218,0.000209106019415987
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,40116,-0.0231230272118636,0.00623769831328496,-0.0353489159059022,-0.0108971385178251,0.000210782193565931
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,-0.0206973926154372,0.00558734046389173,-0.031648579924665,-0.00974620530620942,0.000212955546061986
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,40116,-0.0242747581022301,0.0065544342485035,-0.037121449229297,-0.0114280669751633,0.000213640326350561
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42311,-0.027670923424431,0.00747474673991755,-0.0423214270346694,-0.0130204198141926,0.000214849424490954
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40342,-0.0165853165893814,0.00448564879169592,-0.0253771882211054,-0.00779344495765739,0.000218848970071832
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40182,-0.0211941830155745,0.00573374078882198,-0.0324323149616656,-0.00995605106948345,0.000219744259697241
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,42636,-0.0153621007839605,0.00417644392390012,-0.0235479308748047,-0.00717627069311625,0.000235734681303437
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,42475,0.0123374851792571,0.00336326047277212,0.00574549465262371,0.0189294757058904,0.000245112471561348
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,40199,-0.0155651234978362,0.00425139065870494,-0.0238978491888979,-0.00723239780677454,0.000252228277780098
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,-0.0290965224089146,0.00796656976451933,-0.0447109991473725,-0.0134820456704567,0.000260883140865378
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,42370,-0.0123856323025039,0.00339721985023993,-0.0190441832089741,-0.00572708139603363,0.000267572712520268
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,42636,0.044260283859483,0.0121530001363443,0.0204404035922482,0.0680801641267177,0.000271626707004647
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42495,0.0135888357980202,0.00374061938929628,0.00625722179499949,0.0209204498010409,0.000281442432503975
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,-0.0271556636087737,0.00749298268260047,-0.0418419096666707,-0.0124694175508768,0.000291192035835538
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0170658171363999,0.0047133152874073,-0.0263039150997182,-0.0078277191730816,0.000294801030979389
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40483,-0.00751259223989246,0.00207504812264173,-0.0115796865602703,-0.00344549791951467,0.000295387306000132
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,40182,-0.0194563114116414,0.00537833464786228,-0.0299978473214515,-0.00891477550183133,0.000298756488201126
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40519,-0.00740158527869262,0.00204675966106634,-0.0114132342143827,-0.0033899363430026,0.000300205808567501
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,42334,-0.0218683269801482,0.00605681572053385,-0.0337396857923945,-0.00999696816790181,0.000306706980788234
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,40116,-0.0202636309907805,0.00561511104791229,-0.0312692486446886,-0.0092580133368724,0.000309030538782618
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,-0.0201944231636902,0.00561116318603714,-0.0311923030083229,-0.00919654331905737,0.000320629434211578
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40302,-0.0163745222316999,0.00455698983791547,-0.0253062223140142,-0.00744282214938557,0.00032795890826033
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,-0.0115497028994293,0.00321692420219913,-0.0178548743357396,-0.005244531463119,0.000331743196309031
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,-0.0326023818511686,0.00908195372718913,-0.0504030111564593,-0.0148017525458779,0.000332391427269476
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,40182,-0.0239570497381242,0.00667649560395563,-0.0370429811218773,-0.0108711183543712,0.000334331231470162
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,-0.0438316153166943,0.0122320789341875,-0.0678064900277017,-0.0198567406056869,0.000340440926335234
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,40532,-0.00886691488578352,0.00247585254861352,-0.013719585881066,-0.00401424389050102,0.000343243226778969
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRTN,Neurturin,42370,-0.0180602533297076,0.00505874269398662,-0.0279753890099214,-0.00814511764949381,0.000358105136793067
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.0177544782072197,0.00498312060937692,-0.0275213946015984,-0.00798756181284091,0.000368048559485265
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40199,-0.0317508882171629,0.00893508514369759,-0.0492636550988101,-0.0142381213355156,0.000381722965832419
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,42553,-0.0218069899442852,0.00613927273788431,-0.0338399645105385,-0.00977401537803197,0.000383561896845106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40449,-0.0210085105122458,0.00591559860210913,-0.0326030837723797,-0.00941393725211193,0.000384789321664118
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,-0.0142549442020942,0.00401740326854264,-0.0221290546084378,-0.00638083379575063,0.000389344111881082
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40483,-0.0172592087113614,0.00486447186837006,-0.0267935735733668,-0.00772484384935613,0.000389724748707759
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,40482,-0.0229579306376696,0.00647529850889648,-0.0356495157151067,-0.0102663455602325,0.000393510811154141
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.0238263990959121,0.00672838525594941,-0.0370140341975729,-0.0106387639942512,0.000399688809842429
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40532,-0.0263697130222,0.00744802178506268,-0.0409678357209229,-0.0117715903234772,0.00040097253706401
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,40223,-0.0427268471467563,0.0120823190249444,-0.0664081924356473,-0.0190455018578653,0.000407420619369067
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42594,0.0176057651019819,0.00498985460543797,0.00782565007532351,0.0273858801286404,0.000419618858472377
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,-0.0400903574213826,0.0113633873546539,-0.0623625966365043,-0.0178181182062609,0.000420098353452976
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0186175534941038,0.00530291964542971,0.00822383098906152,0.029011275999146,0.000448476798343124
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.0104611441274421,0.00298047116149596,-0.0163028676039742,-0.00461942065090998,0.000449764718715458
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,40116,0.0145782641551832,0.00415471172583892,0.00643502917253896,0.0227214991378275,0.00045185847396285
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,40482,-0.0276861854435608,0.00791017279748607,-0.0431901241266335,-0.0121822467604881,0.000466924539872428
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIM,Vimentin,42357,-0.0418283138014821,0.0119553270048444,-0.0652607547309772,-0.018395872871987,0.000469045538222648
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,-0.0180925196086821,0.00517282321333126,-0.0282312531068114,-0.00795378611055284,0.00047125795736763
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,-0.01446358032852,0.00413556240966814,-0.0225692826514696,-0.00635787800557045,0.000471724648309999
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,42587,0.00549432873809401,0.00157223133206562,0.00241275532724539,0.00857590214894263,0.000476296875955186
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,-0.0260163913184855,0.00745609938810554,-0.0406303461191723,-0.0114024365177986,0.000485899679896901
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42636,-0.0113630023414162,0.00326191204224284,-0.0177563499442122,-0.00496965473862028,0.000496403207581116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42679,-0.00878895753838467,0.00253525812986237,-0.0137580634729149,-0.00381985160385442,0.000528547990892842
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,-0.0140094195437113,0.00404099262666555,-0.0219297650919758,-0.00608907399544686,0.000528668561063048
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLG,Plasminogen,40285,-0.0076719187899201,0.00221453651877838,-0.0120124103667257,-0.00333142721311447,0.000533532798504418
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,42370,-0.0200874086495227,0.00580337751270461,-0.0314620285744238,-0.00871278872462171,0.000539216136145583
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0256287682472567,0.00741189317681529,-0.0401560788738146,-0.0111014576206987,0.000546629098072627
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,42311,-0.0151299709629039,0.00440819716467132,-0.0237700374056596,-0.00648990452014809,0.000600474688504135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,40080,-0.0199521167974231,0.00582291404522855,-0.0313650283260711,-0.00853920526877515,0.000613711555397389
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,-0.020625188613719,0.00602069421318928,-0.03242574927157,-0.00882462795586799,0.000615016814382522
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42721,-0.029478723275934,0.00864417501748641,-0.0464213063102074,-0.0125361402416607,0.000650950296534008
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,-0.0221814566134749,0.00651555701042635,-0.0349519483539105,-0.00941096487303922,0.000665433169982934
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,-0.00779807870890309,0.00229468142981397,-0.0122956543113385,-0.00330050310646771,0.000679964118581627
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,40124,-0.0347121912136802,0.010218347374488,-0.0547401520676766,-0.0146842303596838,0.000683604467293596
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42457,-0.0153889754169085,0.00453555855011554,-0.0242786701751349,-0.00649928065868202,0.00069343525304241
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,40283,0.0324131403344624,0.0095943591318088,0.0136081964361172,0.0512180842328077,0.00073172177770716
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,42495,-0.0311834845341953,0.00925412170241621,-0.0493215630709311,-0.0130454059974596,0.000754677419950684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,0.0245414741835613,0.00729176027081201,0.0102496240527697,0.0388333243143528,0.000766203796563727
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.0146376860488332,0.00435524482008353,0.00610140620146944,0.0231739658961969,0.000778953634455628
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.0278793645304112,0.00830204885197653,-0.0441513802802852,-0.0116073487805372,0.000786941975908755
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,40451,-0.0200366576089718,0.00597574549232093,-0.0317491187739208,-0.00832419644402278,0.000802051032942617
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40116,-0.0347136506581509,0.0103907827871548,-0.0550795849209743,-0.0143477163953275,0.00083813862442935
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,40116,-0.0246492829048058,0.00740591471304428,-0.0391648757423726,-0.010133690067239,0.00087659106325015
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,42292,-0.0208184106279277,0.00625718927115324,-0.0330825015993881,-0.00855431965646736,0.000879905970634966
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,-0.0407386374174361,0.0122553844734967,-0.0647591909854896,-0.0167180838493827,0.000889289104792639
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGN,Cingulin,40182,-0.014178163280764,0.00426526997897216,-0.0225380924395494,-0.00581823412197854,0.000889960870721851
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,40532,0.00864339658655862,0.00260307210461368,0.00354137526151581,0.0137454179116014,0.000901529954744668
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,42636,-0.0256596693258608,0.00775367569921527,-0.0408568736963227,-0.0104624649553988,0.00093756931047533
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40116,-0.0175135242556473,0.00531013014589552,-0.0279213793416025,-0.00710566916969208,0.000976405704469006
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,40199,-0.0417640553822413,0.0127357750558661,-0.0667261744917388,-0.0168019362727438,0.00104398946816705
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,42154,-0.0125686032142516,0.00383748842423652,-0.0200900805257552,-0.00504712590274803,0.00105858376446709
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,42611,0.0169460715497365,0.00518789519239834,0.00677779697263576,0.0271143461268372,0.00109173136077322
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,-0.0196250992443411,0.00601502415063285,-0.0314145465795814,-0.00783565190910067,0.00110704119485336
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,40199,-0.0210472997818202,0.0064675548015705,-0.0337237071928983,-0.00837089237074198,0.0011401932232875
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,42249,-0.0345689881551697,0.0106418935080593,-0.0554270994309658,-0.0137108768793735,0.00116354678117647
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42636,-0.0210464968244669,0.00647941433310518,-0.033746148917353,-0.00834684473158073,0.0011641865939924
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,-0.0280175083861991,0.00862560800942368,-0.0449237000846695,-0.0111113166877287,0.00116494906399942
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,42460,-0.0189541286620407,0.00583575205399368,-0.0303922026878684,-0.00751605463621312,0.00116535859696935
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.0134098503188994,0.00413853828440324,-0.0215213853563297,-0.00529831528146904,0.00119787391282239
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,-0.0143531430083022,0.00443545249020124,-0.0230466298890966,-0.00565965612750777,0.00121514913468474
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,42721,-0.00993498835140229,0.00307361921004791,-0.0159592820030962,-0.00391069469970838,0.0012307411127499
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,42590,-0.0287927090887815,0.00891169255281907,-0.0462596264923069,-0.0113257916852562,0.00123702879066193
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,40511,-0.00896008490563244,0.00277403724830993,-0.0143971979123199,-0.00352297189894498,0.00124152386877157
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,42346,-0.0143886329176182,0.00445796605861204,-0.0231262463924978,-0.00565101944273857,0.00125129301468989
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,42611,0.0132885701804974,0.0041203676052367,0.00521264967423349,0.0213644906867614,0.00126233192061679
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40451,-0.0173529705595688,0.0053959107799411,-0.0279289556882534,-0.00677698543088428,0.00130381510871672
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,42794,-0.023757301548245,0.00739760262175123,-0.0382566026868774,-0.00925800040961261,0.00132357296600524
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.00783536872845459,0.00244039915114057,0.00305218639221908,0.0126185510646901,0.00132727951400733
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40482,-0.0414699926518959,0.0129469752240529,-0.0668460640910395,-0.0160939212127523,0.00136351116070581
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,-0.028637967571626,0.00894131628900921,-0.046162947498084,-0.0111129876451679,0.0013644415671551
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,40483,-0.0321557637855755,0.0100451307213234,-0.0518442199993694,-0.0124673075717815,0.00137269126049083
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,42594,-0.0256154968857915,0.00802190331210163,-0.0413384273775107,-0.00989256639407231,0.00141033436898567
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,42370,-0.0199200962096831,0.00624115231299332,-0.0321527547431501,-0.00768743767621624,0.00141753560735341
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42698,-0.013543091350682,0.0042479672217077,-0.0218691071052291,-0.00521707559613495,0.00143520396616581
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,-0.0181276861939649,0.00569518602824974,-0.0292902508093344,-0.00696512157859545,0.00146171805107213
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,40451,-0.0174382360739757,0.00549084808829552,-0.028200298327035,-0.00667617382091652,0.00149789298430815
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42370,-0.0189128578564038,0.00596396512378135,-0.0306022294990153,-0.00722348621379238,0.00152164501604997
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,42673,-0.0123620139311036,0.00389988121448462,-0.0200057811114935,-0.00471824675071376,0.00152862099794538
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,-0.0332448976531332,0.0104933351462607,-0.0538118345398041,-0.0126779607664623,0.00153808886029809
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,-0.0243740739411254,0.00770214721524176,-0.0394702824829992,-0.00927786539925155,0.00155717331630204
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,-0.0106175210460432,0.00336085551678009,-0.0172047978589321,-0.0040302442331542,0.00158635435506922
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRL,Prolactin,42711,-0.0242954998826654,0.00769145338143408,-0.0393707485102762,-0.00922025125505459,0.00158787618719739
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42346,-0.0151711157605909,0.00480346634911251,-0.0245859098048514,-0.00575632171633039,0.00159013859742519
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40449,-0.0162605813152108,0.00517595807661931,-0.0264054591453847,-0.00611570348503698,0.00168486145919653
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40483,-0.0777716040477958,0.0247669885863956,-0.126314901677131,-0.0292283064184605,0.0016930762644041
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,42370,-0.0111087907912268,0.00354003982267355,-0.018047268843667,-0.00417031273878669,0.00170455973103707
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40527,-0.00904894131316854,0.00289131092576802,-0.0147159107276739,-0.00338197189866322,0.00175428003564828
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,42346,-0.0234165202312749,0.0074914076113561,-0.0380996791495328,-0.00873336131301695,0.00177718002629132
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42292,-0.0213110458380089,0.00682050523740648,-0.0346792361033256,-0.00794285557269222,0.00178462801678746
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,40199,-0.00562003396135392,0.00179861996646001,-0.00914532909561554,-0.00209473882709231,0.00178487446908001
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,40080,-0.0198124579073149,0.00634733676919933,-0.0322532379749456,-0.00737167783968422,0.0018047595775596
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42587,-0.0169505724727285,0.00543300564424735,-0.0275992635354533,-0.00630188141000368,0.00181280947913425
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42582,-0.0109327331022426,0.00350811458402527,-0.0178086376869321,-0.00405682851755305,0.00183453093599077
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,40482,-0.0152959167524157,0.0049102002617407,-0.0249199092654275,-0.00567192423940395,0.00184323937172428
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,42656,-0.010170080076323,0.00326509202564219,-0.0165696604465817,-0.00377049970606428,0.00184461647708115
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,-0.011381660300898,0.00367090080405083,-0.0185766258768377,-0.00418669472495841,0.00193584445243256
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,-0.0143457395057315,0.00462861182480416,-0.0234178186823476,-0.0052736603291153,0.00194431410151681
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLU,Clusterin,40539,0.0100749764078272,0.00326068048607874,0.00368404265511282,0.0164659101605415,0.00200749810339882
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,40080,0.0151659956955624,0.00491823645393216,0.00552625224585535,0.0248057391452694,0.00205007179291411
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,40511,-0.0305952119246625,0.00997347399501902,-0.0501432209548998,-0.0110472028944252,0.0021625265055332
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,40182,-0.0216663066244184,0.00707344117439178,-0.0355302513262263,-0.00780236192261049,0.00219623278794813
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40199,-0.0180481397247289,0.00589786240913022,-0.0296079500466242,-0.00648832940283369,0.00221784328757632
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,0.0142927144509595,0.00468895126388615,0.00510236997374268,0.0234830589281764,0.00230773308926504
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,0.00654579297595932,0.00215076601870359,0.00233029157930029,0.0107612943726183,0.00234422406269572
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,0.0122818299299068,0.00403822519886665,0.00436690854012815,0.0201967513196854,0.00236044738256462
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,40199,-0.00941267369199026,0.00310571071330093,-0.0154998666900601,-0.00332548069392044,0.00244503362835843
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,42718,0.00789543470490774,0.00260672614812519,0.00278625145458238,0.0130046179552331,0.0024593333576128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,42416,-0.0130150443675662,0.00430072927596721,-0.0214444737484619,-0.00458561498667045,0.00248090924017751
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,40283,-0.0126746835461293,0.00418885878582972,-0.0208848467663555,-0.004464520325903,0.00248537954225089
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,-0.019503513849398,0.00645272954798701,-0.0321508637634526,-0.00685616393534347,0.00251250662990541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,42754,-0.0240092671942239,0.00795348589322855,-0.0395980995449519,-0.00842043484349597,0.00254325205107896
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40483,0.0220552737746613,0.00730620881640563,0.00773510449450632,0.0363754430548164,0.00254426101988246
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,42370,-0.01202350560802,0.00398550640618271,-0.0198350981641381,-0.00421191305190191,0.00255939453661746
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0302317305438882,0.0100232235358761,0.010586212413571,0.0498772486742054,0.00256467940872582
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,42674,-0.0189452266436041,0.0062864061036534,-0.0312665826067648,-0.00662387068044345,0.00258578079884622
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,40451,-0.0130762047005431,0.00434519356465866,-0.0215927840872741,-0.00455962531381209,0.00262387581620336
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42370,-0.0204427872687836,0.00680787798426756,-0.033786228117948,-0.0070993464196192,0.00267998246599147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,0.00902820195646952,0.00300871791713023,0.00313111483889427,0.0149252890740448,0.00269983875584287
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,40136,-0.0264136847885255,0.00880506895533446,-0.043671619940981,-0.00915574963606994,0.00270740994433854
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42794,0.00977394958825109,0.00326367050082186,0.00337715540664024,0.0161707437698619,0.00275144246495406
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,40199,-0.0137738200293635,0.00461981553575097,-0.0228286584794354,-0.00471898157929159,0.00287500371701391
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40482,-0.0116785412354537,0.00392907131392848,-0.0193795210107535,-0.00397756146015389,0.00296161489176011
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42357,-0.0177838649232146,0.00599994180371003,-0.0295437508584862,-0.00602397898794295,0.00304205974364068
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,40527,-0.0255767066837121,0.00863812258471069,-0.042507426949745,-0.00864598641767914,0.00307366860319014
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42689,-0.00842210208059776,0.00285282017365913,-0.0140136296209696,-0.00283057454022587,0.00316059424675958
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.00944924672712489,0.00320432714947919,-0.0157297279401041,-0.00316876551414567,0.00319465696862418
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42781,-0.0179870919833651,0.006114774264815,-0.0299720495424025,-0.00600213442432766,0.00327094569994372
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,40182,-0.0185263014253696,0.00630282395719368,-0.0308798363814693,-0.00617276646927004,0.00329569829823974
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,42794,0.00825292116767697,0.00281083546403395,0.00274368365817044,0.0137621586771835,0.00332913400571217
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,42311,-0.0117508736849951,0.00400743797219338,-0.0196054521104941,-0.00389629525949604,0.00337080025895935
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,-0.0263628642689249,0.00902850787301765,-0.0440587397000395,-0.00866698883781035,0.00350672216690119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40116,-0.0210981144582363,0.00724088647942885,-0.0352902519579168,-0.00690597695855575,0.0035784305167821
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,40527,0.0295500172804518,0.0101434799655788,0.00966879654791732,0.0494312380129862,0.00358440662924988
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,-0.0306295320895006,0.0105243411893554,-0.0512572408206372,-0.010001823358364,0.00361730085292014
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40199,-0.0305936908516015,0.0105266621215019,-0.0512259486097453,-0.00996143309345772,0.00366454167652909
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42587,-0.021694804213099,0.00747407003385962,-0.0363439814794639,-0.00704562694673415,0.00370592658051569
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,0.0190490567723811,0.00656300190000324,0.00618557304837472,0.0319125404963874,0.00370943258034105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,40182,-0.0163854910710875,0.00564771600411842,-0.0274550144391596,-0.00531596770301536,0.00372403397360948
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,42381,-0.0137627227904248,0.00474663870182693,-0.0230661346460056,-0.00445931093484405,0.00374414360065773
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,42346,-0.023844170977795,0.0082295038814901,-0.0399739985855156,-0.00771434337007443,0.00376889654256593
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,40428,0.00830645892701714,0.00287529814524771,0.00267087456233164,0.0139420432917027,0.00387326666208027
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,42311,-0.0193403923293223,0.00670828391196079,-0.0324886287967655,-0.00619215586187918,0.00394471061351013
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,40199,-0.0148323515750323,0.00514856892747784,-0.0249235466728888,-0.00474115647717572,0.00397346787936266
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,42594,-0.0163417836014769,0.00567374240869832,-0.0274623187225256,-0.00522124848042819,0.00397992697747442
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42346,-0.00935791155485746,0.0032527048503524,-0.0157332130615482,-0.00298261004816675,0.00402168442455058
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,40482,-0.00937426602206798,0.00326098714756844,-0.0157658008313021,-0.00298273121283383,0.00405204139732943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40539,0.00793388475727293,0.00276074731088396,0.00252282002794037,0.0133449494866055,0.00406296045494682
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",42721,-0.0215624266009612,0.00750568953278455,-0.0362735780852189,-0.00685127511670344,0.00407470439701166
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,42353,-0.0262746695651428,0.00915099939764013,-0.0442106283845175,-0.00833871074576819,0.00409523993826876
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,40182,-0.014181443629083,0.0049570981090566,-0.0238973559228339,-0.00446553133533206,0.00423322914734779
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40532,-0.00797932916567655,0.00279209727231034,-0.0134518398194048,-0.00250681851194828,0.0042733058823135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,42721,-0.0186040366133376,0.00653931887787043,-0.0314211016139637,-0.00578697161271159,0.00444850650790444
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,42357,-0.0155948279783858,0.00549537285551998,-0.0263657587752049,-0.0048238971815666,0.00454935733477322
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,42611,-0.0127683249345051,0.00452341005812343,-0.021634208648427,-0.00390244122058316,0.00476880519507018
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,42505,0.0376278706104114,0.0133343755465857,0.0114924945391034,0.0637632466817193,0.00478153108450692
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,42620,-0.0269454124735351,0.00956573238330891,-0.0456942479448205,-0.0081965770022496,0.0048565123617674
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,42721,-0.00628114324103755,0.00223089015083222,-0.0106536879366687,-0.00190859854540639,0.0048766929954859
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,40483,0.0227047417222224,0.00808121542320248,0.00686555949274558,0.0385439239516993,0.00496930217419749
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,40383,0.0087346003066994,0.00311166801037894,0.00263573100635667,0.0148334696070421,0.0050084324311019
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,42587,-0.0120603099275108,0.00431130809394015,-0.0205104737916335,-0.00361014606338812,0.0051594531299113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,40136,0.0121831598615266,0.00436231403805137,0.00363302434694596,0.0207332953761073,0.00523414183978812
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,42332,-0.0145611015868095,0.00521405418694712,-0.0247806477932258,-0.00434155538039313,0.00523515389069654
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,42543,0.0144014514964864,0.00515851327694525,0.00429076547367375,0.0245121375192991,0.00524929456715783
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOC,Myocilin,42611,0.0128207494149456,0.00459588110402845,0.00381282245104986,0.0218286763788414,0.00528447950721015
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40527,-0.0182437614965494,0.00655006826545875,-0.0310818952968485,-0.00540562769625027,0.00535706318880325
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,-0.0281862972101684,0.0101278187694988,-0.0480368219983861,-0.00833577242195065,0.00539247324127439
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,42711,-0.0183375050327743,0.00660669238419213,-0.0312866221057909,-0.00538838795975773,0.00551764700860192
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,40451,0.0330854323811092,0.0119231852767515,0.0097159892386763,0.0564548755235421,0.00553128043259752
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,-0.0104871932672918,0.00378395807730215,-0.017903751098804,-0.00307063543577955,0.00558937859654459
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.00809816687178107,0.00292433812160669,-0.0138298695901302,-0.00236646415343195,0.00562805580946707
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,40511,-0.0104074438669036,0.00377602471862707,-0.0178084523154127,-0.00300643541839455,0.00585725275152079
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,0.0097094048773397,0.00352732403511726,0.00279584976850988,0.0166229599861695,0.00592167742066056
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,-0.015463250730495,0.00561965387180861,-0.0264777723192399,-0.00444872914175013,0.00593927095913286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42636,-0.0129940956923637,0.00472495928212579,-0.0222550158853303,-0.00373317549939721,0.00596573097042296
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,-0.0200690857881731,0.00732268028554836,-0.0344215391478479,-0.00571663242849832,0.00614111409917043
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42594,-0.0117247018140853,0.00429724649638265,-0.0201473049469953,-0.00330209868117535,0.00637211020637114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,40451,-0.0169675203009373,0.00624752587150759,-0.0292126710090922,-0.00472236959278246,0.00662010964518811
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,42293,-0.0158399662951792,0.00583983720692726,-0.0272860472207566,-0.00439388536960176,0.00668854314584413
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,-0.0121396598197968,0.00448707380565859,-0.0209343244788877,-0.003344995160706,0.00683097717382095
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.0109475974700926,0.00405598532662831,-0.0188973287102841,-0.00299786622990109,0.00696297502743779
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,-0.0127540354829887,0.00472818897485564,-0.0220212858737057,-0.00348678509227162,0.00699776521951846
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40449,-0.0269897049114219,0.0100221234040736,-0.0466330667834061,-0.00734634303943766,0.00709144614203079
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42583,-0.00910430745821834,0.00339090044209655,-0.0157504723247276,-0.0024581425917091,0.0072635810723541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.015888001849586,0.00592797467585552,-0.0275068322142629,-0.00426917148490921,0.00736739444850744
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.00798420112757008,0.00297961886315832,-0.0138242540993604,-0.00214414815577977,0.00737989000868235
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40199,-0.0177165052533149,0.00661360231263955,-0.0306791657860884,-0.00475384472054139,0.00739967500484084
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42689,0.0127068563704037,0.00474663287445883,0.00340345593646443,0.0220102568043431,0.0074368833710583
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,40199,-0.00980836519129584,0.0036851423888193,-0.0170312442733817,-0.00258548610921001,0.00778838057883568
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,40509,-0.00996282461321448,0.00374747763573829,-0.0173078807792615,-0.00261776844716743,0.0078590104148157
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,40116,-0.0253267713589574,0.0095566382841397,-0.0440577823958713,-0.00659576032204362,0.00805658398669592
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,42754,0.0108056965444624,0.00407914711492347,0.00281056819921239,0.0188008248897124,0.00808217869389433
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,-0.0178661890252611,0.00674890710039432,-0.031094046942034,-0.00463833110848825,0.00812587222718203
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,40116,0.0100814691361579,0.00381642824454988,0.00260126977684017,0.0175616684954757,0.00826334835000557
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40199,-0.00865177214525836,0.00328226556059887,-0.0150850126440321,-0.00221853164648458,0.00840285378208981
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,42594,-0.0166601766311957,0.00633881617032385,-0.0290842563250304,-0.00423609693736094,0.00859159860335776
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,40223,0.014697947372942,0.0056002958506416,0.0037213675056845,0.0256745272401996,0.00868972289293696
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,-0.0158986834554057,0.00605841802708726,-0.0277731827884967,-0.00402418412231465,0.00869649946247843
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,40154,-0.0187155169909721,0.00713296787811325,-0.0326961340320741,-0.00473489994987012,0.00870740422562084
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40439,0.00742726435509363,0.00283206991711273,0.00187640731755268,0.0129781213926346,0.00873903802680869
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,-0.00879787702073743,0.00336159204371834,-0.0153865974264254,-0.00220915661504948,0.00887826505603628
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-0.00800397726469471,0.00305946907525722,-0.0140005366521989,-0.00200741787719057,0.00890500832896729
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F3,Tissue factor,42636,0.00733066917043083,0.00280569467635777,0.0018315076047696,0.0128298307360921,0.00899084655786746
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FN1,Fibronectin,40539,-0.00718348696676562,0.00274995787990213,-0.0125734044113738,-0.00179356952215745,0.00900756541493984
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,42771,0.0126870203200365,0.00486490260253286,0.00315181121907208,0.0222222294210009,0.00912079952287068
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40182,-0.0137785752746081,0.00530203001288743,-0.0241705540998675,-0.00338659644934875,0.00936927363844585
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40199,-0.0166985807323779,0.00643606194859766,-0.0293132621516293,-0.00408389931312645,0.00948448795106308
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42346,-0.0136650999704646,0.00531053232465715,-0.0240737433267926,-0.00325645661413657,0.0100869428259332
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,-0.00890657955492035,0.00346462852083614,-0.0156972514557592,-0.00211590765408151,0.0101615530846429
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,-0.0160406163649109,0.00624547727207471,-0.0282817518181773,-0.00379948091164446,0.0102313500828332
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,-0.0107312863123629,0.00418055291273487,-0.0189251700213233,-0.00253740260340258,0.0102728240330151
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,40116,0.00843680590116193,0.00329128054630027,0.0019858960304134,0.0148877157719105,0.0103790915518506
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,42666,0.00731208659451048,0.00285860415230838,0.00170922245598606,0.0129149507330349,0.0105408130646726
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,0.010475356085478,0.00409771261875584,0.0024438393527166,0.0185068728182395,0.0105896934761447
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,-0.0201292390390916,0.00788915057617021,-0.0355919741683852,-0.00466650390979795,0.0107391270623514
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,40182,-0.0107100760162316,0.00419983642915869,-0.0189417554173826,-0.00247839661508055,0.0107821150617884
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,40333,-0.0164664104048216,0.00647482084229283,-0.0291570592557156,-0.00377576155392766,0.0109993575500764
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,42587,0.0201388239859722,0.00795003649363087,0.00455675245845568,0.0357208955134887,0.0113148022333304
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40449,0.00795464330637731,0.00314106819175834,0.00179814965053097,0.0141111369622237,0.0113398633556689
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,40080,-0.017096393919111,0.00676214313113287,-0.0303501944561314,-0.00384259338209054,0.0114772604982177
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,42346,-0.00922116419973754,0.00365489668417315,-0.0163847617007169,-0.00205756669875816,0.0116488001081454
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,-0.0125565442310349,0.00497817366459753,-0.022313764613646,-0.00279932384842371,0.0116701286594062
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,42483,-0.0266475112575912,0.0105726069397304,-0.0473698208594629,-0.00592520165571952,0.0117327818895955
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,42459,0.0172082096370933,0.00687646969799774,0.00373032902901771,0.0306860902451689,0.0123446873381116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42603,-0.0278684995400623,0.0111716151198185,-0.0497648651749065,-0.00597213390521804,0.0126225311146806
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,42311,0.00912647103034431,0.00366280205528545,0.00194737900198483,0.0163055630587038,0.0127268901651694
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,-0.00963627639731799,0.00391139779856209,-0.0173026160824997,-0.00196993671213629,0.013768482266024
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42635,-0.00953285516388088,0.00387371657345625,-0.0171253396478551,-0.00194037067990663,0.0138711163871975
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42587,-0.0103989860533991,0.0042283850583697,-0.0186866207678037,-0.00211135133899452,0.0139322841684314
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,40482,-0.0173317285410856,0.00704942480190707,-0.0311486011528235,-0.00351485592934779,0.0139628265425787
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0104858589056213,0.00427007195682509,0.0021165178702441,0.0188551999409985,0.0140752181818049
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00777718230335413,0.00317022356365755,0.00156354411858533,0.0139908204881229,0.0141721592470226
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,42587,-0.0484932495035475,0.0197687470970296,-0.0872399938137254,-0.0097465051933695,0.0141786682148238
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,40136,0.0233472604681753,0.00952249576425991,0.00468316877022589,0.0420113521661247,0.0142298592172744
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,-0.0125217343924622,0.00511445506070834,-0.0225460663114506,-0.00249740247347389,0.0143682116997756
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40199,-0.00898701378630095,0.00367297197884384,-0.0161860388648349,-0.00178798870776702,0.014428764442039
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42357,-0.0212892599083601,0.00870638520388646,-0.0383537749079775,-0.00422474490874261,0.0144883201552065
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,42721,0.0152151999166532,0.00623280871107168,0.00299889484295268,0.0274315049903536,0.0146534406892778
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,-0.0118013842425387,0.0048352842399254,-0.0212785413527925,-0.00232422713228493,0.0146749242603049
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,40283,-0.0279288190610447,0.0114555245689089,-0.050381647216106,-0.00547599090598331,0.014783477426116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,-0.00712369853162256,0.00292237041709975,-0.0128515445491381,-0.00139585251410706,0.0147990157206866
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,42636,0.0118128245919392,0.00484796755108035,0.00231080819182174,0.0213148409920567,0.0148367014928798
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,40283,-0.00908702437494604,0.00373882773676135,-0.0164151267389983,-0.00175892201089379,0.0150959445988494
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,42370,-0.0117725966542915,0.00484777889438241,-0.0212742432872811,-0.002270950021302,0.0151767384263588
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,42141,0.00806826220609908,0.00332434497861821,0.00155254604800738,0.0145839783641908,0.0152368367463064
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,40370,-0.0163967436271204,0.006780594289094,-0.0296867084337447,-0.00310677882049618,0.0156139489299512
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,40199,-0.0200764399382263,0.00830694119429212,-0.0363580446790389,-0.00379483519741376,0.0156726127346841
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,40199,-0.007733575662991,0.00320799062907535,-0.0140212372959787,-0.00144591403000332,0.0159372356551205
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,40482,-0.0113168974079512,0.00471914353168054,-0.0205664187300451,-0.00206737608585735,0.0164972703136534
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,42679,0.00914118687103655,0.00382867939985244,0.00163697524732576,0.0166453984947473,0.0169745009142503
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,-0.0164043198510737,0.00688265303308231,-0.029894319795915,-0.00291431990623237,0.0171664544650769
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,40451,0.0137373749131636,0.00577103038814944,0.00242615535239065,0.0250485944739365,0.0173102828285074
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,-0.00824754334684326,0.00346530378018393,-0.0150395387560038,-0.00145554793768276,0.0173279001641763
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,42332,-0.0182382269019113,0.00768117260089486,-0.0332933251996652,-0.00318312860415736,0.0175914635677669
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42297,-0.0137443944444166,0.00582513640166799,-0.0251616617916859,-0.00232712709714739,0.0183142904066973
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,0.00785380767307964,0.00334220386426585,0.00130308809911858,0.0144045272470407,0.0187933589917526
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42689,-0.0165308720359024,0.00703526394249423,-0.0303199893631911,-0.00274175470861367,0.0188020696657109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,40182,-0.012827121848981,0.00547798123275029,-0.0235639650651715,-0.0020902786327904,0.0192201691399417
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40451,-0.00887038230207496,0.00379080447922686,-0.0163003590813596,-0.00144040552279032,0.0193024831709152
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42311,0.0135492261277442,0.00579433415305833,0.00219233118774989,0.0249061210677386,0.0193836407124918
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42311,-0.03584114942332,0.0153788153161217,-0.0659836274429185,-0.00569867140372155,0.0197920054650876
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.0155038040195854,0.00667300130759121,0.00242472145670664,0.0285828865824642,0.0201778949437268
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,-0.0178690192240893,0.00769144559285756,-0.0329442525860901,-0.00279378586208851,0.0201815090348813
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42311,-0.00963419408925973,0.00416347264276805,-0.0177946004690851,-0.00147378770943435,0.0206841725228936
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,40199,-0.0208116905187358,0.00899626942563904,-0.0384443785929883,-0.0031790024444833,0.0207207009492569
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40199,-0.0212317253283871,0.00918421070972497,-0.0392327783194481,-0.00323067233732618,0.020809079617955
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40451,-0.0149492576767387,0.0064783953075438,-0.0276469124795246,-0.00225160287395287,0.0210419125004695
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,-0.016493235550164,0.00715009855883492,-0.0305074287254804,-0.00247904237484752,0.0210891846497079
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.00844833333802162,0.00366694461750111,-0.0156355447883238,-0.00126112188771944,0.0212428438486973
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,42636,0.00806008039302386,0.0035013421343542,0.00119744980968963,0.0149227109763581,0.0213505310193413
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.01162680482206,0.00506972681484778,-0.0215634693791617,-0.00169014026495836,0.0218415471654566
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.0168948616377476,0.00737034437579297,-0.0313407366143018,-0.00244898666119336,0.0219050718385981
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40080,0.0113074552409336,0.00493995736695989,0.00162513880169218,0.020989771680175,0.0220996731537339
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,40080,-0.0139915906946631,0.0061315258500559,-0.0260093813607727,-0.00197380002855357,0.0225138598635911
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,40182,-0.0178417335768583,0.00785334111146218,-0.0332342821553242,-0.00244918499839243,0.0231138881578683
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40483,-0.00794596082589093,0.00350100439278202,-0.0148079294357437,-0.00108399221603818,0.0232492309986371
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,40250,-0.0200452637383768,0.00883930281633483,-0.0373702972583931,-0.00272023021836054,0.0233641103519918
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,40199,-0.00616536215355399,0.00271989911542887,-0.0114963644197946,-0.000834359887313397,0.0234241307455122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,42311,-0.0104856603466901,0.00462727902032771,-0.0195551272265324,-0.00141619346684774,0.0234643499868296
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,42594,0.010046420323246,0.00444630485281337,0.0013316628117318,0.0187611778347602,0.0238683700209277
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,40434,-0.0138730480385309,0.0061797636939901,-0.0259853848787515,-0.00176071119831028,0.0247929154991009
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,-0.0152051816596647,0.00677587182740238,-0.0284858904413733,-0.00192447287795599,0.0248472788543437
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.0196806189268336,0.00877242984770397,-0.0368745814283334,-0.00248665642533386,0.024886760461913
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,40182,-0.00725905362415833,0.00323777735757825,-0.0136050972450117,-0.000913010003304954,0.0249821057278692
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40199,-0.00564867863153286,0.00252123585223141,-0.0105903009019064,-0.000707056361159304,0.0250822191385767
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40511,-0.00730673079523262,0.00328542645987402,-0.0137461666565857,-0.000867294933879549,0.0261692822277247
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,-0.033000541576723,0.0148505950797721,-0.0621077079330764,-0.00389337522036962,0.0262923168215111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRNN,Cornulin,42209,0.0157785964846546,0.00710631201928343,0.00185022492685908,0.0297069680424501,0.0264112523021147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,0.00726881470064629,0.00328210566659918,0.000835887594111892,0.0137017418071807,0.0268025420583402
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40302,-0.0123998445042619,0.00559906057018972,-0.0233740032218337,-0.00142568578669,0.026805727081882
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42587,-0.00534306702010255,0.00241588690962497,-0.0100782053629675,-0.000607928677237617,0.0270085153463031
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.039112413571209,0.017686150498513,0.00444755859412348,0.0737772685482945,0.027020248549072
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.0089753770801487,0.00407638298552623,0.000985666428517279,0.0169650877317801,0.0276968346420605
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,40060,-0.0101092037094915,0.00459160634687688,-0.0191087521493702,-0.00110965526961284,0.0277095401189064
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,42636,-0.0147508933102975,0.00671764773294607,-0.0279174828668718,-0.00158430375372316,0.0281202760360229
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,40080,-0.0139477407444767,0.00635242417908292,-0.0263984921354792,-0.00149698935347414,0.0281375730111958
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00834705653750238,0.00380929395012018,-0.0158132726797379,-0.000880840395266821,0.0284559409381417
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42705,0.00455845587077183,0.00208162166485521,0.000478477407655611,0.00863843433388805,0.0285515737744358
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFP,Properdin,40539,-0.00503635231925266,0.00230228749373684,-0.00954883580697686,-0.00052386883152846,0.0287232623361557
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,42636,-0.0191087547128399,0.00873814093418298,-0.0362355109438385,-0.00198199848184127,0.028772730973039
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,42237,0.0157191496447853,0.00723715712233843,0.00153432168500201,0.0299039776045686,0.0298731557965572
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40482,-0.0168269504494979,0.00775146236147503,-0.0320198166779889,-0.00163408422100682,0.029966323753813
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,-0.0187336986631429,0.00865314036724983,-0.0356938537829526,-0.0017735435433332,0.0304123710013533
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,40080,-0.0163561309699578,0.00757482609930085,-0.0312027901245875,-0.00150947181532814,0.0308506285196465
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,40539,-0.00723030404252123,0.00334946663552594,-0.0137952586481521,-0.000665349436890391,0.0308987475144527
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,-0.0119983465155971,0.00556021227637927,-0.0228963625773004,-0.00110033045389369,0.0309576701843633
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40302,-0.0121198344184345,0.00562460569089141,-0.0231440615725817,-0.00109560726428737,0.0311998329779978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0123764963328008,0.00574400032440941,0.00111825569695836,0.0236347369686433,0.0312044698727551
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,40482,-0.0131838533310492,0.0061218019691484,-0.0251825851905801,-0.00118512147151833,0.0312934245643355
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40182,0.00703230054988566,0.00327451594272692,0.000614249302140905,0.0134503517976304,0.0317685622292553
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,0.0111220110810388,0.00519814245563426,0.000933651867995667,0.021310370294082,0.0324078440780217
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.00697538747740052,0.00326158956033666,0.00058267193914068,0.0133681030156604,0.0324821983807597
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40116,0.0105959949037072,0.00496240913184118,0.000869673005298475,0.0203223168021159,0.0327626010165794
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,40199,0.00973500464022474,0.004567040380721,0.00078360549401159,0.0186864037864379,0.0330636100950362
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCLN,Nicalin,42370,-0.01135454586551,0.00533259380047425,-0.0218064297144396,-0.000902662016580517,0.0332502007920113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,-0.0236669985679019,0.0111201854734381,-0.0454625620958405,-0.00187143503996321,0.0333350932941935
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40302,-0.00982116073333817,0.00463223491516796,-0.0189003411670674,-0.000741980299608957,0.0340131765691203
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40116,0.0095969516599225,0.00453792733403376,0.000702614085216324,0.0184912892346287,0.0344668993082972
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00668955855606798,0.003168274217173,0.000479741090408902,0.0128993760217271,0.0347550135320525
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,42584,-0.0154295425157769,0.00733723385784837,-0.0298105208771597,-0.0010485641543941,0.0354922510913194
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,-0.0060078189906369,0.00286169256900052,-0.0116167364258779,-0.000398901555395893,0.0358012126438858
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,-0.00908462988092876,0.00434331558677956,-0.0175975284310167,-0.000571731330840824,0.0364935532261605
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,40223,-0.0151024053835795,0.00722475230170228,-0.029262919894916,-0.000941890872243051,0.0366074160505941
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,40182,-0.00718838427659316,0.00345268681429729,-0.0139556504326158,-0.000421118120570482,0.0373684556062837
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.00723142738353639,0.0034849120124617,-0.0140618549279613,-0.000400999839111463,0.0380036416506821
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,40136,0.00756195889916935,0.00364719961007334,0.000413447663425599,0.0147104701349131,0.0381621047725159
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0304066638655577,0.0146723489351642,-0.0591644677784796,-0.00164885995263587,0.0382526922999717
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,-0.00573096711521493,0.00278753660262947,-0.0111945388563687,-0.000267395374061165,0.0398135063265538
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",40451,-0.00906290931617354,0.00442400278589557,-0.0177339547765289,-0.000391863855818218,0.0405266585486864
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,40199,0.00651073022541111,0.00318473201384026,0.000268655478284193,0.012752804972538,0.0409420065445257
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,40199,0.0055193528732806,0.00271144752615216,0.000204915722022366,0.0108337900245388,0.0418170272623421
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00724059427849157,0.00356073433168372,0.000261554988391473,0.0142196335685917,0.0420259149789459
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,-0.0099487234296704,0.00491899583084756,-0.0195899552581316,-0.000307491601209178,0.0431437811160191
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42636,-0.00825723958954992,0.00410794461591918,-0.0163088110367515,-0.000205668142348321,0.0444441506283234
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,40116,0.011830713926795,0.00590241365902456,0.000261983155106848,0.0233994446984831,0.0450533944046944
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40116,-0.00912447763987382,0.00456061620086006,-0.0180632853935595,-0.000185669886188103,0.045448186262165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,42311,0.0109503297261703,0.00547625629347049,0.000216867390968101,0.0216837920613724,0.0455639101644115
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,-0.00530463155186367,0.0026650534883492,-0.0105281363890281,-8.11267146992277e-05,0.0465625986580108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,40199,-0.012573327092136,0.00632250223377012,-0.0249654314703254,-0.00018122271394653,0.0467631222805713
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.00525293275475886,0.00264450365452072,6.97055918982446e-05,0.0104361599176195,0.0470175336183902
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42370,-0.00918382360976315,0.00462441151715914,-0.0182476701833951,-0.00011997703613123,0.0470601996385323
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42357,-0.00993757646425845,0.0050127659974101,-0.0197625978191822,-0.000112555109334661,0.0474492432225855
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,-0.00968159081774793,0.00489115778552482,-0.0192682600773766,-9.49215581192882e-05,0.0477951067236098
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,42538,-0.0119145880686444,0.0060293110734887,-0.0237320377726822,-9.71383646064979e-05,0.0481627677925265
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.00915339000775005,0.00463383057694548,7.10820769369101e-05,0.0182356979385632,0.0482539199173621
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.0120756564944629,0.00614038987250945,4.04923443443773e-05,0.0241108206445814,0.0492552216654438
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLPS,Colipase,42590,-0.0146676712892253,0.00749089329342304,-0.0293498221443345,1.4479565883848e-05,0.0502428717229424
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,40182,0.00635307609993206,0.00324818700624028,-1.33704322988837e-05,0.012719522632163,0.0505041557291082
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40451,-0.0108246166565293,0.00555886100656118,-0.0217199842293892,7.07509163306048e-05,0.0515269166972201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,40302,0.00744236588016091,0.00382320658709778,-5.11190305507413e-05,0.0149358507908726,0.0516043708122106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,40116,-0.022541007732491,0.0115870629591066,-0.0452516511323399,0.000169635667357983,0.0517573003248878
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,40182,0.00792006500356344,0.00407529594115546,-6.75150411012584e-05,0.0159076450482281,0.0519893520268337
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40199,-0.00807206110107884,0.00415884081695493,-0.0162233891023105,7.92669001528218e-05,0.0522910375536105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40302,-0.0115062024983806,0.00593516353318646,-0.0231391230234261,0.000126718026664857,0.0525693163199033
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,40116,0.00816290746857799,0.00421598731674813,-0.000100427672248342,0.0164262426094043,0.0528715099725654
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,42311,-0.0110208038280074,0.00570311920303525,-0.0221989174659565,0.000157309809941641,0.0533295764347891
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.0041203597499467,0.00213503287813005,-0.0083050241910816,6.43046911881998e-05,0.0536425168936593
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,40539,-0.00520502606650435,0.00269800998382755,-0.0104931256348063,8.30735017976489e-05,0.0537297897816229
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,40527,-0.00954438401032058,0.00495318357036406,-0.0192526238082341,0.000163855787592985,0.0540146843524331
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,40479,-0.00951077012907263,0.00493674290691176,-0.0191867862266197,0.00016524596847441,0.0540636458921005
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,40302,-0.00887142474458966,0.00461110562267453,-0.0179091917650317,0.000166342275852415,0.0543894155643986
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,42346,-0.00773597431868455,0.00402675449839828,-0.0156284131355452,0.000156464498176082,0.0547351750796884
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,42699,-0.0305124168979049,0.0158867463024385,-0.0616504396506843,0.000625605854874541,0.0548005513324881
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40302,-0.0075770075169904,0.00394918865919029,-0.0153174172890034,0.000163402255022566,0.0550575566813258
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,42594,-0.0124574833850022,0.00649796655471642,-0.0251934978322464,0.000278531062241977,0.0552419395199649
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.0105876877768745,0.00552726555938816,-0.000245752719526263,0.0214211282732753,0.0554499977414661
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42721,-0.00663476465203175,0.00349284439857455,-0.0134807396732379,0.000211210369174371,0.0575160030583003
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42721,0.0114040594845442,0.00601615926438427,-0.000387612673648931,0.0231957316427374,0.0580380366830979
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42311,-0.0166682507365051,0.00881365989801761,-0.0339430241366196,0.000606522663609433,0.0586218276017252
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40116,-0.00786932097618597,0.00416902510263822,-0.0160406101773569,0.000301968224984937,0.0591103739582612
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40182,0.00712198823205934,0.00377361950151524,-0.000274305990910517,0.0145182824550292,0.0591450317049198
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERVV_1,,40116,0.00851508640126994,0.0045190556073685,-0.000342262589172313,0.0173724353917122,0.059556030214794
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40182,-0.0148262444626796,0.00787142173630442,-0.0302542310658363,0.000601742140477037,0.0596517731406168
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40182,0.00737782610330769,0.00392331626545537,-0.000311873776984835,0.0150675259836002,0.0600653569033095
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,40182,-0.010108647116303,0.00539531456316169,-0.0206834636600999,0.000466169427493938,0.061012463434381
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,0.00637983508565669,0.00340781224183302,-0.000299476908336026,0.0130591470796494,0.0612116329381662
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,-0.0186115071845195,0.0100052661789218,-0.0382218288952062,0.000998814526167256,0.0628873809686843
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,40482,0.00972403797147165,0.00525832853805665,-0.000582285963119395,0.0200303619060627,0.0644458189787459
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40136,0.00622511426290485,0.0033665086539844,-0.000373242698904586,0.0128234712247143,0.0644659065946054
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,0.00578700991976995,0.00312970754819203,-0.000347216874686435,0.0119212367142263,0.0644764326535593
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,40136,-0.00876814166275608,0.00474488751470757,-0.0180681211915829,0.000531837866070747,0.0646418275414406
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,42588,-0.0148769914208824,0.00808680986940827,-0.0307271387649226,0.000973155923157776,0.065840090236311
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42346,-0.00779669163907908,0.00424289106207131,-0.0161127581207389,0.000519374842580688,0.0661454766503444
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,42626,0.0125295711018819,0.00682230009859737,-0.000842137091368936,0.0259012792951328,0.0662967965702631
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,40080,0.00799701768905138,0.00436763017611581,-0.000563537456135611,0.0165575728342384,0.0671317288632812
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,-0.006884787684349,0.0037669641895857,-0.014268037495937,0.000498462127238974,0.0676208894064277
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,-0.0201329116613983,0.011015452067197,-0.0417231977131043,0.00145737439030778,0.0676227125939175
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,42346,-0.0138940279943956,0.00762924644804742,-0.0288473510325686,0.00105929504377731,0.0686062527168406
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,40198,-0.0131342197745494,0.00721554915801304,-0.027276696124255,0.00100825657515617,0.0687456376867921
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42676,-0.00543183435437846,0.00298435259136455,-0.011281165433453,0.000417496724696053,0.0687652156863671
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,40136,-0.0207786087444486,0.0114429133057047,-0.0432067188236298,0.00164950133473272,0.0694208137727356
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,-0.0123665497520922,0.00682406983889727,-0.0257417266363308,0.00100862713214648,0.0699826009650213
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,40136,0.0089801648527932,0.0049841670258801,-0.000788802517931791,0.0187491322235182,0.0716140969470886
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,-0.00742592943639725,0.00413438923944888,-0.0155293323457171,0.000677473472922558,0.0725001933555876
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40451,0.00979095253672679,0.00545624075502811,-0.0009032793431283,0.0204851844165819,0.0727681555995684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,40182,-0.0160028665474084,0.00893462213325866,-0.0335147259285953,0.00150899283377862,0.0733035982483013
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,42594,-0.00933048858847222,0.00521422907806018,-0.0195503775814702,0.000889400404525743,0.07356845552221
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,40116,-0.0073697607360521,0.00412279121192969,-0.0154504315114343,0.000710910039330105,0.0738737977625684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42602,0.0104952303030134,0.00587345102505065,-0.00101673370608583,0.0220071943121127,0.0739773186512303
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40182,-0.0142468224039792,0.00797731434136262,-0.0298823585130499,0.00138871370509156,0.0741402429735645
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,42608,-0.0107937684873994,0.00604884913587719,-0.0226495127937187,0.00106197581891989,0.0743758604552143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.0057628138983125,0.00324236191830515,-0.000592215461565605,0.0121178432581906,0.0755374901455011
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42370,-0.0120598138012098,0.00678857828421368,-0.0253654272382686,0.00124579963584903,0.0756759281561625
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,-0.0211451265345587,0.01192762289342,-0.044523267405662,0.00223301433654452,0.0762910863263242
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,40449,-0.0487823852185866,0.0275492404605185,-0.102778896521203,0.00521412608402967,0.0766319561932682
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.0165525587189673,0.00938074002021651,-0.0349388091585916,0.00183369172065709,0.0776705935668318
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTG,Protogenin,42721,-0.00450708147549236,0.00255990585302308,-0.0095244969474176,0.000510333996432883,0.0783213634756993
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40302,-0.009939962432331,0.00564918867808945,-0.0210123722413863,0.00113244737672431,0.0785136877376819
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,-0.00952293410123394,0.00542189671025816,-0.0201498516533399,0.00110398345087205,0.079050369809434
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,42346,-0.013498667815766,0.00769722888471419,-0.0285852364298058,0.00158790079827383,0.0795043810888734
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,0.0112002082395818,0.00638928010173127,-0.00132278075981145,0.0237231972389751,0.0796353764589423
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42346,-0.00714124504114998,0.00408031542386119,-0.0151386632719179,0.000856173189617954,0.0801123269353171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,40080,0.00473674955486584,0.00271250320369576,-0.000579756724377842,0.0100532558341095,0.0807931110981807
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NENF,Neudesin,40451,-0.0198753095101683,0.0113965087652966,-0.0422124666901496,0.00246184766981307,0.0811894727444533
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCN,Decorin,42357,-0.00432786974985762,0.0024817132912803,-0.00919202780076701,0.000536288301051779,0.0811991737580196
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,40419,-0.00611674025026875,0.00352536385893336,-0.0130264534137781,0.000792972913240633,0.0827564981164121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40080,-0.0106046668389474,0.00612225325691092,-0.0226042832224928,0.00139494954459799,0.0832750138987828
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40182,-0.00881430963054487,0.00510073811278065,-0.0188117563315949,0.00118313707050519,0.0840080893782571
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40182,-0.0184070013248667,0.0106519224033497,-0.0392847692354321,0.00247076658569875,0.0840082511392856
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,40451,-0.00640473938232631,0.00370637319565975,-0.0136692308458194,0.000859752081166803,0.0840095297179988
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40136,0.0139746078245611,0.00813563886257092,-0.0019712443460779,0.0299204599952001,0.0858791731126877
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40182,-0.014919915701462,0.00870379238087516,-0.0319793487679773,0.00213951736505335,0.0865228431128117
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,40527,-0.0164544232740924,0.00960461159547234,-0.0352794620012182,0.0023706154530334,0.0867068797586011
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00587262609085633,0.00343388938671333,-0.00085779710710181,0.0126030492888145,0.0872530824608523
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,42794,0.00531257932740958,0.00310787794066807,-0.00077886143629985,0.011404020091119,0.0874013154995587
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,40283,-0.0138711045126158,0.00812056133910893,-0.0297874047372693,0.00204519571203768,0.0876372396664714
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,40532,0.00394990763648446,0.00231378404104875,-0.00058510908397109,0.00848492435694002,0.0878270802765606
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,-0.00929379434490735,0.00544571407450738,-0.0199673939309418,0.0013798052411271,0.0879196381963825
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,40199,-0.00497994622832199,0.00292183433512289,-0.0107067415251629,0.000746849068518883,0.0883364140789499
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40286,-0.0180420601351232,0.0106074165455015,-0.038832596564306,0.00274847629405974,0.0889914725574213
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,0.010736376449974,0.00632071732405487,-0.00165222950517351,0.0231249824051216,0.0894181128201323
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,40136,0.00845854041504637,0.00499316763857908,-0.00132806815656863,0.0182451489866614,0.090289387742223
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40283,0.004687892859935,0.00277056095385213,-0.000742406609615183,0.0101181923294852,0.0906669305100279
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,-0.0116998440586787,0.00692346558057867,-0.0252698365966128,0.00187014847925553,0.0910789542112122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,40080,-0.0127134322217877,0.00752659148057701,-0.0274655515237186,0.00203868708014328,0.0912221198401623
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00414917806371453,0.00245646329755353,-0.00896384612691945,0.000665489999490397,0.0912305449293022
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,-0.0092048098705438,0.00545259610772892,-0.0198918982416925,0.0014822785006049,0.0914058670001292
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,42721,-0.00564473118001063,0.00334437672135275,-0.012199709553862,0.000910247193840748,0.0914673896124476
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,40199,-0.00834900015082746,0.00495382831180155,-0.0180585036419585,0.00136050334030358,0.09194686167271
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_A,,40482,-0.00577599925539912,0.00343328446237412,-0.0125052368016524,0.000953238290854157,0.0925279069501515
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,42488,-0.0089404723014192,0.00531945544795586,-0.0193666049794127,0.00148566037657427,0.0928423721105526
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C5,Complement C5,40539,-0.00260190427461372,0.00155624459494465,-0.00565214368070525,0.000448335131477798,0.0945692196899583
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,40136,-0.012966750510154,0.0077714493404133,-0.0281987912173641,0.00226529019705606,0.0952428950054379
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,40482,-0.00834939459394202,0.005010998163602,-0.0181709509946019,0.00147216180671791,0.0956985719591791
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F2,Prothrombin,40539,0.00255979478618328,0.00153645854656854,-0.000451663965091057,0.00557125353745762,0.0957339117439647
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0117684571702363,0.00708440124003374,-0.00211696926022982,0.0256538836007025,0.0967011093514867
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40116,-0.00681312953872976,0.00412499438964035,-0.0148981185424248,0.00127185946496532,0.0986305859407188
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,40080,-0.00908144537848988,0.00549852484082915,-0.019858554066515,0.00169566330953526,0.0986419296232431
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40417,-0.0073949855445644,0.00448494694045379,-0.0161854815478538,0.00139551045872502,0.099207235336661
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,40136,0.0161887243796273,0.00984136953592654,-0.00310035991078871,0.0354778086700433,0.100005419336309
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,42357,0.00657439547102649,0.00401463507920423,-0.0012942892842138,0.0144430802262668,0.101527554724129
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,40293,0.00416103225259188,0.0025424998090677,-0.000822267373180812,0.00914433187836457,0.101744313548142
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40449,-0.00456475815054948,0.0028278396845395,-0.0101073239322469,0.000977807631147931,0.106507535021244
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,40199,0.00941920053153834,0.00584113765801147,-0.00202942927816414,0.0208678303412408,0.106868228295516
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,40182,-0.0102246247137997,0.00634472750368207,-0.0226602906210166,0.00221104119341713,0.107096201480669
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAG,S-arrestin,40136,0.00875446555401526,0.00543398816563755,-0.00189615125063434,0.0194050823586649,0.107196107168561
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,40182,-0.00592485448744989,0.00368056542019037,-0.013138762711023,0.00128905373612325,0.10747735498713
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,42636,-0.00640615617496298,0.00398867073988181,-0.0142239508251313,0.00141163847520538,0.108278067450019
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,40527,-0.00539139884987231,0.00337411462998293,-0.0120046635246389,0.00122186582489424,0.110099638411917
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,42311,0.00548977713887805,0.00343667935551083,-0.00124611439792318,0.0122256686756793,0.110199005030402
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,42311,-0.00954452904353006,0.00599237449544607,-0.0212895830546044,0.00220052496754424,0.111233843684831
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,40421,-0.0117944992716842,0.00744301469891493,-0.0263828080815575,0.00279380953818905,0.113076302139733
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,40182,-0.00453578782557108,0.0028671361641399,-0.0101553747072853,0.00108379905614312,0.113680070400113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40223,0.00646762086827198,0.00409551424339838,-0.00155958704878884,0.0144948287853328,0.11431972011586
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,42495,-0.0097724675907812,0.00619922695307809,-0.0219229524188143,0.00237801723725185,0.114957199089517
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALLD,Palladin,40199,0.00636134162026882,0.00403958983711091,-0.00155625446046856,0.0142789377010062,0.115343048357495
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,40116,0.00561005088303612,0.00357172801313704,-0.00139053602271248,0.0126106377887847,0.116285370472783
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,42794,0.00389739662600459,0.00248246123988814,-0.000968227404176169,0.00876302065618535,0.11644470293873
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,0.00606810544714515,0.00387994426625707,-0.0015365853147187,0.013672796209009,0.117849772201638
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40182,0.00601497983749477,0.00384999766217962,-0.00153101558037728,0.0135609752553668,0.118238272071481
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,42017,-0.00451871369743302,0.00289674813733182,-0.0101963400466034,0.00115891265173736,0.118801968948535
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.00791290281727132,0.00507748208522701,-0.0178647677043163,0.00203896206977362,0.119154733631269
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,40302,0.00570638912862022,0.00367109941552364,-0.00148896572580612,0.0129017439830466,0.120115431464228
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40116,0.00437486307515806,0.00282064478542703,-0.00115360070427892,0.00990332685459504,0.120927003473379
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.0113176043290822,0.00730440499984131,-0.00299902947060675,0.0256342381287712,0.121308845553418
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,40116,0.00821934021122314,0.00532117594094653,-0.00221016463303206,0.0186488450554783,0.122460563269114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42346,-0.00755382585734506,0.00489774452922034,-0.0171534051346169,0.00204575341992681,0.123023058308698
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,40182,-0.00367502918845056,0.0023989182425719,-0.00837690894389149,0.00102685056699036,0.125562905289245
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40449,0.0234584830041724,0.0153814834051372,-0.00668922446989651,0.0536061904782413,0.12725929331863
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,40449,-0.0176554193571857,0.0116136461477579,-0.0404181658067912,0.00510732709241977,0.128481139143773
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,42370,0.00979650545957163,0.00644604488564719,-0.00283774251629685,0.0224307534354401,0.128592792853172
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,0.00680465383069847,0.00448477300094034,-0.0019855012511446,0.0155948089125415,0.129225090914827
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,40116,-0.00524340189902877,0.00346002122420971,-0.0120250434984798,0.00153823970042227,0.129693804849933
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40182,0.00582151035432191,0.00384202078361231,-0.00170885038155821,0.013351871090202,0.12974522557884
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,40116,0.00746815562002127,0.004939695558386,-0.0022136476744153,0.0171499589144578,0.130596997294952
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,0.0141311209181876,0.00938757830030177,-0.00426853255040389,0.032530774386779,0.132275683632162
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40483,-0.00637907607518977,0.00423984838137452,-0.0146891789026838,0.0019310267523043,0.132467045130324
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40451,-0.00620340547550432,0.00415581608014661,-0.0143488049925917,0.00194199404158304,0.135542572480004
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42311,0.00757764826828116,0.00508295140284958,-0.00238493648130402,0.0175402330178663,0.136038868075689
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,42201,-0.0041865064436967,0.0028083466369848,-0.00969086585218691,0.00131785296479351,0.136054788031617
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,40539,-0.00398617111614172,0.00267509592634435,-0.00922935913177665,0.00125701689949321,0.136224694653623
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40116,0.00631195444518303,0.00425019831591142,-0.00201843425400335,0.0146423431443694,0.137547135764202
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,40136,0.00527959516470935,0.00356430103294004,-0.00170643485985313,0.0122656251892718,0.138570685023507
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,40539,0.00296866041718286,0.00200845167135057,-0.000967904858664255,0.00690522569302997,0.139413038582743
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,0.00914171206227367,0.00620325481499874,-0.00301666737512387,0.0213000914996712,0.140592268644797
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,40302,-0.012659993413304,0.00860505996835222,-0.0295259109512743,0.00420592412466639,0.141258163855722
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,40136,-0.00734179044426557,0.00499142477717274,-0.0171249830075241,0.00244140211899299,0.141352134595752
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40080,0.00466090707834448,0.0031742271948723,-0.00156057822360522,0.0108823923802942,0.142035453822993
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,-0.0133177067333437,0.00909250263954178,-0.0311390119068456,0.00450359844015815,0.143028598499121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,40080,0.00795393894911852,0.00544255831443589,-0.00271347534717582,0.0186213532454129,0.143925280415102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,40451,-0.00561295889363161,0.00386791153226141,-0.013194065496864,0.00196814770960076,0.146763149190927
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40223,-0.00638509517439485,0.00442808644558384,-0.0150641446077392,0.00229395425894947,0.149343859017355
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,42370,-0.00928667930677211,0.00644190310432231,-0.0219128093912438,0.00333945077769962,0.149437621357778
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,40080,-0.0131555404814341,0.00912777854078852,-0.0310459864213797,0.00473490545851136,0.149538819175943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,40116,-0.00553490562150539,0.00384676964061654,-0.0130745741171138,0.00200476287410303,0.150223072386541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40116,-0.00722759475957827,0.00503644256160318,-0.0170990221803205,0.00264383266116396,0.151298776305658
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.0110182825631799,0.00771280832165772,-0.0261353868736291,0.00409882174726919,0.153156555388184
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,0.00619740162155055,0.00434738090851807,-0.00232346495914487,0.014718268202246,0.154027283370448
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,40199,-0.0081626667692013,0.00573281690970232,-0.0193989879122178,0.00307365437381525,0.154518481347382
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,42794,0.00598159190981151,0.00421022061704579,-0.00227044049959823,0.0142336243192213,0.155417836173737
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,40451,-0.00501658498077535,0.00353300009630428,-0.0119412651695317,0.00190809520798104,0.155658048373815
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,42346,-0.00790168040698619,0.00556864540597257,-0.0188162254026924,0.00301286458872005,0.155934620351245
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42587,0.00379466205976411,0.00269320438558626,-0.00148401853598496,0.00907334265551318,0.158865292471358
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,-0.00715684195848743,0.00508311731383774,-0.0171197518936094,0.00280606797663454,0.15917043786125
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.00492766286643526,0.00351916557844552,-0.00196990166731796,0.0118252274001885,0.16146580436177
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.00627276945135923,0.00448815490596331,-0.0150695530670473,0.00252401416432886,0.162252865759287
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.00793755829730151,0.00568215383956702,-0.0190745798228529,0.00319946322824984,0.162463470101001
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,-0.0112464001794171,0.00805471055021138,-0.0270336328578314,0.00454083249899721,0.162667299364167
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,40302,-0.0108488613613912,0.00777354808559141,-0.0260850156091503,0.00438729288636801,0.162859093510733
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40136,0.0105648537882844,0.00760644894586013,-0.00434378614560147,0.0254734937221703,0.16488115888886
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,-0.00925776955623197,0.00667465997324422,-0.0223401031037906,0.00382456399132669,0.165469114435173
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.00998658531287,0.00723637895268808,-0.00419671743439863,0.0241698880601386,0.167598150887989
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,40182,0.00415886891929573,0.00301654574595976,-0.0017535607427854,0.0100712985813769,0.168019701964955
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40116,0.00556870342390807,0.00405577825438194,-0.00238062195468054,0.0135180288024967,0.169771345508472
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,40136,0.00400442218016189,0.00291719939850017,-0.00171328864089845,0.00972213300122223,0.169875621002992
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,-0.00577981540559158,0.00423804515560369,-0.0140863839105748,0.00252675309939166,0.172655363110744
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,40136,0.00722161564942398,0.00530098509676608,-0.00316831514023754,0.0176115464390855,0.173126290376521
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.00893679523429264,0.00658014236129568,-0.0218338742624322,0.00396028379384688,0.1744449717075
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00716129635443911,0.00527461464754441,-0.00317694835474793,0.0174995410636262,0.174589663580122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40116,-0.00628029718968404,0.00464574084455388,-0.0153859492450096,0.00282535486564156,0.176454575436673
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,42587,0.0121378788784052,0.00905701611107944,-0.00561387269931049,0.0298896304561209,0.180215056765507
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,-0.00699128757810276,0.005234109528568,-0.017250142254096,0.00326756709789053,0.181665059429206
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,40116,0.00690337733896306,0.00517275712595951,-0.00323522662791758,0.0170419813058437,0.182046787468626
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,40532,0.0200754901136509,0.0150690139851896,-0.00945977729732062,0.0496107575246224,0.182809269656939
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40449,-0.0111984156378159,0.00840833403211053,-0.0276787503407525,0.00528191906512076,0.182945211157752
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,40065,0.00568333827028784,0.00427037254504646,-0.00268659191800323,0.0140532684585789,0.183257578110451
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,40080,0.00437940230923588,0.00329120894026785,-0.0020713672136891,0.0108301718321609,0.183336561094258
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,40116,-0.00684348536355546,0.00514983617251364,-0.0169371642616822,0.00325019353457128,0.183917177293191
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,40080,-0.00468922035255498,0.0035414951154787,-0.0116305507788932,0.00225211007378328,0.18550451190386
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,0.00444263764388164,0.003363082337457,-0.00214900373753409,0.0110342790252974,0.18652845670028
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,42689,-0.00797513876586233,0.0060481731726183,-0.0198295581841942,0.00387928065246953,0.187324276266124
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42794,-0.00216384403246932,0.00164260605057192,-0.00538335189159028,0.00105566382665164,0.187752306058476
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,40302,0.00606974868219408,0.00462042929381628,-0.00298629273368583,0.015125790098074,0.188982274638699
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,-0.0064436229101633,0.00490505156809778,-0.016057523983635,0.00317027816330835,0.188984149868327
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,40302,0.00804347578554377,0.006133159683898,-0.00397751719489631,0.0200644687659839,0.189724981067041
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,42346,-0.0142595545861476,0.0109055024521059,-0.0356343393922752,0.00711523021997995,0.191046823294533
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40223,-0.00539921179321989,0.00413843779682757,-0.0135105498750019,0.00271212628856214,0.192039365231263
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42794,-0.00360465365558357,0.00277095414805607,-0.00903572378577347,0.00182641647460632,0.193324683593459
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,40116,0.00659412469532651,0.00508542793902187,-0.00337331406515636,0.0165615634558094,0.194771956581916
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,40182,-0.0122022332795049,0.0094180984115228,-0.0306617061660896,0.00625723960707978,0.195135239440027
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40182,-0.00478965136759276,0.00374847111817805,-0.0121366547592217,0.00255735202403622,0.201360594044321
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,42357,0.00695651286421511,0.0054455918285369,-0.00371684711971721,0.0176298728481474,0.201463258164852
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,42370,0.00646039072587192,0.00505808568989627,-0.00345345722632476,0.0163742386780686,0.201539940155805
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,40302,0.00504542066845336,0.00395277751896259,-0.00270202326871331,0.01279286460562,0.201832310597234
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,-0.0102271976422766,0.00802754088104692,-0.0259611777691286,0.00550678248457535,0.202681028516889
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,42652,-0.00597376862994531,0.00471476956859005,-0.0152147169843818,0.00326717972449119,0.205165415878566
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,40337,-0.00448787341493395,0.00354608095024746,-0.011438192077419,0.00246244524755107,0.20568749826757
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,40302,0.00461096439481819,0.00364811944771148,-0.00253934972269631,0.0117612785123327,0.206281992329349
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,0.00666005673944426,0.00527133220492344,-0.00367175438220568,0.0169918678610942,0.206455013398596
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42292,0.00730879751776172,0.00579851384207276,-0.00405628961270089,0.0186738846482243,0.20752575115758
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,40080,0.00900957189367526,0.00715395860249082,-0.00501218696720675,0.0230313307545573,0.207919126949517
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,40199,0.00436378032020042,0.00348211494308452,-0.00246116496824524,0.0111887256086461,0.210160194941276
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00695730866774497,0.00555766629081067,-0.00393571726224394,0.0178503345977339,0.210654950420452
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,40267,0.00390199483970217,0.00313347253904841,-0.00223961133683271,0.0100436010162371,0.213061744335201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,42611,0.00806320018486521,0.0064806574928489,-0.00463888850111864,0.0207652888708491,0.213449621633851
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,40080,0.0103327496778615,0.00830642649572319,-0.00594784625375592,0.026613345609479,0.213546060135054
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,40199,-0.0126071730331555,0.0101383753698657,-0.0324783887580923,0.00726404269178118,0.21370637892253
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,40182,0.00768220626011821,0.00619094882171019,-0.00445205343043376,0.0198164659506702,0.214677667182953
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,-0.00924753089736743,0.00746230418211646,-0.0238736470943157,0.00537858529958082,0.215285121897165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.0100529356784945,0.00816118119296544,-0.0059429794597178,0.0260488508167067,0.218050498319612
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.00708928531954756,0.00575528957100338,-0.0183696528787142,0.00419108223961906,0.218055628254163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,40199,-0.00365185737783882,0.00296848864759286,-0.00947009512712083,0.00216638037144319,0.218645660074086
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,0.0103348149262432,0.00840502597635049,-0.0061390359874038,0.0268086658398901,0.218873196734666
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.00759531989632794,0.00618331748668974,-0.00452398237758396,0.0197146221702398,0.219335030561399
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,42587,-0.00268929484255532,0.00219389867561918,-0.00698933624676891,0.00161074656165827,0.220293125339146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,40116,0.00765333632571373,0.00625470683719443,-0.00460588907518736,0.0199125617266148,0.221124907652401
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40136,-0.0108500829885895,0.00887737417777781,-0.028249736377034,0.00654957039985502,0.221651676177392
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40145,-0.00484703938927164,0.00396968976461794,-0.0126276313279228,0.00293355254937953,0.222107711284799
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.00456927198449491,0.00376030078122218,-0.00280091754670057,0.0119394615156904,0.224335875570723
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,40199,0.00578400046887352,0.00477959819609843,-0.0035840119954794,0.0151520129332264,0.226249762982829
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,40199,-0.00409268594179047,0.00338950240952917,-0.0107361106644676,0.00255073878088669,0.227281290068355
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,42594,0.00605922762415656,0.00502066011747432,-0.00378126620609311,0.0158997214544062,0.22750784777895
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,42370,-0.00936963433967512,0.00777450873296932,-0.024607671456295,0.00586840277694474,0.228157853399034
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,40116,-0.00827305646168041,0.00687220968633261,-0.0217425874468923,0.0051964745235315,0.228676640835097
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,42357,0.00887407384472947,0.00738366014124381,-0.00559790003210841,0.0233460477215673,0.229442121546915
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,40080,0.00655217471909484,0.00545924406734589,-0.00414794365290311,0.0172522930910928,0.230088504915915
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40283,0.0034644828302481,0.00289264722043499,-0.00220510572180448,0.00913407138230068,0.231064914724464
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,-0.00352195251726412,0.00294488980754586,-0.009293936540054,0.00225003150552576,0.231740307897129
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40302,-0.010744364438621,0.00899503721868974,-0.0283746373872529,0.00688590851001092,0.232316964659404
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.00319803045355606,0.00267860795226985,-0.00205204113289285,0.00844810204000497,0.232537114142047
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,40482,-0.00474102122257713,0.00397465410869641,-0.0125313432756221,0.00304930083046783,0.232967479393021
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,40116,0.00621261559891416,0.00521906697913309,-0.00401675568018671,0.016441986878015,0.233927259309363
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40482,-0.00421350203195934,0.00354513220591315,-0.0111619611555491,0.00273495709163044,0.234648999501058
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.0069824524963639,0.0059069616890135,-0.0185600974068304,0.00459519241410256,0.237202922874451
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,42629,-0.0225349158676596,0.0191125467168453,-0.0599955074326764,0.0149256756973572,0.238393570350427
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40136,0.00737787811688083,0.0062639017252324,-0.00489936926457467,0.0196551254983363,0.238885753483297
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,40080,0.0051728437535147,0.00440046817001138,-0.0034520738597076,0.013797761366737,0.239811957642762
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,-0.0052745476199539,0.00448874967656053,-0.0140724969860125,0.00352340174610474,0.239996364628214
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTTG1,Securin,40302,-0.00497948050592477,0.00424374556212691,-0.0132972218076935,0.00333826079584398,0.240672925774196
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,-0.00460782568923612,0.00394053463727691,-0.0123312735782989,0.00311562219982663,0.242291956317207
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,40116,0.00719950604251552,0.00615896080293878,-0.0048720571312445,0.0192710692162755,0.242450020484656
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40182,0.00508170822869471,0.00434956706381614,-0.00344344321638493,0.0136068596737743,0.242701015844704
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,40199,-0.00773978039904554,0.00665106892485361,-0.0207758754917586,0.00529631469366754,0.24457501420827
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40116,0.00576265960642295,0.00499377760869252,-0.00402514450661438,0.0155504637194603,0.248538534596608
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,42611,0.00238349217565221,0.00207810528609989,-0.00168959418510356,0.00645657853640799,0.251420885651409
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,40182,-0.00717715407416059,0.00628297328113079,-0.0194917817051769,0.00513747355685575,0.25334671269489
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,40080,-0.00740526522271239,0.00648269552337882,-0.0201113484485349,0.0053008180031101,0.253349200901102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,-0.00640910023624754,0.00564405008671761,-0.0174714384062141,0.00465323793371897,0.256169774873618
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,-0.00431842676833738,0.00381353626807511,-0.0117929578537646,0.00315610431708983,0.257489303030024
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,-0.00984705445977892,0.00870233074114251,-0.0269036227124182,0.00720951379286041,0.257851647068153
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40136,-0.0141617848281404,0.0125175412067824,-0.038696165593434,0.0103725959371531,0.257930431317544
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00818699608905997,0.00723970901314352,-0.0223768257548213,0.00600283357670133,0.258144739178513
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40080,0.00295133870898217,0.00261365481000106,-0.00217142471861991,0.00807410213658424,0.258838404714973
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,-0.0101149636111744,0.00897283764505113,-0.0277017253954747,0.00747179817312578,0.259645985505092
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,40080,0.00400096140296503,0.00355558243425003,-0.00296798016816504,0.0109699029740951,0.260502883227348
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,40199,0.00524274707170615,0.00467781951207065,-0.00392577917195233,0.0144112733153646,0.262411389776194
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00301327549016819,0.00270168786919267,-0.00830858371378582,0.00228203273344945,0.264732465181477
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0029529942863657,0.00265097769898594,-0.00224292200364674,0.00814891057637814,0.265330667515483
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40302,0.0033419365902689,0.0030009978910329,-0.00254001927615559,0.00922389245669339,0.265471298776392
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,42357,-0.00698930634168299,0.00630235157637911,-0.019341915431386,0.00536330274802007,0.267450549689586
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,-0.00512721314383836,0.00462361199210348,-0.0141894926483612,0.00393506636068446,0.2674891764976
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,40286,-0.0114256196035536,0.0103299234492263,-0.0316722695640372,0.00882103035693005,0.268720161690781
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,-0.00959091374144168,0.00868296697730208,-0.0266095290169537,0.00742770153407039,0.269367769680146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,40482,0.00406346543028371,0.00369863882444455,-0.0031858666656276,0.011312797526195,0.271949396207938
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,40199,-0.00807014585744089,0.00735950317802881,-0.0224947720863774,0.00635448037149558,0.272857237696945
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40136,-0.00797154653484678,0.00727726224613296,-0.0222349805372674,0.00629188746757383,0.273363529924904
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00407617511229501,0.00372448449399299,-0.00322381449593124,0.0113761647205213,0.273787940832941
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,40199,-0.00628502057323434,0.00574544870091599,-0.0175461000270297,0.004976058880561,0.274017113852616
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,40511,-0.00552196930494024,0.00505344830003677,-0.0154267279730123,0.00438278936313183,0.274543033298013
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.003318250993088,0.00303810594464597,-0.00263643665841811,0.0092729386445941,0.274764529574894
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,42495,0.00134376823164402,0.00123351899220194,-0.00107392899307179,0.00376146545635983,0.276007044180554
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,40302,0.00397064524429582,0.00364671153584176,-0.00317690936595403,0.0111181998545457,0.276252926211947
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,-0.00500250542572142,0.00459588578458633,-0.0140104415635106,0.00400543071206778,0.276408899686153
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,42346,-0.0156760695755044,0.0144067804528906,-0.04391335926317,0.0125612201121612,0.276569316581611
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,40483,0.00293619670766537,0.00270037491879,-0.00235653813316302,0.00822893154849377,0.27691452873731
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,-0.00373358412280982,0.00344189045582679,-0.0104796894162303,0.00301252117061069,0.278056346391951
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,40116,0.00604572824353285,0.00558368920377147,-0.00489830259585924,0.0169897590829249,0.278944201079449
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.0071027537836362,0.00656625403079757,-0.0199726116839994,0.00576710411672705,0.279406844384919
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,40116,-0.00943423885043643,0.00877565582464652,-0.0266345242667436,0.00776604656587075,0.282377618811677
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARTN,Artemin,42370,-0.00492938557545995,0.00459894459313614,-0.0139433169780068,0.00408454582708688,0.283806377277969
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40116,0.00821452430981693,0.00771410443432442,-0.00690512038145893,0.0233341690010928,0.28695795563358
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,42370,-0.00637123460202966,0.00599708658088384,-0.018125524300562,0.00538305509650268,0.288078915429984
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,0.00397299747165887,0.00375463102365474,-0.00338607933470441,0.0113320742780222,0.29000625711715
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,40302,-0.00663777334977779,0.00635651749048708,-0.0190965476311325,0.00582100093157688,0.296393921754789
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,0.0025434651726493,0.00244085594480413,-0.00224061247916678,0.00732754282446539,0.297416802402494
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,40136,-0.00384800804270495,0.00370876985044062,-0.0111171969495686,0.00342118086415867,0.299505813306311
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40199,-0.00789723681996908,0.00763034186786421,-0.0228527068809829,0.00705823324104476,0.300701875074312
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,40182,0.00747635169980455,0.00723562583972495,-0.00670547494605635,0.0216581783456654,0.301500523792594
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,42794,-0.00332417391246959,0.00321811578078593,-0.00963168084281002,0.00298333301787084,0.301642580542863
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,0.00328687595774314,0.00318701223593926,-0.00295966802469781,0.00953341994018409,0.302406855160166
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,40136,0.00582922126068168,0.00566711311432848,-0.00527832044340215,0.0169367629647655,0.303688032875608
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,42611,-0.00384663257266425,0.0037460527457707,-0.0111888959543748,0.00349563080904633,0.304509825406931
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,40479,-0.00274026294913262,0.00267489561253342,-0.00798305834969812,0.00250253245143287,0.305650710905322
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,40223,0.00663841157573709,0.00648409351420432,-0.00607041171210338,0.0193472348635776,0.305952450221831
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,40182,0.00513040533898149,0.00502408456738307,-0.00471680041308933,0.0149776110910523,0.307200071320577
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40199,-0.0092322458872917,0.00908353386836937,-0.0270359722692957,0.00857148049471227,0.309474806299172
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),40324,0.0191046134840392,0.0188291835504957,-0.0178005862749324,0.0560098132430108,0.310305327741279
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40473,-0.00718687749954701,0.0071085370662001,-0.0211196101492992,0.00674585515020518,0.31202825214309
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,40223,-0.00766069805019914,0.00759018932340491,-0.0225374691240728,0.00721607302367448,0.31285797741327
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCIN,Adseverin,40136,-0.00761970014248947,0.00756274971780433,-0.022442689589386,0.00720328930440702,0.313702242500635
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,42721,0.00458819506389622,0.00458761696240676,-0.00440353418242102,0.0135799243102135,0.31726741847325
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,42370,-0.00431840287346534,0.00433046572665895,-0.0128061156977169,0.0041693099507862,0.318678755356002
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENG,Endoglin,42794,0.00178457547511245,0.00179115555107559,-0.00172608940499572,0.00529524035522062,0.319109330371865
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40449,-0.00571323624585533,0.00576276176940668,-0.0170082493138924,0.00558177682218177,0.321508714134565
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40136,-0.0114365569184665,0.0116165373451239,-0.0342049701149093,0.0113318562779763,0.324888288620887
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,42569,-0.00289365324239571,0.00294455208551979,-0.0086649753300145,0.00287766884522308,0.325765879574545
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,40065,-0.00361134215801242,0.00370331870787415,-0.0108698468254457,0.00364716250942091,0.329500738819991
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40080,-0.00931740411604341,0.00957698999938819,-0.0280883045148443,0.00945349628275744,0.330627188565723
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40116,-0.00593528900356198,0.00613088896550548,-0.0179518313759527,0.00608125336882876,0.333017870284783
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTN,Titin,40116,-0.00656863677009267,0.00679692519057026,-0.0198906101436104,0.00675333660342504,0.333858966420847
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40182,0.00420265925896993,0.00435157376316604,-0.00432642531683551,0.0127317438347754,0.334175953130496
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,42370,0.00309239460879695,0.00320988283969634,-0.00319897575700788,0.00938376497460179,0.335365525412693
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,40136,0.00941521861809774,0.00977539247077404,-0.00974455062461938,0.0285749878608149,0.335491003644012
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,40451,-0.00431791812259595,0.00450679791551318,-0.0131512420370018,0.00451540579180989,0.338037941533505
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40199,-0.0028837746641545,0.0030151517981682,-0.00879347218856417,0.00302592286025516,0.338877210753733
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-0.00663894086316886,0.00694509433481227,-0.0202513257594009,0.00697344403306318,0.339134454206014
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,-0.00627006059248308,0.00659396040342313,-0.0191942229831924,0.00665410179822625,0.341686328653929
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,40080,-0.00622243862532297,0.00654424577243072,-0.0190491603392872,0.00660428308864124,0.341713852292149
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42346,-0.00516496071171496,0.00546020389515151,-0.0158669603462119,0.005537038922782,0.344202599083783
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,-0.00246607407490598,0.00261195449619773,-0.00758550488745353,0.00265335673764158,0.345113669387922
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40284,0.00523503358382443,0.00554522745713566,-0.00563361223216146,0.0161036793998103,0.345158987843278
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,-0.00291863077774578,0.00309980275911901,-0.00899424418561905,0.00315698263012749,0.34643851996543
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.0058373892158756,0.00620988433869301,-0.0180087625197139,0.00633398408796269,0.347230259413926
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,42370,0.0134447437371418,0.01434040614422,-0.0146624523055295,0.041551939779813,0.348496631466238
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,42357,-0.00469452691458421,0.00502608651703613,-0.014545656487975,0.0051566026588066,0.350304389115382
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,42370,-0.00308020980028763,0.00330039687728335,-0.00954898767976299,0.00338856807918774,0.350690111516051
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,40539,-0.00200457843188194,0.00214853601277868,-0.00621570901692815,0.00220655215316427,0.350841185800258
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40429,-0.00381436481692544,0.0040883246331215,-0.0118274810978436,0.0041987514639927,0.350845330459786
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40136,-0.00428204544995274,0.00460581651592767,-0.013309445821171,0.00474535492126549,0.352544938492676
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.00477028655968434,0.00516603576610444,-0.014895716661249,0.00535514354188035,0.355822180298907
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,0.00440379083119609,0.00477212654628293,-0.00494957719951845,0.0137571588619106,0.356123789631636
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,-0.00733795219904785,0.00796193294594414,-0.0229433407730984,0.00826743637500266,0.356738821225337
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40136,-0.00740441706580764,0.0081145656769233,-0.0233089657925773,0.00850013166096203,0.361533721062456
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40182,0.00403979711368023,0.00443509559622272,-0.00465299025491631,0.0127325844822768,0.362383666736524
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40223,-0.00524055104816123,0.00575923095183945,-0.0165286437137665,0.00604754161744409,0.36287436458736
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,42346,0.00730992903002612,0.00811600265923346,-0.00859743618207147,0.0232172942421237,0.367774469137977
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40451,-0.00413585560773827,0.00461110013757971,-0.0131736118773945,0.00490190066191796,0.369772956394081
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,42311,-0.00353970949358995,0.00395110813293192,-0.0112838814341365,0.00420446244695662,0.370334548917171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,-0.00459031962514553,0.00513096230939547,-0.0146470057515607,0.00546636650126959,0.371003913296313
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40136,0.00563859839620733,0.00632652904447224,-0.00676139853095827,0.0180385953233729,0.372807933074941
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,40182,0.00450726961290352,0.00507990657948344,-0.00544934728288403,0.0144638865086911,0.374950758263526
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,42654,-0.0100064267819975,0.0112816886185707,-0.032118536474396,0.0121056829104011,0.375115317489732
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,40302,-0.00375682812082504,0.00425535299630432,-0.0120973199935815,0.00458366375193143,0.377337731013491
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEB,Nebulin,40116,-0.00349033629763824,0.00397677685300914,-0.0112848189295362,0.00430414633425968,0.380136871966693
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.0017921099946939,0.0020453215096069,-0.00580094015352342,0.00221672016413562,0.380940057095546
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40223,-0.0243444484184618,0.0280361881709543,-0.0792953772335322,0.0306064803966085,0.38523679127731
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,40182,-0.00374267548127292,0.00433182239657469,-0.0122330473785593,0.00474769641601347,0.387609168410677
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,42711,0.00207655588888674,0.00240634258887651,-0.00263987558531122,0.00679298736308469,0.388179685650361
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42594,-0.00318436809237433,0.00369091467901713,-0.0104185608632479,0.00404982467849925,0.388285689183643
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00228778662111284,0.00265251689073038,-0.0074867197269444,0.00291114648471871,0.388433093620142
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,40223,-0.00162130857003809,0.00188331817897401,-0.00531261220082716,0.00206999506075098,0.389323549474119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,40451,-0.00232360621132364,0.00273537915797478,-0.00768494936095421,0.00303773693830692,0.395641200331474
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,40302,-0.00478495345080682,0.005637195489966,-0.0158338566111402,0.00626394970952655,0.396000819757609
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.00875901345428547,0.0103506401156345,-0.0290462680809291,0.0115282411723582,0.397443459303484
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,42611,-0.00209800452584617,0.0024898268798706,-0.00697806521039255,0.0027820561587002,0.39945004524139
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00354626759822755,0.00421355519725317,-0.00471230058838866,0.0118048357848438,0.400011738926797
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42346,-0.00418958401944372,0.00498402509854788,-0.0139582732125976,0.00557910517371012,0.400585932359071
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,40302,0.00243167644716397,0.00291182091671058,-0.00327549254958877,0.0081388454439167,0.403676505897071
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40511,-0.00240508680944794,0.0028809331659342,-0.00805171581467897,0.0032415421957831,0.403831567666038
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.00618325766129507,0.00742225636266276,-0.00836436480952394,0.0207308801321141,0.404823578193952
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.00287286696173724,0.00344986099141465,-0.00388886058143547,0.00963459450490995,0.405004695735946
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEO1,Neogenin,40482,-0.00191234460420049,0.00229953598655302,-0.00641943513784441,0.00259474592944344,0.405639959032539
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,40199,-0.00408008573449929,0.00490689864897499,-0.0136976070864903,0.00553743561749168,0.405709325602474
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,42710,0.00380534123210111,0.00458446103581479,-0.00518020239809588,0.0127908848622981,0.406524022185982
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,40527,-0.00396088563358181,0.00484576015599333,-0.0134585755393287,0.00553680427216512,0.4137216235621
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,40302,0.00345332408731353,0.00424417601051217,-0.00486526089329032,0.0117719090679174,0.415856137902588
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,40182,0.00290249662710708,0.00357986780852406,-0.00411404427760009,0.00991903753181424,0.417507752231278
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,-0.00506709070286422,0.00628009666546554,-0.0173760801671767,0.00724189876144825,0.419770930780526
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42636,-0.00145129229338819,0.00180315314686219,-0.00498547246123809,0.0020828878744617,0.420912643579379
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40136,0.00479314621649361,0.00596807088596217,-0.00690427271999224,0.0164905651529795,0.421916129765761
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,40199,-0.00491746449848428,0.0061266873440951,-0.0169257716929107,0.00709084269594211,0.422205820482951
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,-0.00528873335535729,0.0065990062378624,-0.0182227855815676,0.00764531887085301,0.422891620077977
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,42495,0.00462266945398497,0.00577450340095609,-0.00669535721188897,0.0159406961198589,0.423417460821043
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,40302,-0.00194195175411099,0.00242618188031802,-0.00669726823953431,0.00281336473131232,0.423487658029401
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,0.00558477526448218,0.00700011424534212,-0.00813544865638837,0.0193049991853527,0.424996931632926
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42315,-0.00237760479877928,0.00299683668476279,-0.00825140470091435,0.00349619510335578,0.427575760032481
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,40483,0.00845804562045651,0.010705360546722,-0.0125244610511186,0.0294405522920316,0.429500134052691
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42370,-0.00319066603836169,0.00403850533160608,-0.0111061364883096,0.00472480441158622,0.429506293923053
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,40283,-0.00445769387725457,0.0056562156777648,-0.0155438766056736,0.00662848885116443,0.430651928136509
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,40080,0.00960747137009734,0.0122452165947654,-0.0143931531556429,0.0336080958958375,0.432711217118272
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40182,-0.0054705026871174,0.00698849497191198,-0.0191679528320649,0.00822694745783008,0.433769099955245
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,0.00515723844590941,0.00661519471671911,-0.00780854319886005,0.0181230200906789,0.435640311942475
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,42587,0.00222896303981405,0.00286538986499992,-0.00338720109558578,0.00784512717521389,0.436646593296043
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00227533525081946,0.00292572328919846,-0.00345908239600952,0.00800975289764843,0.436759529200066
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,-0.0032315361925455,0.00419831438955558,-0.0114602323960744,0.00499716001098345,0.441481008944879
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPHS2,Podocin,40199,0.00835737457360552,0.0108883619128934,-0.0129838147756656,0.0296985639228767,0.442770368352882
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,42311,0.00587886900905677,0.00767976125404485,-0.00917346304887112,0.0209312010669847,0.443986727593877
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.00299068629561915,0.00392415238025788,-0.0106820249609246,0.00470065236968629,0.446003128296769
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,40080,-0.00329115003135494,0.00431982390716136,-0.0117580048893912,0.00517570482668133,0.446153301722467
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,0.00380512084980024,0.00501251783125116,-0.00601941409945203,0.0136296557990525,0.447794973200704
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.0038465364059053,0.00507449561708038,-0.00609947500357226,0.0137925478153828,0.448459106100384
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,0.00383005797519253,0.00507075750785572,-0.00610862674020469,0.0137687426905898,0.450068631829421
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,40182,0.00261422507448079,0.0034658011740332,-0.00417874522662428,0.00940719537558586,0.450690246763399
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSC1,Hamartin,40199,-0.00568954702692154,0.00760801193924748,-0.0206012504278466,0.00922215637400353,0.454574920797599
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,42721,-0.00351708670835303,0.00474076316571976,-0.0128089825131638,0.0057748090964577,0.458171732289728
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSPN,Claspin,42292,-0.00265928400400485,0.00361062965536521,-0.00973611812852066,0.00441755012051097,0.461430347262045
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,42311,0.00508278636358934,0.00690278617803234,-0.00844667454535404,0.0186122472725327,0.461537965177083
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,42475,-0.00351520108579813,0.00478700342748626,-0.0128977278036712,0.00586732563207494,0.4627655842919
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40116,-0.00245909564175011,0.003373165653502,-0.00907050032261403,0.0041523090391138,0.466006798131768
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,-0.00322362316315077,0.00443317930488926,-0.0119126546007337,0.00546540827443219,0.467144474826223
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,40136,0.00579675197885492,0.00798628111755377,-0.00985635901155046,0.0214498629692603,0.467953177682018
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,42611,-0.00249606133916503,0.00346010888599936,-0.00927787475572377,0.00428575207739371,0.470686897871937
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,40199,0.00218118058442933,0.00303739690603725,-0.00377211735140368,0.00813447852026235,0.472705623844879
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,40136,0.00367755025230216,0.00515931870769709,-0.00643471441478414,0.0137898149193885,0.475986179601702
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,42370,-0.00239115434997255,0.00336798428034931,-0.0089924035394572,0.00421009483951211,0.477737780675303
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,0.00359978821596904,0.00507467895931848,-0.00634658254429518,0.0135461589762333,0.478114590319872
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,40527,0.00385301183372636,0.00545675545422277,-0.00684222885655027,0.014548252524003,0.480140830232461
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.00347267901217419,0.00492767391060971,-0.00618556185262083,0.0131309198769692,0.480993383529341
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40080,0.00230213699149276,0.00326955463353915,-0.00410619009024397,0.00871046407322949,0.481377262253903
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,42357,0.00769832579792676,0.0109758722346119,-0.0138143837819125,0.029211035377766,0.483074404032326
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,-0.00887817718570061,0.0126696222138737,-0.0337106367248931,0.0159542823534919,0.483474427715826
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40080,-0.00210065036166026,0.00299807995058442,-0.00797688706480573,0.0037755863414852,0.483526938292216
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,40116,0.00373800013514431,0.0053970269420474,-0.00684017267126861,0.0143161729415572,0.488573093697286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,40080,-0.00304033194575656,0.0044125823640048,-0.011688993379206,0.00560832948769285,0.490829010640924
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,-0.0015467703181704,0.0022493356849895,-0.00595546826074981,0.00286192762440902,0.491681148696322
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00257298065110703,0.00375645752340867,-0.00478967609477397,0.00993563739698803,0.493390748945013
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,42711,-0.00890958732547803,0.0130994416697907,-0.0345844929982678,0.0167653183473117,0.496421036208259
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40482,-0.00526924804615333,0.00781040678179555,-0.0205776453384726,0.0100391492461659,0.499915464553616
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,40080,0.00552081304539345,0.00821825924025339,-0.0105869750655032,0.0216286011562901,0.501741826199433
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40136,-0.00345526329979733,0.00517936474859361,-0.0136068182070408,0.00669629160744615,0.504708876830542
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,40136,0.00502912188269195,0.00755283493577008,-0.00977443459141739,0.0198326783568013,0.505515370017778
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,42370,0.00319798474257453,0.00480637580724827,-0.00622251183963208,0.0126184813247811,0.505829975344085
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,40199,-0.00151580429106692,0.00228159286361295,-0.00598772630374829,0.00295611772161446,0.506472372950554
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,42454,0.00169479937562619,0.00255769869665791,-0.0033182900698233,0.00670788882107569,0.507581200501853
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,40451,0.00376721435799089,0.0056943535003061,-0.00739371850260908,0.0149281472185909,0.508260277349946
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,40136,-0.0042349036503374,0.00642082187198031,-0.0168197145194188,0.00834990721874401,0.509551473564588
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,-0.0014471303864644,0.00220832981111081,-0.00577545681624159,0.0028811960433128,0.512282366670475
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,42679,0.00187936307009029,0.0028905281088503,-0.0037860720232563,0.00754479816343689,0.515587145182356
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,-0.00351546891765535,0.00542826110842671,-0.0141548606901717,0.00712392285486101,0.517242170627475
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,40511,0.00712317216955875,0.0110033205759225,-0.0144433361592493,0.0286896804983668,0.517408429696756
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,40483,-0.00546592089966618,0.00844386058787862,-0.0220158876519083,0.0110840458525759,0.517434875835743
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,-0.0036585470590018,0.00567257213070771,-0.0147767884351889,0.00745969431718532,0.518971286533195
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40116,-0.00260202624620986,0.00408263250057397,-0.0106039859473348,0.00539993345491512,0.523916561633139
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,-0.00207590480526485,0.00326658850729091,-0.00847841827955503,0.00432660866902533,0.525115847367956
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40302,0.00262887910724369,0.00413748302036566,-0.005480587612673,0.0107383458271604,0.525192886258964
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,40116,-0.00316648794712236,0.00500042688950536,-0.0129673246505529,0.00663434875630815,0.526587885847289
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,40136,-0.00486576249110226,0.00768724325085783,-0.0199327592627836,0.0102012342805791,0.526769169089854
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,0.00317150698124896,0.005036803405759,-0.00670062769403869,0.0130436416565366,0.528925896741896
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,0.00264609256293447,0.00422676333139019,-0.0056383635665903,0.0109305486924592,0.531306073231984
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40080,-0.00372184186641798,0.00595048471130704,-0.0153847919005798,0.00794110816774383,0.531676604341193
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00218945222649798,0.00351492359737403,-0.00907870247735107,0.00469979802435512,0.533362062340936
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.00202428015738854,0.00328751652241481,-0.00846781254132156,0.00441925222654448,0.538071821820368
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00236944882069145,0.00391284490493066,-0.00529972719297264,0.0100386248343555,0.544821390208134
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00367078075884575,0.00606452407828989,-0.0155572479522939,0.00821568643460244,0.545000523172032
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,40451,0.00239523085695199,0.00395945700949014,-0.00536530488164869,0.0101557665955527,0.545231572301945
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40302,0.00464022217549537,0.00767273583165705,-0.0103983400545525,0.0196787844055432,0.545345765314753
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42592,-0.0030490608018128,0.00504179196671588,-0.0129309730565759,0.00683285145295032,0.545350470543273
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,-0.00321766712725513,0.00533855953906439,-0.0136812438238213,0.00724590956931108,0.546706218043134
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.00279542925318118,0.00468763748600216,-0.0119831987257454,0.00639234021938306,0.55096001337976
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,40182,-0.00399645961693909,0.00670827780972036,-0.017144684123991,0.00915176489011282,0.55135421105236
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,40116,-0.00207883614724093,0.00349124091724211,-0.00892166834503547,0.00476399605055361,0.551559500698585
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40283,0.00327169039391864,0.00550907146362956,-0.0075260896747953,0.0140694704626326,0.552608979078735
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,40182,0.00362241806920674,0.00613960002197098,-0.00841119797385638,0.0156560341122699,0.555196879159567
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,40449,-0.00693278929651831,0.0117612394592014,-0.0299848186365531,0.0161192400435165,0.555564051149071
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42587,-0.00120890126966166,0.00206091926266404,-0.00524830302448317,0.00283050048515985,0.557493341741768
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,-0.00208965705096418,0.00356249866100188,-0.00907215442652785,0.0048928403245995,0.557504248276315
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,40182,0.00430862296393256,0.00738444401472858,-0.0101648873049355,0.0187821332328006,0.559586970791555
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00351486562682124,0.00608555222648328,-0.00841281673708599,0.0154425479907285,0.563562724166747
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,40527,0.0019528844006063,0.00339386108760851,-0.00469908333110638,0.00860485213231897,0.565020925976929
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIT,Vitrin,40511,0.00228582230516493,0.00398478155250265,-0.00552434953774026,0.0100959941480701,0.566224159285783
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42346,-0.00270689040613148,0.00477059358435809,-0.0120572538314733,0.00664347301921037,0.5704442172082
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.00261925106377306,0.00462579514910111,-0.0116858095560112,0.00644730742846511,0.571250950055907
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,-0.00301482176949968,0.00534519129561766,-0.0134913967089103,0.00746175316991092,0.572746596229794
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,-0.00164704511998373,0.00292709271518308,-0.00738414684174256,0.00409005660177511,0.57365548497903
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,40269,0.00217469330518773,0.00386582295493693,-0.00540231968648866,0.00975170629686412,0.573757208323149
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,-0.00352683218521082,0.00641191488871267,-0.0160941853670876,0.009040520996666,0.582300756629844
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40136,0.00444329604345926,0.00808160452759383,-0.0113966488306247,0.0202832409175432,0.582465244437541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,40532,-0.00296521729727423,0.0054300121136808,-0.0136080410400886,0.00767760644554015,0.585022161990422
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,-0.00359170762992179,0.00663510193088113,-0.0165965074144488,0.00941309215460522,0.588298711825689
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,40199,0.0031095282511928,0.00580044634761609,-0.00825934659013474,0.0144784030925203,0.591911121274689
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,42346,0.00473425433911963,0.00883307441855093,-0.0125785715212402,0.0220470801994795,0.591989017623815
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00317889483460127,0.00597778017059896,-0.0085375542997727,0.0148953439689752,0.594885647801052
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,42679,-0.00436085005280752,0.00825391481859106,-0.020538523097246,0.011816822991631,0.597274027070661
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42794,-0.00123503262192606,0.00234375051324245,-0.00582878362788126,0.00335871838402915,0.59823889381954
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,42689,-0.00163900952302415,0.00311345960393749,-0.00774139034674164,0.00446337130069333,0.598600139434539
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,40080,-0.00206990035214643,0.00394052029746132,-0.00979332013517063,0.00565351943087776,0.599395049881174
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,40182,0.00365873065011447,0.00697341937298517,-0.0100091713209365,0.0173266326211654,0.599824525534301
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,0.00241798908687848,0.0046496768748722,-0.00669537758787103,0.011531355761628,0.603050250398299
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,42346,-0.00470212862087824,0.00907784414506001,-0.0224947031451959,0.0130904459034394,0.604481942394864
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,42595,-0.00702163111887794,0.0135567793260258,-0.0335929185978885,0.0195496563601326,0.604506992796985
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,-0.00335450147982506,0.00652028119622576,-0.0161342526244275,0.00942524966477742,0.606932334427854
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,42322,-0.00452498601344607,0.00885687649350727,-0.0218844639407203,0.0128344919138282,0.609429054686539
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40449,0.00245131716934579,0.0048208862656339,-0.00699761991129664,0.0119002542499882,0.611127757258763
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRN1,Neuritin,40482,-0.0019082740534017,0.00376532517284892,-0.00928831139218557,0.00547176328538218,0.612303703416424
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,40461,0.00123830824147921,0.00247679572019667,-0.00361621137010626,0.00609282785306467,0.617110319336405
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,42370,0.00146857394805278,0.0029471446960226,-0.00430782965615151,0.00724497755225707,0.618278116536577
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,0.00283408316038791,0.00569305872683707,-0.00832431194421274,0.0139924782649886,0.61862529722202
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,40302,-0.00365356343263627,0.00733973083156086,-0.0180394358624955,0.010732308997223,0.618649715267175
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40136,0.00467452692638639,0.00942184849626751,-0.0137922961262979,0.0231413499790707,0.619807775453617
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,40080,-0.00392676038076688,0.00796987316260154,-0.0195477117794659,0.0116941910179321,0.622234171298643
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,-0.00361761559871435,0.00738041333452905,-0.0180832257343913,0.0108479945369626,0.624027383135936
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00219445720005147,0.0045106375896656,-0.011035306875796,0.0066463924756931,0.62661736270893
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,40199,-0.00188480575937322,0.0038807013280922,-0.00949098036243393,0.00572136884368749,0.627198849427768
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,42679,-0.00139314116904508,0.0028914160291987,-0.00706031658627452,0.00427403424818437,0.629941861308972
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,0.00193631766634729,0.00402417999145575,-0.00595107511690598,0.00982371044960057,0.630404793595677
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42679,-0.0013581575068019,0.00283547317656351,-0.00691568493286638,0.00419936991926257,0.631954962059066
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40136,0.00254782369542271,0.00532742639678599,-0.00789393204227784,0.0129895794331233,0.632484235403957
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,-0.00185457696605091,0.00390273022552606,-0.00950392820808199,0.00579477427598017,0.634653700513992
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,-0.00324533731463349,0.00689067632484698,-0.0167510629113336,0.0102603882820666,0.637666312957842
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,40199,0.00228600118990241,0.00485378910071731,-0.00722742544750352,0.0117994278273083,0.63766970788076
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,-0.00427964099807648,0.00911200215954621,-0.022139165230787,0.0135798832346341,0.638599636400539
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,42370,0.00210551802101115,0.00450627418333306,-0.00672677937832165,0.010937815420344,0.640334877555815
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,42311,-0.00222933323963813,0.00488945429497704,-0.0118126636577931,0.00735399717851686,0.648435459182396
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,40283,0.00392274608946586,0.00860759235359651,-0.0129481349235833,0.020793627102515,0.64859239942035
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,0.00399418715161285,0.00876695964949029,-0.0131890537613881,0.0211774280646138,0.648689984250469
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40182,-0.00141489833437025,0.00311445019416486,-0.00751922071493336,0.00468942404619287,0.649621055311262
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40199,0.0019336910316569,0.00425880267171379,-0.00641356220490213,0.0102809442682159,0.649804890030452
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,40429,-0.00248824882788088,0.00552821524251938,-0.0133235507032189,0.00834705304745711,0.652647132350352
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,42711,0.00146905948665082,0.00329345915377239,-0.00498612045474306,0.0079242394280447,0.655565634968053
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,40516,-0.000674304724688585,0.00152014979098715,-0.00365379831502339,0.00230518886564622,0.657356323515769
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,40083,-0.00399992739085029,0.0090978691202958,-0.0218317508666301,0.0138318960849295,0.660195426506501
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40199,0.00134244760871051,0.00306518371069269,-0.00466531246424716,0.00735020768166818,0.661419204561908
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESPL1,Separin,40080,0.00261120379809739,0.00596238138404344,-0.00907506371462776,0.0142974713108225,0.661433787274054
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41948,-0.00132326873620806,0.00302549432277629,-0.0072532376088496,0.00460670013643348,0.661848457321694
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42495,0.00211824338805744,0.00487411341238817,-0.00743501890022337,0.0116715056763382,0.663866741468269
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,40080,0.00426563437447656,0.00982335025461843,-0.0149881321245756,0.0235194008735287,0.664127006027717
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,40223,-0.00384425774753793,0.00887137027592432,-0.0212321434883496,0.0135436279932737,0.664781321376061
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,42651,0.0015627111485786,0.00361601666691677,-0.00552468151857827,0.00865010381573547,0.665629363269624
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.00429811201068029,0.00997947973216363,-0.0152616682643604,0.023857892285721,0.66669868277793
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.00188760564707041,0.00440119725592606,-0.00673874097454468,0.0105139522686855,0.668015615598556
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40449,-0.00113816619136736,0.00265580420890656,-0.00634354244082421,0.0040672100580895,0.668253103425236
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00225022082916673,0.00536406856596372,-0.0127637952184556,0.00826335356012216,0.674859764170075
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40116,-0.00415357176792479,0.00990605725399089,-0.0235694439857469,0.0152623004498973,0.67500794876684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,42357,0.00119310961396159,0.0028496405513063,-0.00439218586659875,0.00677840509452193,0.675451174712891
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,0.00285515417528927,0.00684078131704054,-0.0105527772061102,0.0162630855566887,0.676414178467421
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,-0.00260183891214895,0.00624297309050686,-0.0148380661695424,0.00963438834524448,0.676858598195052
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,-0.00187961292590211,0.00456613910623976,-0.010829245574132,0.00707001972232782,0.680610115829302
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00246760463845745,0.00600225032107265,-0.00929680599084494,0.0142320152677598,0.680997587049286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,40302,0.00239562278260024,0.00582782929300503,-0.00902692263168961,0.0138181681968901,0.681032031307688
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,40116,-0.00194646303087183,0.00477814735071334,-0.01131163183827,0.00741870577652632,0.683745909442849
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,40059,-0.00209635777118417,0.00515010453268023,-0.0121905626552374,0.00799784711286909,0.683978182915271
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPGN,Epigen,40451,-0.00190361683630556,0.00471290615990791,-0.0111409129097251,0.00733367923711395,0.686282376426467
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,-0.00153531003401334,0.00381713652961509,-0.00901689763205891,0.00594627756403224,0.68753345340467
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40511,0.00162615666004617,0.00408371049776363,-0.00637791591557054,0.00963022923566288,0.690486101176416
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,-0.00116483766093238,0.00294748428748826,-0.00694190686440938,0.00461223154254462,0.692704987688258
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,40283,0.00142470163722434,0.00361363596342782,-0.0056580248510942,0.00850742812554287,0.693398813873048
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,40302,-0.00703777421309865,0.0178972709219123,-0.0421164252200468,0.0280408767938495,0.694155907452595
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,40482,0.00646407119439509,0.0165532245933935,-0.0259802490086561,0.0389083913974463,0.696172572158153
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00203485014029876,0.00524009418163334,-0.00823573445570259,0.0123054347363001,0.69778446439365
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,40199,-0.00169247524769041,0.00437885497058253,-0.0102750309900322,0.00689008049465134,0.699125792057721
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42594,-0.00190236528170466,0.00492641909214806,-0.0115581467023149,0.00775341613890553,0.699387420588587
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,40116,0.00292849429303973,0.00762530808401692,-0.0120171095516334,0.0178740981377129,0.700949378224514
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40116,0.00137693664399102,0.00359518513198872,-0.00566962621470686,0.0084234995026889,0.701731189961386
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40136,-0.00332547607106011,0.00871810760466075,-0.0204129669761952,0.013762014834075,0.702880693094441
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,-0.0068871505226165,0.0181327000569271,-0.0424272426341937,0.0286529415889607,0.704086677035088
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,0.00336033088993327,0.00887435372021809,-0.0140334024016942,0.0207540641815607,0.704949222856312
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.00201738990700112,0.00538259221282302,-0.00853249083013201,0.0125672706441342,0.707817272592208
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,40199,-0.00124393855456627,0.00332674177953265,-0.00776435244245026,0.00527647533331772,0.708470308634984
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,42370,0.00247719579409735,0.00663323135009737,-0.0105239376520935,0.0154783292402882,0.708817816204734
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,40527,0.00167015662493646,0.00447830541409423,-0.00710732198668822,0.0104476352365611,0.709197182731382
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,-0.00191613443315677,0.0052169214394481,-0.012141300454475,0.00830903158816151,0.713408191937975
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,42370,0.00242738764112309,0.00672355944314389,-0.0107507888674389,0.0156055641496851,0.718084923979165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,40116,-0.00174449588914722,0.00490183014022024,-0.0113520829639789,0.00786309118568445,0.721932330109506
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,42711,-0.00109051576885812,0.00311402724361339,-0.00719400916634037,0.00501297762862414,0.726198056801855
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,42311,-0.00208725411252332,0.00600281304313617,-0.0138527676770702,0.00967825945202358,0.728061564497591
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,42357,-0.00219194068368313,0.00636874332124149,-0.0146746775933164,0.0102907962259502,0.730722724470151
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40302,-0.00283268691420488,0.00827851528352145,-0.0190585768699069,0.0133932030414972,0.732226949055756
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,42594,-0.0032700694074997,0.0095704169738829,-0.0220280866763102,0.0154879478613108,0.732593202996074
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42346,-0.00158648000106311,0.00465235528665015,-0.0107050963628974,0.00753213636077118,0.733104684452011
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,42370,0.00327020753292517,0.00963572420913995,-0.0156158119169891,0.0221562269828395,0.734326120975235
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,40116,0.00157202717077597,0.00469631851899436,-0.00763275712645297,0.0107768114680049,0.737830622910332
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,0.00212142370540714,0.00634756747115932,-0.0103198085380651,0.0145626559488794,0.738227137294401
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42346,-0.00198380750124911,0.00594935257680515,-0.0136445385517872,0.00967692354928899,0.738800463739745
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,0.00130038135221743,0.00390801326714661,-0.00635932465138992,0.00896008735582478,0.739331333644749
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,40116,-0.00246472490692463,0.00741454218471958,-0.016997227588975,0.0120677777751257,0.739580270025221
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,40080,0.00139458089491253,0.00424395437361582,-0.00692356967737449,0.00971273146719954,0.74246125376322
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42689,0.00120271203281127,0.00370866440959378,-0.00606627020999253,0.00847169427561507,0.745717545191779
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,42311,-0.00106136143471295,0.00333832276514826,-0.00760447405440355,0.00548175118497764,0.75054117031177
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.00116262428432683,0.0036582915556444,-0.00600762716473618,0.00833287573338985,0.750638693325399
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,-0.00177369253952703,0.00558520387093049,-0.0127206921265508,0.00917330704749673,0.750817281920307
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42475,-0.00130569601521211,0.00416549544648621,-0.00947006709032509,0.00685867505990087,0.753939809786225
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,42611,-0.000793675372994355,0.00253512075914816,-0.00576251206092474,0.00417516131493603,0.754230813511488
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40483,-0.00088353292648519,0.00282241911346289,-0.00641547438887245,0.00464840853590207,0.754255289084778
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,40080,-0.00149691965708128,0.00478811969290569,-0.0108816342551764,0.00788779494101387,0.754566216798563
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,42247,0.00214714049936507,0.00687675757210907,-0.0113313043419687,0.0156255853406988,0.75486956322563
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00152354760921447,0.00489576490791696,-0.0111192468287317,0.00807215161030277,0.755655622564922
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,40302,0.000979592307904667,0.00316890636342717,-0.00523146416441259,0.00719064878022193,0.757231249453186
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,0.000860099313099782,0.0028354783079091,-0.00469743817040205,0.00641763679660161,0.761639349838555
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,42679,0.00088355782086127,0.00291317718197408,-0.00482626945580792,0.00659338509753046,0.761668231693954
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,40036,-0.00109347162160747,0.00362389450411042,-0.00819630484966389,0.00600936160644896,0.762856545399016
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40483,-0.00124478689750796,0.00412857137974815,-0.00933678680181432,0.00684721300679841,0.763034624960108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,42782,0.0014125226046516,0.00469791964174649,-0.00779539989317152,0.0106204451024747,0.763670892564535
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,42114,-0.00151161042820239,0.0050332974800583,-0.0113768734891167,0.00835365263271188,0.763936315576103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00113383120341512,0.0038170139163461,-0.00634751607262323,0.00861517847945346,0.766436507631158
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,-0.0017053986347838,0.00584303413703482,-0.013157745543372,0.00974694827380444,0.770391637860879
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.00122715231429715,0.00421711090343675,-0.00703838505643887,0.00949268968503318,0.771060809516536
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,40116,0.00153180502373565,0.00534435700493078,-0.00894313470592868,0.0120067447534,0.774407959048697
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,-0.000553899312696071,0.00193791352309532,-0.00435220981796289,0.00324441119257075,0.775019282754492
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,40451,-0.00228285261140458,0.00803054907464211,-0.0180227287977031,0.013457023574894,0.776207899305858
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42611,0.00100606962826477,0.00354380690672348,-0.00593979190891326,0.0079519311654428,0.776495106511639
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40281,0.00159364748964577,0.00564357388415956,-0.00946775732330698,0.0126550523025985,0.777655369179421
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,40302,-0.0017995962250267,0.00638373919999353,-0.014311725057014,0.0107125326069606,0.778023021422958
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00164965995232871,0.00593490330052286,-0.0099827505166961,0.0132820704213535,0.781049072109824
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,40080,-0.00213477127666954,0.00774233153091522,-0.0173097410772634,0.0130401985239243,0.782762847859213
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,40539,-0.00206481514088799,0.00751518479649956,-0.0167945773420271,0.0126649470602512,0.783511464974445
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40302,-0.00200265699538178,0.00733401953843759,-0.0163773352907194,0.0123720212999559,0.784809065756337
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.000957829569840056,0.00352632317283175,-0.00786942298859028,0.00595376384891016,0.785916332862367
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.00512562184087926,0.0188844291605134,-0.0318878593137269,0.0421391029954855,0.78607179956457
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,-0.00162640492800078,0.00601916012227088,-0.0134239587676517,0.0101711489116501,0.78700792754724
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,40199,-0.000811360224286038,0.003016119499032,-0.00672295444238876,0.00510023399381668,0.78792858202762
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,42594,-0.00156539247276496,0.00583232602383956,-0.0129967514794905,0.00986596653396059,0.788396076816803
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,40482,-0.00132610803847805,0.00495977551633068,-0.0110472680504862,0.00839505197353009,0.789187184174186
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,40302,0.00150182084514097,0.00563928539050981,-0.00955117852025826,0.0125548202105402,0.790002308156826
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.000824923120582572,0.00310558129544177,-0.00526201621848329,0.00691186245964843,0.79053209532222
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,-0.00196591238400598,0.00742531073019417,-0.0165195214151866,0.0125876966471746,0.791200655756978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.0010090023876986,0.00384177423621132,-0.0085388798906728,0.00652087511527559,0.792833099837817
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.00180643155745868,0.00723834109885763,-0.0123807169963023,0.0159935801112196,0.802928075660885
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40482,0.000916626009356698,0.00372761928142877,-0.0063895077822437,0.0082227598009571,0.805763195050987
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40116,-0.000957460608794404,0.00391517197346521,-0.00863119767678621,0.0067162764591974,0.806808427872916
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,-0.00319922843521531,0.0130925538853787,-0.0288606340505575,0.0224621771801269,0.806959854050743
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.000702071294799619,0.0029571253682916,-0.00649803701665115,0.00509389442705192,0.812337733619872
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,-0.00192236029694648,0.00813640376395337,-0.0178697116742951,0.0140249910804021,0.813230221389165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,40080,-0.00150477695776864,0.00640523839643403,-0.0140590442147793,0.0110494902992421,0.814268173679181
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40511,0.000886704523101441,0.00382580935889039,-0.00661188182032373,0.00838529086652661,0.816721522021895
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,-0.000649281514442427,0.00281289831416624,-0.00616256221020826,0.0048639991813234,0.817456526730012
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,0.000907097421887482,0.00409141675001533,-0.00711207940814257,0.00892627425191754,0.824545653850573
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,0.000937449130049408,0.00424426834408803,-0.00738131682436312,0.00925621508446194,0.82519453555468
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40199,-0.0011039329442177,0.0050759479420253,-0.0110527909105873,0.00884492502215189,0.827835900243949
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,42311,-0.000651224525555591,0.00300911210572268,-0.00654908425277204,0.00524663520166086,0.828665690233048
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,40009,-0.000879652261913584,0.00406553121613654,-0.00884809344554121,0.00708878892171404,0.828704719470751
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,42370,0.00110912550039247,0.00519938160282621,-0.00908166244114691,0.0112999134419318,0.831081662710404
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,0.00114215796885865,0.00535752817027891,-0.00935859724488801,0.0116429131826053,0.831184807799361
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.000964288116827948,0.00454770659713494,-0.00987779304721242,0.00794921681355653,0.83208102069183
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.000833149878434755,0.00393463959336063,-0.00854504348142159,0.00687874372455208,0.832308015735794
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,42587,0.000418209030557551,0.00199353734133779,-0.00348912415846453,0.00432554221957963,0.833840707902732
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00151028560267188,0.00720357643258986,-0.015629295410548,0.0126087242052042,0.833938716208653
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.000876976829557333,0.00422462731775833,-0.00915724637236366,0.00740329271324899,0.83555548891963
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,40080,0.000913661300319357,0.00442068971630647,-0.00775089054364132,0.00957821314428003,0.836264853488754
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40080,0.000551779580741963,0.00271011414834891,-0.00476004415002189,0.00586360331150582,0.838669800655012
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,42474,0.000593617309529445,0.00295796884426372,-0.00520400162522745,0.00639123624428633,0.84094866790113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40482,0.00073428761144178,0.00373496628801997,-0.00658624631307737,0.00805482153596093,0.844145526518637
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,40080,0.00131001548830097,0.00688121294222052,-0.0121771618784512,0.0147971928550532,0.849018315489008
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,0.000622623288710455,0.00328298033941667,-0.00581201817654621,0.00705726475396712,0.849585458594189
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00147422007593152,0.00784229020293981,-0.0138966687218305,0.0168451088736935,0.850893179915228
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,42654,-0.001590355474431,0.00851802661383209,-0.0182856876375419,0.0151049766886799,0.851894996547669
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,-0.00135796057876679,0.00733511482430991,-0.0157347856344142,0.0130188644768806,0.853128697538348
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.00099245600627509,0.00539383170985514,-0.0115643661575912,0.00957945414504099,0.854018199869052
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,-0.00104632611854577,0.00584517306401595,-0.012502865324017,0.0104102130869255,0.857935061867417
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,-0.000883395134991103,0.00497407183170291,-0.0106325759251288,0.00886578565514659,0.859040421534685
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40317,-0.000241364081871764,0.00139467881664523,-0.00297493456249641,0.00249220639875289,0.862606870445532
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40182,0.000900509126749476,0.00523593152434643,-0.00936191666096953,0.0111629349144685,0.863451371195294
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,40136,-0.00101079384927267,0.00591355872842506,-0.0126013689569858,0.0105797812584404,0.864283396321882
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,0.000857880563571417,0.00503595239329601,-0.00901258612728876,0.0107283472544316,0.864737098440197
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,0.00110327681885827,0.00649274869704219,-0.0116225106273444,0.0138290642650609,0.865072685669307
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,-0.00198883557640563,0.0117223961180644,-0.0249647319678119,0.0209870608150006,0.865279208651467
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40080,-0.00111356663903583,0.00656421125770267,-0.0139794207041331,0.0117522874260614,0.865294756810121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42559,-0.000376672984357609,0.00222844069690499,-0.00474441675029138,0.00399107078157616,0.865775724671419
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,42311,-0.000847957484800114,0.0050786646487071,-0.010802140196266,0.00910622522666581,0.867400434338433
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,40284,-0.000520187276812346,0.00320414388741153,-0.00680030929613894,0.00575993474251425,0.871034547940523
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,40516,0.000368689846713706,0.00229184326865253,-0.00412332295984524,0.00486070265327266,0.872198310635706
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,40199,-0.000958059126330092,0.00596759836118148,-0.0126545519142458,0.0107384336615856,0.872455904776311
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,41779,-0.000824044801271008,0.0051531594084677,-0.0109242372418677,0.00927614763932568,0.872954066494064
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLC,Galectin-10,42611,-0.00106990209925979,0.00678955177551137,-0.0143774235792621,0.0122376193807425,0.874789609787005
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,42346,0.00133339261646129,0.00869249011195979,-0.0157038880029799,0.0183706732359025,0.878088406593971
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,-0.00136019977709927,0.00888398046684217,-0.0187728014921099,0.0160524019379114,0.878316189305432
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,40527,0.00142630507014693,0.00933975205340962,-0.0168796089545359,0.0197322190948298,0.878627030379488
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,40080,-0.000482364979747342,0.00323924850296801,-0.00683129204556463,0.00586656208606995,0.881625341675517
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,40483,0.000639120334871369,0.0043813166573732,-0.0079482603135801,0.00922650098332284,0.884023434673272
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40449,-0.000655029780234862,0.00454729791761738,-0.00956773369876493,0.00825767413829521,0.885465039439911
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,40199,-0.000388023945070613,0.00275609671311828,-0.00578997350278243,0.00501392561264121,0.888040400987763
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,40483,0.000326673548798822,0.00233909325845887,-0.00425794923778056,0.0049112963353782,0.88893254738784
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00158328088173315,0.0114163830550351,-0.0207928299061357,0.023959391669602,0.889701642627877
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,40080,-0.000545257053812594,0.00404088623309733,-0.00846539407068335,0.00737487996305817,0.89266574759106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,40080,-0.000585008372929535,0.00438254027481105,-0.0091747873115592,0.00800477056570013,0.893811394398738
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,40527,0.000345714349015885,0.00264181532945535,-0.0048322436967166,0.00552367239474837,0.895886465665705
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40327,-0.000107686721435144,0.000846082283047592,-0.00176600799620842,0.00155063455333814,0.89872354951954
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,39926,-0.000918950322921968,0.00724805416568973,-0.0151251364876738,0.0132872358418299,0.899112312692887
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,40511,0.000394440636434198,0.00312248404631417,-0.00572562809434158,0.00651450936720998,0.899478726933605
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.000790371870162598,0.00637617255137821,-0.0132876700708639,0.0117069263305387,0.901351504638119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,40136,0.00080014206155109,0.00646976716262401,-0.011880601577192,0.0134808857002942,0.901575660678082
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,42638,0.000424212352525404,0.00352104450865248,-0.00647703488443345,0.00732545958948426,0.904105417424693
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40136,0.00052303994399158,0.00448488464234154,-0.00826733395499783,0.00931341384298099,0.907161084911431
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,40080,-0.000470519243430406,0.00427630094191084,-0.00885206908957566,0.00791103060271485,0.912388009593155
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42346,-0.000367348234611082,0.003351385102295,-0.00693606303510928,0.00620136656588712,0.912719662409094
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,42357,-0.000369978584898067,0.00342657178561326,-0.00708605928470006,0.00634610211490393,0.914018443106989
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.000492642946563999,0.00469995939933923,-0.0087192774761409,0.0097045633692689,0.916521390099179
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.000696995111041273,0.00676505712830624,-0.0125625168604389,0.0139565070825215,0.917941759672684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,42370,-0.000500548190534615,0.00488465001087545,-0.0100744622118505,0.00907336583078127,0.918382241720314
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,40080,-0.000505878357693204,0.00495557459638925,-0.0102188045666161,0.00920704785122974,0.918692925204862
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.000578358230091413,0.00582804674110789,-0.0108446133824801,0.0120013298426629,0.920951867533715
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.000288651835300903,0.00306106846382083,-0.00571104235378792,0.00628834602438973,0.924874079730743
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40136,-0.000457189464789039,0.00490334528790216,-0.0100677462290773,0.0091533672994992,0.925714353308706
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,40136,0.000351008246207683,0.00385924745408778,-0.00721311676380436,0.00791513325621973,0.927531990229002
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42346,-0.000474036140968198,0.005382465800279,-0.011023669109515,0.0100755968275786,0.929822029967182
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,42636,-0.000716596664225413,0.00816851484642098,-0.0167268857632105,0.0152936924347597,0.93009522289002
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.000300813410884509,0.00349291132112614,-0.00714691960029175,0.00654529277852273,0.931371427540401
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.000498257958629003,0.00579368641738371,-0.0118538833367011,0.0108573674194431,0.931467857003231
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,40116,-0.0003868947260951,0.00449881618521771,-0.00920457444912181,0.00843078499693161,0.931468606021633
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,42346,0.0014277664244564,0.0172154611462401,-0.0323145374221743,0.0351700702710871,0.933904386551283
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,40515,-0.000880575916502162,0.0113734937625927,-0.0231726236911839,0.0214114718581796,0.938287999278834
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,40136,0.000525507596330657,0.00680645115138264,-0.0128151366603793,0.0138661518530406,0.93846006004579
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.000425870486554467,0.00560270870046534,-0.0114071795394665,0.0105554385663576,0.939411311069724
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BSND,Barttin,40080,0.000253044924034255,0.00353880716707714,-0.00668301712343694,0.00718910697150545,0.942996592712625
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,0.000362321896247875,0.00535020050975569,-0.0101240711028733,0.010848714895369,0.946008825499317
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40302,0.00029962383316817,0.00449964674142646,-0.0085196837800277,0.00911893144636404,0.946910657631725
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,42495,-0.000213606015786779,0.003485666527095,-0.00704551240889297,0.00661830037731942,0.951136140613902
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00048773520529677,0.00834851381096317,-0.0168508222747846,0.0158753518641911,0.953413701308767
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,40136,-0.000536022648662959,0.00944201688250273,-0.0190423757383683,0.0179703304410424,0.954729503293652
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.000148047465326461,0.00274460187185157,-0.00523137220350261,0.00552746713415554,0.956982902632163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,42346,0.000159801753038616,0.00328329016737537,-0.0062754469750171,0.00659505048109433,0.961182047203643
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,42311,0.000266580327569434,0.00548660221672826,-0.010487160017218,0.0110203206723568,0.96124876533877
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,40199,-0.000177400303640992,0.00429917182536674,-0.0086037770813598,0.00824897647407782,0.967086314991995
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00030215768539244,0.00738483378767543,-0.0147764319092363,0.0141721165384514,0.967363627250081
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,40136,0.000399828033707649,0.0101121285354439,-0.0194199438957624,0.0202195999631777,0.968461020287476
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,40482,0.000145809459390547,0.00376215840114869,-0.00722802100686088,0.00751963992564197,0.969084922344823
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,40116,0.000141614796981606,0.00397905764884018,-0.00765733819474515,0.00794056778870836,0.971609905403736
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,40065,-0.000288327310584646,0.00836760954383677,-0.0166888420165047,0.0161121873953354,0.972512926350632
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40080,0.000192540601887184,0.00575882524725024,-0.0110947568827233,0.0114798380864977,0.973329104358353
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.000271700489825691,0.00926784811148868,-0.0178932818086921,0.0184366827883435,0.976612636690196
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.000110727435815976,0.00494402655734488,-0.00980101948821194,0.00957956461657998,0.982132317476645
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.000167760592836215,0.00793576010793276,-0.015386329218712,0.0157218504043844,0.98313448960292
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,40080,-9.17551479307598e-05,0.00464950173390072,-0.00920477854637617,0.00902126825051465,0.984255606970607
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40302,-0.000117018524104057,0.00681814183179179,-0.013480576514416,0.0132465394662078,0.986307033377716
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,-5.85506376695501e-05,0.00383588195617635,-0.00757687927177519,0.00745977799643609,0.987821894080535
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,5.16468360366914e-05,0.00432211217803607,-0.008419693032914,0.00852298670498738,0.990466166876442
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,40080,7.82993636525303e-05,0.00690999790809913,-0.0134652965362218,0.0136218952635268,0.990959319741662
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-3.87578166285894e-05,0.00358543323350259,-0.00706620695429367,0.00698869132103649,0.991375393427161
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,40136,2.3284852550731e-05,0.00521944240286387,-0.0102068222570624,0.0102533919621639,0.996440589470592
